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Periplasmic binding proteins (PBPs) form a superfamily of bacterial proteins with a conserved 
bilobal structure, which are involved in substrate scavenging for bacterial cells. A wide variety of 
natural ligand-binding domains has evolved. PBPs are composed of two domains connected by a hinge 
region, which form a binding pocket between the two domains. They can be found in two stable 
conformations; in absence of ligand the PBP adopts an open conformation, where the binding pocket 
is exposed. In presence of the ligand, the protein changes to the closed conformation where the ligand 
is buried in the middle of the protein. This project focused on the ribose-binding protein of Escherichia 
coli (RbsB). Ribose binding to RbsB stabilizes the closed state. RbsB-bound ribose is presented to a 
cytoplasmic transport channels (RbsAC), from where it is imported into the cell, or interacts to 
membrane receptors (i.e., Trg) and can elicit a chemotactic signal. 
Due to their unique ligand-binding characteristics and wide variety of natural binding pockets 
PBPs have been of interest for the development of biosensors and bioreporter systems. PBP 
bioreporters were initiated over 20 years ago by a development in the group of Hazelbauer, who fused 
the C-terminal part of the E. coli EnvZ osmoregulation histidine kinase to the N-terminal part of the Trg 
methyl-accepting chemotaxis receptor protein, creating a hybrid receptor Trz1. Ligand bound 
galactose-binding protein (GBP) and ribose-bound RbsB interact with Trz1, which eventually leads to 
phosphorylation of the response regulator OmpR, activating transcription from the ompC promotor 
(and any reporter gene fused to this). In 2003, Hellinga’s group proposed that based on crystal 
structure information of ligand-bound PBPs variants with new ligand recognition specificities could be 
designed by computational approaches. Notably, they claimed the design of a RbsB-variant with nM 
affinity for recognition of 2,4,6-trinitrotoluene (TNT). This idea inspired the scientific community, 
because it could easily extend PBP-binding to a tremendous variety of compounds, including non-
natural molecules, and would thus permit a wide variety of biosensor and bioreporter systems based 
on RbsB/GBP and Trz1. Unfortunately, independent engineering of some of the most promising 
published mutants failed to reproduce the reported in vivo and in vitro results. These studies further 
concluded that the published variants were actually misfolded proteins and/or impaired in stability as 
result of the introduced ligand-pocket mutations. This fact was largely ignored by Hellinga’s 
publications. 
Still inspired by the concept and trying to understand the reason of such limited success, our 
group raised the hypothesis that changing from ribose to TNT in a single step was likely unfeasible, but 
– given the wide range of naturally evolved PBP ligand binding pockets, a step by step change of ribose 
binding to a non-natural analogue should be possible. To test this, we selected compounds with 
distinct differences but still chemically similar to ribose: 1,3-cyclohexanediol (13CHD) and cyclohexanol 
(CH). Mutant ligand binding pockets that might accommodate 13CHD and/or CH were computationally 
simulated and calculated using Rosetta, from which a list of critical amino acid residues to mutate in 
RbsB was selected. These were then synthesized and cloned into E. coli; a resulting set of 2 million 
mutants containing one of five possible substitutions at each of 9 selected critical amino acid positions. 
The library was introduced into an E. coli bioreporter strain, which carries the Trz1 hybrid signaling 
pathway coupled to GFP production when the (new) ligand would bind the (mutant) RbsB. The main 
goals of this work were to screen and characterize mutants from this first library, and potentially 
improve mutants for the new ligand binding in further rounds of mutagenesis. 
In the first part of this work a precise and user-friendly high-throughput strategy to screen the 
mutant library was developed. Clones were grown as individual microcolonies in alginate beads, to 
reduce single cell GFP expression variability, which were screened by fluorescence activated cell 
sorting (FACS) for gain-of-function GFP expression in presence of 13CHD. Six mutants with modest (1.5-
fold) but consistent induction with 1 mM 13CHD were isolated. Moreover, these mutants completely 
lost the capacity to react to ribose. The RbsB mutants were characterized in terms of periplasmic 
space abundance, stability, secondary structure and ligand affinity. Isothermal microcalorimetry 
confirmed 13CHD binding, although only two mutants were sufficiently stable upon 
purification. Circular dichroism and quantification of periplasmic space abundance suggested the 
mutants to be prone to misfolding and/or defects in translocation.  
In the second part of this work, we used random and semi-random mutagenesis to improve 
the affinity and/or stability of the six isolated mutants with 13CHD binding capacity. Several mutant 
libraries were produced and screened with the previous described strategy. Variants displaying higher 
expression levels of GFP in presence of 13CHD were collected by FACS, and were used as starting point 
for the next round of evolution. This mutagenesis and rigorous screening strategy allowed us to isolate 
7 mutants with improved (3.2-fold) GFP induction in presence of 13CHD and in a concentration-
dependent manner.  Several variants were observed that displayed open and closed conformations 
simultaneously, suggesting they were impaired in transition dynamics. Moreover, our screening 
strategy largely ignores potential variants with improved binding and closed conformation stability, 
but that are unable to interact with Trz1 receptor (e.i., trigger the signaling cascade). 
Finally in the third part of this work, we developed and tested an in vivo system to characterize 






proteins were fused to mCherry reporter protein to study protein abundance and subcellular 
localization. Whereas RbsB-mCherry proteins clearly localized to the periplasmic space and centered 
in polar regions depending on chemoreceptor availability, mutant-RbsB-mCherry expression resulted 
in high proportions of cells devoid of clear foci and low proportions of cells with multiple fluorescent 
foci, suggesting poorer translocation and mislocalisation. In addition, polar foci of mutants were less 
fluorescent, suggesting poorer chemoreceptor binding. By spiking further derivative mutant libraries 
generated by error-prone PCR without or with different proportions of E. coli expressing wild-type 
RbsB-mCherry we could estimate the potential improvement and deterioration of mutants with wild-
type-like periplasmic localisation. The in vivo translocation system may thus be used to detect mutants 
with better signal transduction capacity. 
 
In conclusion, we firmly showed that design of PBP receptor proteins with new binding 
capacities for non-natural compounds is feasible, but still largely a matter of trial and error. The 
combination of computational simulations, random mutagenesis and rigorous screening allowed us to 
isolate variants with new recognition for 13CHD and loss of ribose binding. However, our results also 
showed that most predicted ligand-binding pocket mutations lead to poorly folding and functioning 
proteins, and it is likely that the dynamic transition needed between open and closed conformations 
of (here) RbsB is insufficiently understood and currently predictable to allow rational expansion to a 





























Les protéines de liaison périplasmiques (PLP) constituent une superfamille de protéines 
bactériennes avec une structure bilobée. Elles sont impliquées dans la captation de substrats pour les 
cellules bactériennes, et montrent grande diversité de domaines de liaison à des composés naturels. 
Les PLP sont composées de deux domaines connectés par une région charnière, ce qui forme une 
poche de liaison au substrat entre les deux domaines. Les PLP montrent deux états stables : ouverte 
en l’absence de ligand, conformation dans laquelle la poche de liaison est exposée, et fermée quand 
le ligand est séquestré dans la poche de liaison. Ce projet a porté sur l’étude de la PLP RbsB liant le 
ribose chez Escherichia coli. La liaison du ribose stabilise l’état fermé de RbsB et permet l’interaction 
avec le transporteur cytoplasmique RbsAC et son passage dans le cytoplasme de la cellule, ou son 
interaction avec des récepteurs membranaires tels que Trg permettant en une réponse 
chimiotactique. 
Étant données leurs caractéristiques uniques de liaison aux ligands et la grande variété de 
poches de liaison naturellement observée chez les PLP, elles présentent un grand intérêt pour le 
développement de biosenseurs et de systèmes biorapporteurs. Les premiers biorapporteurs basés sur 
des PLP ont été développés 20 ans auparavant par le groupe de Hazelbauer. Cette équipe a fusionné 
la partie C-terminale de la protéine kinase à histidine impliquée dans l’osmorégulation (EnvZ) et 
l’extrémité N-terminale du récepteur chimiotactique accepteur de groupement méthyle (Trg), pour 
créer le récepteur hybride Trz1. Les PLP liant le galactose (GBP) et le ribose (RbsB) interagissent avec 
Trz1, ce qui entraine la phosphorylation du régulateur réponse OmpR qui lui-même va activer la 
transcription à partir du promoteur du gène ompC (ou n’importe quel système rapporteur placé en 
aval de ce promoteur). En 2003, le groupe de Hellinga proposait que, sur la base de la structure 
cristallographique de différents PLP liées à leur ligand, des variants reconnaissant de nouveaux ligands 
pourraient être générés sur la base d’une approche informatique. En particulier, cette équipe se targue 
d’avoir générer un variant de RbsB permettant de lier le 2,4,6-trinitrotoluène (TNT) avec une affinité 
de l’ordre du nanomolaire. Cette idée a inspiré la communauté scientifique car cette approche pourrait 
s’étendre à une diversité incroyable de composés naturels ou non, ce qui permettrait le 
développement de biosenseurs et biorapporteurs variés basés sur ce système. Malheureusement, la 
construction des mutants les plus prometteurs par des équipes indépendantes n’ont pas permis de 
rapporter de l’activité in vivo et/ou in vitro. Cela a été ignoré dans les publications du groupe Hellinga. 
Inspirés par ce concept et voulant savoir quelles étaient les raisons de ce succès quelque peu 
limité, notre groupe a émis l’hypothèse que le changement de spécificité de RbsB du ribose au TNT en 
viii 
 
une étape était probablement infaisable mais, étant donnée la grande diversité de poches de liaisons 
naturellement observées chez les LPL, un changement pas à pas du ribose vers un composé analogue 
non naturel devrait être possible. Pour tester cela, nous avons sélectionné des composés distincts du 
ribose mais présentant tout de même des similarités : 1,3-cyclohexanediol (13CHD) and cyclohexanol 
(CH). Des mutants qui pourraient accueillir le 13CHD et/ou CH ont été générés par simulation 
informatique en utilisant le programme Rosetta, lequel a fourni une liste d’acides aminés critiques à 
muter. Une librairie de mutant a été synthétisée, celle-ci contenant 2 millions de variants de RbsB avec 
1 substition parmi 5 possibles à 9 positions sélectionnées pour leur aspect critique dans la 
reconnaissance du substrat. La librairie a été introduite et criblée chez une souche reportrice d’E. coli 
contenant la chaine de signalisation hybride Trz1 couplée à la production de la protéine fluorescente 
verte (GFP) lorsque le (nouveau) ligand se liera à la protéine RbsB (sauvage ou mutante). Le but 
principal de ce travail était de caractériser cette librairie de mutants, et éventuellement d’améliorer la 
capacité de ces mutants à lier un autre composant par des cycles de mutagénèses additionnels. 
 
Dans la première partie de ce travail, une stratégie simple et efficace pour cribler la librairie 
de mutant a été développée. Les différents clones/variants ont été cultivés individuellement en 
microcolonies dans des billes d’alginate afin de réduire la variabilité du signal GFP observé au niveau 
de la cellule unique. Les billes ont été analysées par trieur de cellules reposant sur la fluorescence 
(FACS) afin de détecter des mutants présentant une activité GFP accrue en présence de 13CHD. Six 
mutants ont été isolés pour leur modeste mais significative induction (1,5 fois) en présence de 1 mM 
de 13CHD. De plus, ces mutants avaient totalement perdu leur capacité à réagir au ribose. Les mutants 
RbsB ont été caractérisés plus en détails pour leur localisation dans périplasme, leur stabilité, leur 
abondance et leur affinité pour le ligand. La technique de microcalorimétrie isotherme a confirmé que 
ces mutants lient le 13CHD, bien que seulement 2 de ces protéines mutantes se soient révélées 
suffisamment stables après purification. L’analyse par dichroïsme circulaire et la quantification de 
l’abondance des protéines dans l’espace périplasmique suggèrent que les protéines mutantes sont 
sujettes à un mauvais repliement et/ou un problème dans la translocation du cytoplasme au 
périplasme. 
 
Dans une seconde partie, nous avons muté les six mutants isolés précédemment de façon 
aléatoire ou semi-aléatoire afin d’améliorer leur affinité pour le 13CHD et/ou leur stabilité. Plusieurs 
librairies de mutants ont été produites et analysées selon la méthode décrite plus tôt. Les variants 
montrant une plus forte expression du système rapporteur GFP en présence de 13CHD ont été isolés 





l’analyse rigoureuse des librairies nous ont permis d’isoler 7 mutants avec une augmentation de 3,2 
fois du signal GFP en présence de 13CHD, et d’une façon dose-dépendante. Plusieurs variants ont 
montré qu’ils adoptaient la conformation ouverte et fermées au sein de la population bactérienne. 
Cette dernière observation suggère que ces mutants sont affectés dans leur capacité à passer d’une 
conformation à l’autre. De plus, notre stratégie de crible ne tient pas compte les variants qui 
montreraient une liaison accrue et une bonne stabilité de la conformation fermée, mais qui seraient 
incapables d’interagir avec le récepteur Trz1 (et donc de déclencher la cascade de signalisation du 
rapporteur). 
 
Finalement, dans la troisième partie de ce travail, nous avons développé et testé un système 
in vivo permettant de caractériser la qualité du processus de translocation dans l’espace périplasmique 
et l’interaction avec les récepteurs. Les protéines RbsB sauvage et mutantes ont été fusionnées à la 
protéine fluorescente rouge mCherry afin de visualiser l’abondance et la localisation sub-cellulaire des 
protéines au niveau de la cellule unique en utilisant la microscopy à épifluorescence et le traitement 
des images obtenues. Alors que la protéine de fusion RbsB sauvage montre une localisation 
périplasmique centrées au niveau des pôles de la cellule dépendamment de la disponibilité des 
chimiorécepteurs, les fusions avec les variants de RbsB montraient une forte proportion de cellules 
dépourvues de foci, et une faible proportion de cellules avec de multiples foci, suggérant une plus 
faible liaison aux chimiorécepteurs. En analysant plus en détails des librairies de mutants générées par 
PCR mutagène, en mélangeant ou non avec des cellules contenant la protéine de fusion RbsB sauvage, 
nous avons pu estimer l’amélioration potentielle ou la détérioration des qualités des mutants RbsB par 
rapport au sauvage en terme de localisation périplasmique. Ce système de translocation in vivo 
pourrait être utilisé afin de détecter des mutants permettant une meilleure transduction du signal. 
En conclusion, nous avons montré que la conception de protéines réceptrices PLP présentant 
de nouvelles capacités de liaison pour des composés non naturels est bien faisable, mais repose encore 
sur une stratégie d’essais et erreurs. La combinaison de simulations informatiques, de mutagénèses 
aléatoires et de crible rigoureux nous a permis d’isoler des variants de RbsB avec une capacité à 
reconnaitre le 13CHD, tout en ne liant plus le ribose. Néanmoins, nos résultats ont également montré 
que la plupart des prédictions de mutations au niveau de la poche de liaison ont mené à un mauvais 
repliement ou fonctionnement des protéines. Il est très probable que la dynamique de transition entre 
la conformation ouverte et fermée (de RbsB pour cette étude) ne soit pas encore assez bien comprise, 
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Biosensors based on whole cell living bacteria or their isolated components mostly use the 
capacity of natural protein classes to ‘sense’, in other words to interact with, chemical ligands. 
Frequently deployed sensor protein classes consist of transcription regulators, two-component 
sensory proteins, methyl-accepting chemoreceptors and periplasmic binding proteins. All classes have 
been linked to some form of transducer and sensor output upon binding of the ligand, such as by de 
novo synthesis of reporter proteins, through Föster resonance energy transfer, from cell accumulation 
from chemotaxis, or in dye-encapsulating competitive liposome assays. Despite the partially successful 
deployment of such biosensors, one of their current limitations is the covered spectrum of chemical 
ligands, which in most cases reflects the cognate ligand of the used sensory protein. Here we will 
summarize some of the past and recent efforts to obtain new ligand-binding specificities in these 
sensory protein classes. Most strategies have followed combinations of random mutagenesis, 
selection and screening methodologies, and protein-structure guided predictions. They have led to 
some success of obtaining new specificities, but which not unexpectedly lay relatively close to the 
original ligand. Computational structure-function predictions have become more important to reduce 
the mutagenesis efforts to smaller library sizes, but their success has been limited so far to those 
sensory proteins that do not undergo major conformational changes upon ligand-binding. In particular 
for the class of periplasmic binding proteins, new ligand-binding specificities have been notoriously 
difficult to predict, likely as a result of the current limitations in dynamic structure predictions. It is to 
be expected that future advances in computational algorithms will facilitate this process, which will 
make it more straightforward to obtain sensory proteins with targeted ligand-binding properties, 
enabling plug-and-play biosensor design. 
 
Key words: 
Bioreporters, Transcription Regulators, Periplasmic binding proteins, Methylaccepting chemotaxis 




Introduction: What are bioreporters 
Bioreporters are engineered living micro-organisms, which contain a synthetic genetic circuit 
that enables the cell to sense one or more input signals or conditions, execute the instructions imposed 
by the circuit and produce one or more outputs (Figure 1) [1-3]. Traditionally, outputs of bioreporters 
consist of de novo synthesized (reporter) protein(s) formed in response to the input signal, yielding 
some sort of proportional and quantifiable relation between input and output in the context of the 
assay [4, 5]. For ease of quantification, the choice of deployed reporter output has frequently fallen on 
light-emitting or color-producing enzymes or autofluorescent reporter proteins, whose (spectral) 
activity can be easily and/or non-invasively measured [4]. Bioreporter assays are relatively simple and 
consist in essence of an incubation of the bioreporter cells with a liquid sample for a defined duration, 
after which the reporter output is recorded [6, 7]. The ease of designing a bioreporter genetic circuit, 
the quantifiable aspect and the assay simplicity have attracted both scientific interest and popularity 
as potential alternative for environmental, medical or food analytics [2, 8-11]. Numerous bioreporters 
have thus been produced and tested with different applications in mind (Table 1). Some have been 
quite successful in terms of (correctly) quantifying inputs, although eventually very few have been 
tested sufficiently rigorously for robustness and on real samples [2, 8, 12, 13] (Table 1). Engineering and 
application aspects of bioreporters have been reviewed elsewhere and are not but briefly rehearsed 
here [6]. Instead, the main focus of the underlying review is the question of the sensing elements that 





Figure 1 – Conceptual idea of bioreporter cells. Two scenarios are depicted, where the bioreporter 
senses the ligand inside (A) or outside (B) the cell and, as a consequence, trigger de novo expression 
of a reporter gene. This leads to formation of reporter protein in the cell, which is measured in the 
bioreporter assay after a defined duration of the incubation with the sample. C) Schematic simplified 
instructions to be engineered on a synthetic reporter gene circuit. Colored arrows: coding regions of 
the sensing/regulatory protein and reporter protein; colored ellipses: ribosome binding sites; colored 
hexagons: transcription terminators; 90°-angle arrows: promoter sequences; colored square: operator 
site for the interaction of the sensor/regulatory protein with the DNA that leads to transmission of the 
sensed signal to altered reporter gene expression. 
 
Sensor elements for bioreporters 
The sensing elements that enable the bioreporter cell to recognize an input signal are either 
protein or RNA (e.g., aptamers) [14]. Sensor proteins and aptamers form specific three-dimensional 
domains/configurations for interaction with ligands. Ligand-binding effectuates an intramolecular 
conformational change, which allosterically may effect a different domain in the protein, for example, 
one that is involved in DNA binding or yielding a chemical modification of specific amino acid residues 
on the protein. In other cases, the sensory proteins transmit ligand binding intermolecularly in a chain 
of phosphorylation events to one or more separate protein(s). In particular transcription regulators 
(TRs) have been frequently deployed as sensory switches or as synthetic building blocks for hybrid 
switches in bioreporter circuits. TRs combine sensing and transducing domains in a single protein 
(although they are active mostly in multimeric forms) [15]. Ligand binding leads to altered DNA-binding 
properties of the TR on an ‘operator’ site, which directly influences transcription efficiency or 
frequency from the promoters controlled by the TR [16]. The coupling of sensing to ‘actuation’ in a single 
protein leading to the change in occupancy of a promoter has been one of the most useful properties 
for bioreporter constructions, since the promoter can be used to control expression of the reporter 
gene. The wide repertoire of regulatory proteins in microorganisms has been exploited intensively for 
the construction of bioreporters, capitalizing on the native ligands recognized by the individual TRs [6].  
Various other protein families carry sensing domains useful for bioreporting purposes, but do 
not directly interact themselves with operator sites in or nearby promoters. Examples include 
periplasmic binding proteins (PBPs), which have high affinity for specific ligands that they scavenge for 
the cell, frequently in order to present those to import channels [17]. PBPs can also interact with methyl-
accepting chemotaxis proteins (MCPs) [18], a wide class of proteins that enable bacterial cells to 
recognize gradients of chemical compounds and either become attracted or repelled [19]. Further 
sensory proteins operate in the so-called bacterial two-component signaling pathways [20]. Ligand-
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binding to the sensory protein results in autophosphorylation, which is transmitted to a response 
regulator protein that controls gene expression or specific physiological reactions. Sensory proteins of 
two-component signaling pathways may span across the cytoplasmic membrane or be found within 
the cytoplasm itself. Finally, antibodies or specific designed ligand-binding proteins have been 
deployed as sensory proteins for bioreporter developments [14, 21]. Ligand perception by aptamers 
influences the efficiency of translation of the reporter gene rather than its transcription [14].  
Strategies for obtaining new sensory proteins 
The design of bioreporter bacteria has so far mostly exploited natural compounds and their 
cognate sensory proteins (TRs, PBPs, MCPs, etc.) [8, 9, 22-26]. This has yielded a number of very sensitive 
and potentially applicable bioreporters, but the current weak part in bioreporter deployment is their 
limited range of detectable compounds, which may not align with the environmental, industrial or 
medical interest in the analysis [21]. Characterization of promoter activation as a consequence of ligand 
exposure by global gene expression analysis, may in some cases reveal novel signaling chains or TRs 
exploitable as sensory elements in bioreporters [27, 28]. One of the alternatives to obtain sensory 
proteins that recognize non-natural ligands is to alter or extend the ligand-binding capacities of existing 
sensory proteins through mutagenesis. Different strategies have been deployed for this, which usually 
consist of some form of DNA gene shuffling, or directed mutagenesis procedure on the full gene coding 
for the sensory protein, followed by rigorous selection and or screening of promising mutants [29]. 
Alternatively or as a complement to this strategy, computational approaches have been proposed to 
better predict the amino acid residues or protein areas to target and to limit the mutagenesis effort to 
restricted or site–specific libraries [30]. 
In the following we will briefly expose in general terms a number of current mutagenesis and 
selection or screening strategies, after which we will focus more specifically on actual obtained sensory 
mutants in the TR, PBP and MCP families, respectively.  
Most sensory domains of TRs, PBPs or MCPs are too large to produce completely randomized 
mutant gene libraries that would encode all possible variants. And if this were possible, the screening 
of these variants would not be realistically achievable. Practically speaking, random mutant libraries 
span sizes from 104 (clone libraries) to 1012 (e.g., phage or ribosome display) mutants. Mutants are 
typically produced by error-prone DNA amplification, sometimes in combination with DNA synthesis 
strategies, that aim to obtain between on average 1–3 mutations per gene[31]. These DNAs are 
subsequently cloned into appropriate vectors and introduced into bacterial cells, or expressed on 
bacteriophages, or kept as in vitro transcription-translation systems. The next step consists of an 
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appropriate library selection or screening strategy to find potential mutants fulfilling the intended new 
or altered ligand-binding properties. Screening can be based on the ligand-binding reaction itself, in 
which case one can, for example, present the ligand and capture mutant protein from a library display 
[32]. In other cases ligand binding can be detected indirectly through, e.g., ATPase activity of the TR or 
phosphorylation of the sensory protein [33]. Selection can also be based on conditional or exclusive 
mutant growth in the presence of the new ligand, which has the advantage that in principle only 
positive genotypes survive [31, 34]. The problem in screening new sensing specificities from large libraries 
and in contrast to, for instance, screening of enzymatic variants using color reactions, is that sensor 
selection is indirect. The sensory element is coupled to a conditionally lethal output and only if the 
mutant displays the proper new properties, the cell can grow and multiply [31]. Several strategies for 
conditional lethality and counterselection have been developed and have shown some degree of 
success [31]. In practice, however, a significant proportion of false positives appears that have overcome 
the conditionality in a non-intended manner.  
As a third variant, sensor mutant libraries may be screened rather than selected for proper 
signaling in the presence of the new ligand. In this case, the sensory element is coupled to the synthesis 
of, for instance, a reporter protein [35]. Cells with outlier reporter protein production are then indicative 
for mutant protein behaviour, and can be detected and separated. This procedure has the 
disadvantage that high-throughput screening strategies are required for large mutant library sizes [36]. 
On the other hand, there is less chance for selection of off-target false-positive mutations. Particularly 
autofluorescent protein reporters can be easily measured in high-throughput on individual cells, on in 
vitro transcription/translation systems in water–in–oil emulsion droplets, or on cells or microcolonies 
immobilized in microbeads using flow cytometry [35, 37]. Potential mutants with outlier fluorescence can 
be separated using fluorescence activated cell sorting (FACS) and recovered. As the signal increase in 
positive mutants need not be a priori extremely large, the separation of interesting mutants from the 
rest of the population remains challenging. Furthermore, single cell screening is prone to significant 
cell-to-cell variability, which adds to the complexity of identifying bona fide mutants with outlier 
fluorescence. To overcome these limitations, new strategies have been proposed recently. Van 
Rossum and coworkers used a conditional resistance to kanamycin in combination with a fluorescent 
bioreporter system [38], to reduce the complexity of a large mutant library to a smaller subset based on 
growth of surviving clones. Others showed how phenotypic variation among individual cells of 
different mutants can be reduced by screening libraries embedded and grown to microcolonies in 




Mutagenesis and selection of mutant transcription activators 
TRs are proteins that influence the transcription of a gene or a set of genes. TRs that carry 
ligand-sensing and DNA-binding domains can be used as part of a bioreporter system, by fusing a 
promoterless reporter gene downstream of the promotor that the TR controls (Figure 1C). Both TR 
activators and repressors, single- or two-component systems, have been deployed within reporter 
gene circuitry [6]. The affinity of the TR towards its specific ligand(s) and to its operator site in the 
promoter region determine the sensitivity of the obtained bioreporter system [39, 40]. A number of well-
characterized TRs have been used as test cases to attempt to obtain mutants with new ligand-binding 
properties. Early attempts focused on well-known members of activator and repressor TR families, 
such as TetR- [41, 42], LuxR-, LysR- [43], NtrC- and AraC-families [44]. Notably NahR and DntR, the LysR-type 
transcription activators for salicylate, were used for random as well as computation-inferred 
mutagenesis. Lonneborg and colleagues [45] used crystal structure information to predict the binding 
pocket of DntR for salicylate and propose specific mutations that would result in binding of 2,4-
dinitrotoluene. Interestingly, although a number of designed mutants were obtained, this procedure 
was at that point not extremely effective, apparently because the ligand-binding site in the mutant 
protein was slightly distoring the protein elsewhere, which influenced its activation process. The NtrC-
type sigma54-dependent transcription activators XylR, DmpR and HbpR, for xylenes, phenol and 2-
hydroxybiphenyl, respectively, have been used in directed evolution and DNA shuffling experiments 
to screen for ligand-binding specificities expanding the original spectrum. Indeed, even with limited 
library sizes of up to 105 clones mutant proteins could be retrieved that displayed activation by non-
native ligands, such as dinitrotoluene [46-48], chlorophenols [49] or 2-chlorobiphenyl [50]. More recently, 
the crystal structure of the related NtrC-type protein MopR with its ligand phenol was solved [33]. This 
was used to computationally infer amino acid changes in the binding pocket that resulted in binding 
and activation by methyl- and ethyl-substituted benzenes. Also the structure of LacI with its ligand 
allolactose was used to predict and build variant libraries for four new sugar ligands, which could 
subsequently be retrieved through selection and screening approaches [51].  
These examples have shown that randomized mutagenesis strategies are more likely to show 
fruitful results when supported by computational predictions of the ligand-binding cavities in known 
or closely related crystal structures of the TRs. Although most examples have expanded or shifted the 
range of native ligands to closely related molecules, it shows that computationally inferred mutant 
production is a valuable method to obtain new sensory capacity for bioreporters. Protein sensory 
domains can be further shuffled with different other protein domains as blocks to create artificial TRs 
in biosensing pathways [52]. It is to be expected that as predictions of structural protein domains 





Figure 2 – Strategies for obtaining new ligand-binding properties in sensory proteins. (A) Sensory 
protein classes: PBP- Periplasmic Binding Proteins; MCP- Methyl-accepting Chemotaxis Proteins; TR- 
Transcription regulators. (B) Mutagenesis strategies to design new sensing elements. (C), (D) and (E) 
Screening and selection strategies to find and isolate potential candidate proteins with new or altered 
ligand-binding properties from mutant libraries. FACS- Fluorescence-activated cell sorting; PMT- 
Photomultiplier; FSC-A, Forward Scatter Area. 
 
Periplasmic binding proteins and selection 
Periplasmic binding proteins have a conserved protein structure, named the bilobal structural 
fold [53], which consists of two domains connected by a hinge region, with the binding pocket formed 
between the two domains. Based on the connecting hinges, PBPs have been classified in three major 
groups (I–III). Class I PBPs have three β-sheets connecting the two lobes; which in Class II are two β-
sheets only. Class III PBPs have a single α-helix between the two lobes [17, 18]. In absence of ligand, PBPs 
adopt an open conformation, in which the binding site is exposed. Ligand-binding stabilizes the closed 
form of the protein, with the two lobes approaching each other and burying the ligand within the 
surrounding protein like a ‘Venus fly-trap’ [54, 55]. PBPs facilitate nutrient and trace mineral scavenging 
for the bacterial cell, by binding the ligand at high affinity and 'presenting' the bound ligand to specific 




Some PBPs are additionally involved in chemotactic sensing and also interact in ligand-bound form 
with MCPs in the cytoplasmic membrane. Galactose-binding protein (GBP) and ribose-binding protein 
(RBP) of E. coli are two well-known examples involved in chemosensing as well as sugar scavenging. 
Ligand-bound GBP and RBP interact with the Trg chemoreceptor, which leads to a phosphorylation 
cascade that biases flagellar movement of the cell [56, 57]. 
PBPs constitute a widely distributed and evolutionary ancient protein family, members of 
which bind a large range of natural organic and inorganic ligands. The primary structure homology of 
PBPs that even bind structurally close ligands is surprisingly rather low. For example, GBP and RBP only 
share 29% amino acid conservation. Ligand-binding to PBPs has been exploited intensively for the 
development of biosensors. The configuration change of both protein lobes along the hinge upon 
ligand-binding can be followed by a variety of biochemical techniques. Most interesting for biosensing 
purposes is, for example, Föster resonance energy transfer (FRET) [58-60]. For FRET to occur, two 
different fluorophores are attached to either side of the PBP lobes. The primary fluorophore (the 
donor) is excited by the illuminating light and its emission light excites the second fluorophore, which 
is measured. Depending on the type of PBP and the placement of the fluorophores, ligand binding can 
either diminish or increase the FRET signal [61]. FRET on PBPs is commonly engineered by using native 
Cys-residues or modifying other PBP residues to Cys, which can be coupled in a thiol reaction to the 
fluorophore on the purified protein. The second fluorophore is frequently an autofluorescent protein 
(for example, yellow fluorescent protein), which is attached to the N-terminal region of the PBP [60]. 
Recently, it was shown how fluorophore–bound amino acids, such as L-(7-hydroxycoumarin-4-
yl)ethylglycine, can be incorporated directly in the protein using the capacity of E. coli engineered 
amber mutants to incorporate non-natural amino acids [60]. PBP ligand binding can also be detected in 
competitive surface or liposome-based assays, leading to low sensitivities of detection in the nM-µM-
range [62]. Different groups have demonstrated ligand detection by purified PBPs of, for example, 
thiamine[63], glucose [64-66], amino acids [60, 67, 68], phosphate [69], phosphonate [70], or maltose [71-73]. 
Whereas most groups have exploited the natural binding properties of the investigated PBPs, 
very few have actually attempted to change their binding specificity. PBP binding specificity alteration 
through protein structure computational guidance was heralded in the early 2000’s in a number of 
conceptual publications [74, 75]. Computational modeling has been used to explain how mutations in the 
D-glucose/D-galactose-binding protein (GGBP) reduced affinity for glucose by 5000 times, bringing it 
to physiological human range (mM). The modified PBP may be used as a glucose blood biosensor [65]. 
Mutations improved the specificity of a leucine-binding protein (LBP) towards L-Leu by reducing cross-
reaction to structurally similar amino acids. Further modification increased the affinity for L-Leu by 14 




PBPs have been integrated in whole cell living bioreporters thanks to a discovery in the group 
of Hazelbauer in 1994 [76] that ligand-bound RBP and GBP can activate an E. coli hybrid chemoreceptor 
formed between Trg and EnvZ. This hybrid chemoreceptor (Trz1) consists of the 265 N-terminal amino 
acids of the Trg chemoreceptor linked to the 230 C-terminal amino acids of the EnvZ histidine kinase 
of the osmoregulation system. Ligand-bound GBP or RBP interaction to the periplasmic Trg'-domain of 
Trz1 triggers histidine kinase activity of the cytoplasmic EnvZ-domain, leading to autophosphorylation 
and subsequent phosphorylation of the cognate response regulator OmpR [77]. Phosphorylated OmpR 
has increased affinity for the ompC promoter, and ligand-binding to RBP or GBP thus causes an 
increased transcription rate from this promoter. Coupling a reporter gene to the ompC promoter yields 
a bioreporter for galactose and ribose with good sensitivity in the low µM (galactose) to nM-range 
(ribose, 50 nM detection limit) [78].   
In addition to proposing computational prediction of PBPs with new ligand-binding capacities 
on purified protein, several engineered PBP variants were included in the E. coli Trz1-OmpR platform. 
In this case ligand interaction with the engineered mutant RBP would bind Trz1 and trigger reporter 
gene expression. One of the publications specifically reported the successful design of mutant proteins 
based on the native E. coli ribose binding protein (RbsB) yielding detection of non-natural substrates 
trinitrotoluene (TNT), lactate or serotonin, down to the nM-mM range. The publication claimed a 
design of a mutant protein (TNT.R3) that would effectively and sensitively recognize trinitrotoluene 
(TNT) with a constant of affinity (KD) of 2 nM [75]. Unfortunately, this work was largely questioned and 
independent studies were unable to reproduce the initial findings [78, 79]. Further subsequent studies 
have shown that RbsB becomes very sensitive to misfolding upon mutations that locate both in the 
ribose binding pocket as well as elsewhere in the protein [80, 81]. The initial idea of computational 
redesigned ligand-binding based on predictions of the (wild-type) binding pocket, which works 
successfully in TRs (see above), may have largely underestimated the necessary conformational 
characteristic changes in PBPs that determine its activity. Computational predictions of amino acid 
changes that would drastically alter the PBP's ligand, and at the same time maintain correct protein 








Bacterial bioreporters based on methyaccepting chemotaxis proteins  
Methyl-accepting chemotaxis proteins (MCPs) are membrane-spanning proteins that provide 
sensory information to bacteria about chemical gradients in which they live. This permits the cells to 
swim towards possible attractants such as sugars or amino acids or retreat from toxic repellents. MCPs 
have four structural domains, which are called the ligand binding (LB), the transmembrane (TM), the 
histidine kinases, adenylate cyclases, methyl accepting proteins and phosphatases (HAMP), and the 
signal transmitter (ST) domains [84].  
The LB domain is responsible for the specificity of chemical recognition, which can consist of 
one or a group of closely related chemical compounds. LB domains have been clustered into two main 
groups [85] with two subgroups each [19, 86], although this classification is not sufficient to predict their 
cognate ligands. The first cluster is comprised of the four helix bundle (4HB) and single CACHE (sCACHE) 
classes. E. coli MCPs all belong to the 4HB class [19]. In contrast to the 4HB class with its four helical 
bundels, the sCACHE class also displays a β-sheet structure that interacts with the ligand. The second 
cluster is comprised of the helical bimodular (HBM) and double CACHE (dCACHE) classes. HBM is 
essence consist of two coupled 4HB domains, one of which is proximal and the other distal to the 
cytoplasmic membrane. Both 4HB domains in the HBM can have different ligand specificities. The 
dCACHE class is comprised of two sCACHE subdomains, but in contrast to HBM, only a single one of 
these binds the ligand [19]. LB domains can bind ligands directly, like for the Tar-MCP of E. coli [87], or 
interact with a PBP that is associated with the ligand, as is the case for Trg [88]. 
The membrane-spanning TM domain locates the MCPs to the cytoplasmic membrane. The 
HAMP domain is commonly seen as a linker to the ST domain [89]. Some MCP-like proteins have several 
HAMPs, which are referred to as poly-HAMP arrays [90]. The ST domain interacts with the soluble 
cytoplasmic response regulator (RR) and determines the further downstream reaction of the cell upon 
perception of the stimulus. Frequently, signal transduction is achieved by protein phosphorylation, 
either by the ST itself or with help of an associated kinase [91]. On the basis of extensive homology 
searches, 7 different cytoplasmic ST-domains of MCPs have been recognized, relative to the number 
of helical bundles (named 24H–44H) [92]. 
Chemotaxis mediated by MCPs is one of the best described two-component signaling 
pathways. E. coli has four MCPs involved in chemotaxis and one in aerotaxis, which are called Trg, Tar, 
Tsr and Tap, and Aer [93]. Trg provides taxis towards ribose and galactose, Tar towards aspartate and 
maltose, Tsr towards serine and Tap towards dipeptides[93]. The RR for MCPs in E. coli is CheY, which is 
phosphorylated by the ST-associated kinase CheA in presence of an MCP-activating ligand. This 
complex is stabilized by CheW[94]. Phosphorylated CheY has increased affinity for FliM, a component 




clockwise direction, leading to more frequent tumbling [95, 96]. When the cells perceive a gradient of 
attractant, the MCPs in the ligand-bound form reduce phosphorylation. This will lower the 
phosphorylation rate of CheY, which as a result of constant dephosphorylation by CheZ, decreases the 
intracellular CheY~P levels[97]. The result is less frequent tumbling and more frequent long directional 
swims. This on average leads the motile cells to move in the direction of the higher attractant 
concentration. Repellents lead to the opposite reaction [96]. MCP-chemotaxis responses are transient 
and, to some extent relative (or insensitive to the actual chemical concentration itself). Longer 
exposure to higher attractant concentrations leads to a reset of the system through MCP methylation 
at the ST-domain by CheR [98]. Demethylation is regulated by CheB which is activated by 
phosphorylation by CheA as CheY [97]. The transient reaction of MCPs upon instant change of chemical 
concentration can be measured by FRET between CheY~P and CheZ, and yields a concentration-
dependent signal which can be interpreted as a biosensor measurement [99]. Also the accumulation of 
motile cells as a result of chemotaxis in a constant chemical gradient can be quantified as a biosensor 
response [100]. 
MCPs share the HAMP domain with a large range of other two-component signal transduction 
systems [89, 101]. This actually allowed the construction of the first functional chimeric transmembrane 
receptor Trz1, mentioned above [76], by fusing the LB domain of the chemoreceptor Trg to the ST-kinase 
domain of the osmosensor EnvZ. The structure of EnvZ is slightly different from MCPs as it has no LB 
domain but a cytoplasmic sensory domain sensitive to osmotic stress. Upon osmotic stress the ST of 
EnvZ phosphorylates OmpR, which then activates the ompC promoter and expression of the porin 
OmpC to compensate the turgor pressure [102-104]. In the Trz1 hybrid system, OmpR phosphorylation is 
triggered upon binding of the ribose-bound-RBP to the Trz1-LB domain. As mentioned, by fusing a 
reporter gene like gfp to the ompC promoter, a very sensitive and quantitative bioreporter for ribose 
can be obtained [78]. 
  
Understanding the mode of action of two-component systems was greatly improved by a 
resolved almost complete structure of the NarQ nitrate sensory histidine kinase [105]. The NarQ N-
terminus is located inside the cytosol, after which the protein spans the cytoplasmic membrane in a 
first TM helix. In the periplasm, the NarQ-LB domain is then formed by four antiparallel helices, which 
connect to the membrane by a small loop between the second and third helix. A next TM helix connects 
the periplasmic LB domain to the cytosol via the HAMP domain. The HAMP domain consists of a helix–
loop–helix motif with a parallel helix bundle and four rotations [105]. NarQ forms a dimer whereas MCPs 
form trimers of dimers, which assemble themselves into MCP clusters located at the cell poles [94, 106]. 




induces a displacement of the LB–helices of up to 1 Å, resulting into a ‘piston-like’ shift in the TM 
helices. This shift translates into a ‘scissor-like’ motion of the HAMP-domain through the interaction 
with the N-terminus of the first TM helix that pushes the second helix of the HAMP further into the 
cytoplasm. This motion displaces the end of the HAMP-domain 7Å between the bound and unbound 
state, and is assumed to lead to activation of the ST domain [105]. 
The exploitation of MCPs has a good potential for future classes of biosensors or bioreporter 
cells. The natural variability of the LB-domains of MCPs deduced from genome information is large, 
although their cognate ligands are currently not well described and in most cases not predictable from 
protein homology [95]. Some MCPs have been reported to react to environmentally relevant 
compounds, such as 2,4-dichlorophenoxyacetic acid (2,4-D; a previously widely applied herbicide) [107], 
naphthalene [108] or toluene [109]. The ligand-properties of MCPs can be changed to some extent by site-
directed or random mutagenesis. For example, Tar mutants have been described that permit a 
chemotactic response towards cysteic acid, phenylalanine or glutamate [110]. Bi and coworkers used 
structural prediction of the Tar LB-domain to produce binding to eight non-cognate ligands, including 
a variety of aspartate derivates and phthalic acid [111]. 
MCP LB-domains may be connected in a plug-and-play manner to other protein domains, in 
order to obtain quantitative standardized output. This principle was shown in a recent impressive work 
where a variety of MCP LB-domains were fused to the Tar cytoplasmic parts at sites close to the HAMP 
linker [99]. Activation of the MCP-Tar hybrid by ligand-interaction was then quantified through FRET 
between CheY~P and CheZ. In this case a yellow fluorescent protein (YFP) was fusÔed to CheY and a 
cyan fluorescent protein (CFP) was fused to CheZ. CheY~P binding to FliM triggers the FRET signal in 
seconds, and is influenced by ligand interactions at the MCP-LB domains [99, 112]. Since the response is 
ephemeral, the cells have to be exposed to instantly changing chemical concentrations in order to 
observe maximal FRET output, after which the signal within a few minutes gradually returns to baseline 
[99].  
MCP-LB domains can also be coupled to the cytoplasmic signaling domains of related two-
component systems, in which case ligand-interaction with the receptor can be transmitted into de 
novo gene expression of a reporter gene. This was the concept behind the Trz1 fusion as mentioned 
earlier [78]. Apart from the Trz1 Trg-EnvZ hybrid, also Tar-EnvZ hybrids[113] DcuS-EnvZ [114] and NarX-EnvZ 
[115] have been constructed. Activation of the EnvZ autokinase activity would then in all cases lead to 
reporter gene production from the ompC or ompF promoter [115]. In contrast to the MCP-LB-domain–
Tar fusions measured by FRET, very little response was observed from MCP-EnvZ hybrids [115], except 
for Trz1. This suggests that obtaining correctly functioning hybrid proteins fused by HAMP linkers is 




Finally, MCP sensory input for biosensors can be exploited from chemotaxis itself, by 
measuring the accumulation of motile chemotactic cells in chemical gradients. This exploitation has 
somewhat been hindered by the inherent difficulty to produce stable gradients, but microfluidic 
devices have been instrumental in this respect [116-118]. Recent work showed the quantitative and 
temporal response of E. coli motile and chemotactic cells to serine, aspartate and methylaspartate in 





Sensory proteins are pivotal for the development of whole cell based bacterial sensors. Past 
work has successfully exploited the wide variety of sensory protein classes, either directly, or in 
different plug-and-play manners. But the difficulty for future sensor development is to achieve a more 
straightforward manner to predict and mutate existing (or de novo) sensory proteins for non-cognate 
ligands. For the case of PBPs, computational predictions of new ligand properties have not been 
successful (yet), and some of the past claims have proven irreproducible. For the case of TRs, 
computational-guided predictions have been more successful in obtaining new ligand-binding 
properties, perhaps because these proteins undergo less drastic conformational changes upon ligand 
interaction. It can be expected that the accuracy of the systems in free energy scoring function 
calculations, molecular dynamics involved on protein-ligand interactions and prediction of 





Table 1 – Selected examples of periplasmic binding proteins, transcription activators and methyaccepting chemotaxis proteins used in bioreporter systems.  
Sensor 
protein class 
Sensor Protein Host chassis Reporter system Ligand molecules Detection sensitivity Reference 




Benzene, Toluene and 
xylene 
40 µM [119] 
TR 
HbpR of Pseudomonas 
nitroreducens 
E. coli luxAB Hydroxylated biphenyls 0.4 µM [120, 121] 
TR 
AlkS of Pseudomonas 
oleovorans 
E. coli luxAB C6-C10 alkanes 10 nM [122] 
TR ArsR of E. coli  E. coli luxAB Arsenite 5 nM [13, 123] 
TR MerR of E. coli E. coli luxCDABE Hg2+ 1 nM [124] 
TR TetR of E. coli E. coli luxCDABE Tetracyclines 45 nM [125] 
TR YqJF of E. coli E. coli luxCDABE 
2,4-dinitrotoluene and 
2,4,6-trinitrotolene 
 [28, 126] 
PBP RbsB of E. coli E. coli  gfp D-Ribose 50 nM [78] 
PBP LivK (LBP) of E. coli E. coli FRET L-Leu 400 nM [60] 
PBP MalE of E. coli E. coli FRET Maltose  4 mM [71] 
PBP TBP of E. coli Cell free liposomes Thiamine 0.5 nM [62] 
MCP Tsr, Tar of E. coli E. coli Cell accumulation Serine, aspartate 10 µM [127] 
MCP Hybrids to Tar E. coli FRET Nitrite, nitrate, L-malate ~0.3 µM [99] 
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Aims of the thesis 
 
The overall aim of this thesis was to develop new sensory proteins by computational design 
and mutagenesis that could be used for biosensing purposes in whole cell bacterial bioreporters. Our 
main focus was on the ribose-binding protein RbsB of E. coli that had been proposed as a flexible 
platform for mutagenesis and ligand-range expansion. Our main strategy consisted of demonstrating 
to change RbsB ligand specificity from ribose to non-natural compounds. We expected that amino acid 
substitutions would not only change binding specificity, but also help us to better understand the 
molecular binding, folding and signaling mechanisms of this protein. 
 
The first aim was to develop a precise and user-friendly high-throughput strategy to screen a 
library of 2 million mutants, based on a bioreporter assay measured by fluorescence activated cell 
sorting (FACS) and flow cytometer. Our goal was to isolate RbsB variants with changed specificity from 
ribose to 1,3-cyclohexanediol (13CHD) and/or cyclohexanol (CH). This is described in Chapter 2. 
 
The second aim was to improve the binding affinity and/or solved stability/unfolding issues of 
the isolated mutants (Chapter 2) with 13CHD binding capacity. These mutants were used as a scaffold 
to produce several new mutant libraries based on random mutagenesis, site saturation or DNA 
shuffling approaches. Here we tried not only to improve the protein function but also learn more about 
the stability and ligand binding mechanism of RbsB. This is described in Chapter 3. 
 
Finally, our third aim was to develop an in vivo system to detect expression and subcellular 
localisation differences between wild-type RbsB and variants. Our goal was to develop a screening 
system to select variants with potentially improved folding, translocation and receptor interactions. 
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Bacterial periplasmic-binding proteins have been acclaimed as general biosensing platform, 
but their range of natural ligands is too limited for optimal development of chemical compound 
detection. Computational redesign of the ligand-binding pocket of periplasmic-binding proteins may 
yield variants with new properties, but, despite earlier claims, genuine changes of specificity to non-
natural ligands have so far not been achieved. In order to better understand the reasons of such limited 
success, we revisited here the Escherichia coli RbsB ribose-binding protein, aiming to achieve 
perceptible transition from ribose to structurally related chemical ligands 1,3-cyclohexanediol and 
cyclohexanol. Combinations of mutations were computationally predicted for nine residues in the 
RbsB binding pocket, then synthesized and tested in an E. coli reporter chassis. Two million variants 
were screened in a microcolony-in-bead fluorescence-assisted sorting procedure, which yielded six 
mutants no longer responsive to ribose but with 1.2-1.5 times induction in presence of 1 mM 1,3-
cyclohexanediol, one of which responded to cyclohexanol as well. Isothermal microcalorimetry 
confirmed 1,3-cyclohexanediol binding, although only two mutant proteins were sufficiently stable 
upon purification. Circular dichroism spectroscopy indicated discernable structural differences 
between these two mutant proteins and wild-type RbsB. This and further quantification of periplasmic-
space abundance suggested most mutants to be prone to misfolding and/or with defects in 
translocation compared to wild-type. Our results thus affirm that computational design and library 
screening can yield RbsB mutants with recognition of non-natural but structurally similar ligands. The 
inherent arisal of protein instability or misfolding concomitant with designed altered ligand-binding 
















Periplasmic binding proteins (PBPs) form a versatile superfamily of proteins with a conserved 
protein structure, named the bilobal structural fold [1, 2]. PBPs facilitate nutrient and trace mineral 
scavenging for bacterial cells, by binding the ligand in the periplasmic space at high affinity and 
delivering the bound-ligand to a specific membrane-spanning transport channel [2]. Some PBPs are 
additionally involved in chemotactic sensing and interact in the ligand-bound state with a membrane-
located chemoreceptor [3]. The crystal structures of several PBPs have been determined, showing two 
domains connected by a hinge region, with the binding pocket located between the two domains [3]. 
Both structure and nuclear-magnetic resonance data indicate that PBPs switch between two semi-
stable conformations. Without ligand the protein adopts an open conformation, in which the binding 
site is exposed. Suitable ligand molecules become buried within the surrounding protein, and stabilize 
the closed protein form [4, 5]. High-quality crystal structures of various PBPs have been determined, and 
this triggered pioneering ideas more than a decade ago to deploy PBPs as a generalized platform for 
computational design–based construction of new ligand-binding properties [6]. PBPs form an 
interesting class of proteins for biosensing. Biosensing can be achieved by measuring the 
intermolecular motion of the purified protein itself upon interaction with the target ligand [7]. 
Alternatively, the PBP protein is expressed in a living bacterial cell and triggers a synthetic signaling 
cascade upon ligand binding. This principle is embedded in so-called bioreporter cells or bactosensors 
[8]. By maintaining a single unique signaling cascade and reporter output, but varying the PBP-element 
with different ligand recognition, one could potentially develop a wide class of applicable bioreporters. 
 
The concept of computational design of PBP variants with novel ligand-binding properties was 
proposed over a decade ago by the group of Hellinga and coworkers [9]. On the examples of five 
different PBPs in Escherichia coli they predicted and constructed mutant variants with binding pockets 
accommodating the non-natural substrates trinitrotoluene (TNT), lactate or serotonin at reported nM–
mM in vitro affinities [9]. Particularly mutants of the ribose binding protein (RbsB) for TNT were further 
embedded in an E. coli synthetic bioreporter, in which ligand-bound RbsB-mutant contacts the Trz1 
hybrid membrane receptor, increasing expression of a reporter gene fused to the ompC promoter [9]. 
This Trz1 receptor consists of a fusion of the 230 C-terminal amino acids of the E. coli EnvZ 
osmoregulation histidine kinase to the 265 N-terminal amino acids of the Trg methyl-accepting 
chemotaxis receptor protein [10]. Contact activation of Trz1 by ligand-bound RbsB triggers 
autophosphorylation of the cytoplasmic EnvZ-domain, leading to subsequent phosphorylation of the 




of the most sensitive published RbsB mutant (named TNT.R3), however, failed to reproduce the 
reported TNT detection at sub–µM concentrations in the E. coli Trz1-OmpR background and also failed 
to demonstrate TNT binding by a purifed TNT.R3 mutant using in vitro microcalorimetry [12]. 
Subsequent analysis of effects of alanine-substitutions in wild-type E. coli RbsB showed that mutations 
at 12 positions result in misfolded or poorly translocated proteins, one of which was also targeted in 
the TNT.R3 variant [13]. Purification and biophysical analysis of a further set of published mutant PBPs 
also failed to reproduce the original measurements, and suggested the cause being their misfolding 
and unintended oligomerization [14]. The initial studies may thus have underestimated to a large extent 
the propensity of PBPs to become misfolded as a result of binding pocket mutations.  
 
More recently, ligand-specificities have been successfully interchanged between PBPs by using 
binding-pocket grafting (i.e., exchange of binding pockets between functionally closely related PBPs) 
[15, 16], improved prediction of native ligand binding [17] and statistical coupling analysis (i.e., the 
prediction of mutations based on correlating amino acid residues in sectors of two classes of related 
proteins) [15]. So far, however, there have been no reports of non-cognate altered ligand-binding 
properties of PBPs. The goal of the underlying work was thus to revisit the concept of computational 
prediction of altered ligand-binding in RbsB. Because of the apparent difficulties to predict structure-
function related side-effects such as protein folding, we hypothesized that predictions of minor 
changes in ligand-specificity might be more successful than major ones (e.g., from ribose to TNT). We 
thus chose to target molecules structurally related to ribose, in particular, 1,3-cyclohexanediol (13CHD) 
and cyclohexanol (CH). The computational protein design was based on exploration of sequence-space 
and estimations of Free energy of binding using Rosetta [18-20], to identify a list of mutated protein 
sequences with potentially sufficiently low energy of binding with the new target ligands. The DNA 
encoding for a large set of approximately 2 million mutants was then chemically synthesized and 
cloned into a vector for screening of inducible GFP expression in the E. coli Trz1-OmpR, ompCp::gfp 
signaling reporter background [12]. Mutant libraries were screened on bead-encapsulated microcolony-
grown cells by flow cytometry and sorted using fluorescence-assisted bead-sorting (FABS) (Fig. 1). 
Positively-responding mutant strains were recovered, their RbsB mutant proteins were purified and 
further characterized for in vitro ligand binding by isothermal microcalorimetry. Periplasmic 
abundance of the mutant proteins was quantified by peptide mass-spectrometry in comparison to 
wild-type RbsB, and their folding was addressed by circular dichroism spectroscopy. We recovered a 
small number of mutants with modest inducibility but significant change in ligand-binding specificity 
compared to wild-type RbsB and ribose, indicating that the computational design correctly targeted 
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the intended new ligand-binding properties. However, despite some of gain of inducibility, our results 
indicate the mutant proteins to be unstable, and prone to misfolding during synthesis and secretion.  
 
Results 
RbsB mutant library design 
Exploration of sequence space using Rosetta enzyme design simulations produced a library of 
targeted RbsB mutants, which were predicted to have improved affinity for the non-cognate ligands 
13CHD and/or CH. The used design template was the scaffold of wild-type ribose-binding protein RbsB 
of E. coli in its closed configuration (PBD ID: 2DRI, Fig. 2A). First, prior to the design simulations, 
interactions between RbsB and ribose, 13CHD or CH were studied using docking and molecular 
dynamics simulations in CHARMM and Merck Molecular Force Fields (MMFF), to gain intuition on the 
stability of the binding pocket. The average spatial deviation of the RbsB binding pocket with placed 
ribose during 2 ns (as the root-mean squared deviation) was less than 0.2 Å, but for docked 13CHD and 
CH molecules was around 0.3 Å (Fig. S1). The ligands themselves showed varying positions with an 
average root-mean squared deviation of 0.7 Å for ribose, 1 Å for 13CHD and 1.5 Å for CH (Fig. S1). 
Calculated free energies of binding (ΔGbinding) from CHARMM and MMFF were lowest for ribose, as 
expected, with –38.35 kcal mol–1, but –19.57 kcal mol–1 for 13CHD and –14.31 kcal mol–1 for CH. These 
results indicated unstable interactions of 13CHD and CH in the wild-type RbsB binding pocket. We 
conducted a per-residue free energy decomposition analysis [21] using the simulation trajectories. The 
poorer ∆Gbinding of 13CHD and CH seemed largely contributed by the RbsB residues D89, R90 and D215 






Figure 1- Overview of the mutant library screening strategy. A) Library replicates are encapsulated as 
on average one cell per agarose bead and grown to microcolony size in fumarate medium without 
inducer. Beads are passed on flow cytometry and beads with GFP fluorescence intensity below 1000 
U are sorted and recovered. B) Cells are recovered from collected beads, again encapsulated and 
grown to microcolonies, after which they are exposed to the new ligands. Beads with GFP fluorescence 
intensity higher than 1000 U are recovered and further screened. 
Next, we used Rosetta to predict potential beneficial mutations in RbsB for binding of 13CHD 
and CH. Defined key residues in the RbsB binding pocket (Table 1, Fig. 2B) were computationally 
replaced by alanine. The 13CHD and CH molecules were then docked 1000 times independently into 
the ‘’stripped’’ binding pocket to obtain the positions with the lowest minimal binding energy, which 
were used as a starting point for the design mode. Design simulations (100 repetitions each producing 
100 designs) then explored the combinatorial mutations on the defined 9 positions, from which pool 
200 sequences were ranked according to the lowest predicted binding energy, minimal packing energy, 
hydrogen bond counts, and ligand-solvent exposure. This yielded a list of one of four possible amino 
acids at the 9 positions in RbsB (Table 1). The DNA encoding these RbsB variants in all their 
combinations plus the original wild-type residue was produced as a mixed library by DNA synthesis, 
cloned and introduced into an E. coli host enabling GFPmut2 production through the hybrid Trz1-OmpR 
signaling chain (strain 4172, Table 2, Fig. S2). Independent cloning reactions resulted in three mutant 
libraries with estimated sizes of 7×106, 24×106 and 3.3×106 primary transformants.  
Computational redesign of RbsB 
 33 
A total of 4×108 alginate beads encapsulating individual cells from the mutant libraries and 
grown to microcolonies was screened by FABS for GFPmut2 fluorescence, in first instance in absence 
of inducer (Fig. 1A). An estimated 0.53 ± 0.28 % of the screened beads displayed fluorescence above 
1200 units under non-induced conditions, and were considered constitutive–ON mutants. 
Approximately 60 million beads with fluorescence below 1000 units were sorted and recovered as 
mixture. Cells were released from the beads, freshly cultured, encapsulated in new alginate beads, 
regrown to microcolonies and induced with 1 mM 13CHD (Fig. 1B). In this second phase, beads with a 
fluorescence level higher than 1000 units were sorted and plated to grow individual colonies (a total 
of 2.3×104). After rescreening six mutants displayed consistently between 1.2–1.5-fold higher GFP 
fluorescence upon incubation with 1 mM 13CHD in comparison to media alone, which was a moderate 
response but statistically significant (p-values < 0.05). These mutants were no longer inducible and 
even slightly inhibited with 0.1 mM ribose (Table 3). In contrast, the same E. coli host expressing wild-
type RbsB was not inducible with 13CHD but is 13-fold inducible with 0.1 mM ribose (Table 3). Only 
one of the six mutants (DT016) responded to 1 mM CH with a statistically significant increase in GFP 





Figure 2 –  Structures of wild-type RbsB (WT RbsB) and DT002, DT016 mutants. (A) Global view of 
closed RbsB (PDB ID: 2DRI) molecular structure with ribose (cyan) bound in its pocket. (B) Details of 
the RbsB binding pocket with 13CHD (red) and ribose (cyan) molecules. Critical amino acid residues for 
substrate binding are indicated and color–coded based on amino acid characteristics (nonpolar- 
orange; positively charged- blue; polar- green; negatively charged- purple). (C) Details of the DT002 
binding pocket (threaded on the RbsB structure, PDB ID: 2DRI) with 13CHD (red, placed according to 
docking with Rosetta) with indication of mutated amino acids. (D) Same as in (C) but for the DT016 
mutant. (E) Overview of the targeted residues in the recovered mutants compared to wild-type RbsB.  
 
All six recovered mutants contained different amino acid substitutions, with some, but little 
overlap (Fig. 2E). Mutant DT001 displayed five mutations and four wild-type residues at the 9 targeted 
positions, followed by DT011 with 7 mutations, DT015 and DT016 with 8, and clones DT002 and DT013 
with all 9 targets substituted (Fig. 2E). In the majority of the 13CHD-responsive mutants, positions D89, 
R90 and Q235 were replaced by a polar residue, whereas position T135 was replaced by a non-polar 
residue. Also, in four of six mutants, N190 was substituted by a histidine (Fig. 2E). 
Reduced periplasmic space abundance of RbsB mutants responsive to 13CHD 
The relative periplasmic space abundance of four RbsB mutants determined by quantitative 
mass spectrometry was lower compared to wild-type RbsB (Table 4). The DT002 and DT015 proteins 
displayed the lowest relative abundance, followed by DT011 and DT001. The periplasmic abundance 
of mutant DT016 was 2 times higher than RbsB. Interestingly, the relative abundance of MglB 
(galactose-binding protein) was higher in the periplasmic space of E. coli expressing mutants DT011 or 
DT015, in comparison to those expressing wild-type RbsB or the other mutant proteins (Table 4). Also, 
the summed abundance of all periplasmic binding proteins (excluding RbsB) was higher in all E. coli 
expressing RbsB mutant proteins than wild-type, with up to between 4.5 and 6 times increase in 
mutants DT015 and DT011 (Table 4). Quantitative mass spectrometry data thus suggest that 
translocation was affected for most RbsB mutant proteins and that this also influenced the 
translocation of other periplasmic binding proteins to the periplasm. 
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Figure 3- Overexpression and purification of RbsB-His6 and mutants DT002-His6 and DT016-His6. (A) 
SDS-PAGE gel of purification steps with a HisTrap column of RbsB-His6. (B) and (C) as for panel (A) but 
for mutants DT0016-His6 and DT002-His6, respectively. (D) SDS-PAGE gel of elution steps after a gel 
filtration column for mutant DT016-His6. M, Marker; Elu, Elution step. Black triangle indicates the 
expected position of RbsB-His6, DT002-His6 and DT016-His6 proteins. Red triangle indicates the position 
of the assumed E. coli chaperones. Images in panels (A)-(D) stem from single individual SDS-PAGE gels, 
as indicated by the white line separator and panel lettering. Individual panel images and lanes were 
not further combined digitally and show the full protein size range. 
 
In vitro 13CHD binding by mutant RbsB 
Cytoplasmic overexpressed His6-tagged RbsB was readily purified and resulted in protein with 
>97% purity on SDS-PAGE and a molecular mass of around 30 kDa as expected (Fig. 3A, black triangle). 
Contrary to wild-type RbsB, contaminating proteins were consistently observed in purified His6-tagged 
mutant RbsBs. One or two prominent contaminants with a mass of around 70 kDa were observed after 
affinity (Fig. 3B and C, red triangle) and gel-filtration columns. These contaminants contributed to an 
estimated 5-15 % of the total protein quantity. Interestingly, addition of 10 mM ATP to the eluted 
protein fraction after affinity purification but before gel filtration led to removal of these contaminants 
(Fig. 3D). Possibly, therefore, they consisted of E. coli chaperones such as Hsp70 or DnaK, involved in 
protein folding and refolding [22], which remained attached to the mutant RbsBs and detached upon 
addition of ATP. This suggests that the mutant RbsB proteins produced in the E. coli cytoplasm suffer 
from partial misfolding and are stabilized by chaperones [23]. 
Binding of ribose to wild-type purified RbsB-His6 in isothermal titration calorimetry (ITC) 
resulted in a clear heat release with an estimated binding affinity constant KD of 530 nM (Fig. 4A), 
which is similar to literature values[14]. Purified RbsB-His6 showed no significant interaction with 13CHD 
(Fig. 4D). In contrast, modest but consistent heat release was observed with purified DT002-His6 and 




single 13CHD ligand per protomer, we found an apparent KD of 190 µM for DT002-His6 and 5 µM for 
DT016-His6. Kinetic heat release and molar ratios suggested that actually only part of the purified 
protein fraction engages in binding of the ligand, possibly because another fraction was misfolded and 
inactive (Fig. 4B, C). No binding of ribose by either of the two mutant proteins was observed (Fig. 4E, 
F), and none of the other purified mutant proteins (DT001-His6, DT011-His6, DT013-His6 or DT015-His6) 
yielded measurable heat release with either 13CHD or ribose as substrates (not shown).  
The RbsB protein fraction after affinity purification and gel filtration was stable and displayed 
consistent binding to ribose in ITC, even upon –80°C freezing and thawing of aliquoted fractions. In 
contrast, mutant protein fractions purified in the same manner except for addition of ATP before gel 
filtration were unstable. Purified DT002-His6 fractions could be kept on ice for at least 4 h and produced 
similar heat release in ITC upon addition of 13CHD for three consecutive measurements. In contrast, 
after freezing at –80°C and thawing, the apparent binding affinity was reduced and sometimes even 
lost. 13CHD-binding to purified DT016-His6 disappeared within 2 or 3 h after purification, even while 
maintaining the protein solution on ice. After –80°C freezing and thawing, the DT016-His6 protein 
fraction no longer showed any heat-release from added 13CHD in ITC. These observations and the 
poor molar ratio of 13CHD binding (Fig. 4B, C) suggested that the DT002-His6 and DT016-His6 mutant 
proteins have strongly reduced stability and spontaneously misfold during purification and ITC. Not 
unlikely, the other four RbsB mutant proteins already completely misfolded during purification, and 
no sufficiently stable fractions were obtained to measure productive ligand-binding in ITC.  
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Figure 4-  In vitro ligand binding measurements using isothermal microcalorimetry (ITC) with purified 
proteins. (A) Binding affinity of RbsB-His6 protein with ribose. (B) Binding affinity of DT002-His6 protein 
with 13CHD. (C) DT016-His6 protein with 13CHD. (D) RbsB-His6 protein with 13CHD. (E) DT002-His6 
protein with ribose. (F) DT016-His6 protein with ribose. Kd, constant of affinity, assuming a single-
ligand per protomer binding model. Graphs display immediate heat release in µcal s—1 (upper panels) 
and calculated heat released per mol of injectant (lower panels). 
 
Secondary structure changes in mutant proteins compared to RbsB 
To detect secondary structure differences between wild-type and mutant proteins and 
observe ligand-induced changes, we analyzed purified protein fractions by circular dichroism 
spectroscopy in absence and presence of ligand (ribose or 13CHD, Fig. 5). All three His-tagged proteins 
(RbsB, DT002 and DT016) had similar circular dichroism spectra but with different ∆ε intensities, which 




5A). Secondary structure protein-fold predictions from circular dichroism spectra using recently 
published tools [24] on repeated independently purified protein batches indicated DT002 and DT016 to 
carry smaller proportions of helices but increased proportions of anti-parallel/parallel and ‘turn’–folds 
compared to RbsB (Fig. 5B). This suggests notable distortions in the RbsB-folds as a result of the 
introduced mutations (Fig. 2). Addition of ribose to RbsB resulted in a notable predicted reduction of 
the antiparallel-2 relaxed fold (for definition, see Ref [24]) and an increase of ‘other’ folds and turns (Fig. 
5B). This might correspond to the closed configuration of the protein (see, e.g., Fig. 3B in Reimer et al. 
[13]). This decrease of the proportion of antiparallel-2 relaxed fold was also observed in one preparation 
of the purified DT016-protein after addition of 13CHD (see asterisk within Fig. 5B), but not with 
addition of ribose or CH. Addition of ligands to DT002 protein preparations did not cause any consistent 
or pronounced changes in the predicted secondary structure fold composition (Fig. 5B). 
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Figure 5-  Secondary structure analysis and temperature melting curves of purified wild-type RbsB-
His6, DT002-His6 and DT016-His6. (A) Circular dichroism spectra of purified proteins in buffer A (without 
imidazole) at a protein concentration of 0.1 mg ml—1, in absence or presence of inducer (ribose, 0.1 
mM, CH or 13CHD, 1 mM). Spectra were fitted according to reference[24]. (B) Inferred secondary 
structure fold composition of the three purified proteins in two independent purified batches 
(alternating white or grey background), in presence or absence of ligands. Asterisks note the significant 
changes in antiparallel-2 relaxed protein fold upon productive ligand-addition. Protein fold 
terminology as in reference[24]. (C) Melting curves of purified proteins at a protein concentration of 0.3 
mg ml—1, in buffer or in presence of ribose (0.1 mM) or 13CHD (1 mM). 
 
 
 Melting curves of wild-type, DT002 and DT016 purified protein fractions indicated important 
differences in thermal stability (Fig. 5C). Whereas wild-type RbsB showed a melting temperature (Tm) 
of 58.9±0.1°C (Sigmoidal curve fitting), that of DT016 was only 46.1±0.1°C and that of DT002 not more 
than 34.7±0.7°C (Fig. 5C). A robust shift in Tm of ~8°C was observed for RbsB upon addition of 0.1 mM 
ribose (Fig. 5C). This result is in accordance with previously reported data [14, 25]. In presence of 1 mM 
13CHD, however, the Tm of RbsB was slightly reduced to 58.5±0.2°C (Fig. 5C). In contrast, the melting 
temperatures of mutants DT016 and DT002 were not measurably affected by addition of ribose or 
13CHD (Fig. 5C). This indicated that both DT002 and DT016 mutant proteins were indeed much less 
stable than wild-type RbsB and that interaction with 13CHD did not further stabilize the proteins. 
 
Effect of secondary mutations 
In order to potentially improve the stability and/or translocation to the periplasm of the two 
most promising mutants (DT002 and DT016), further targeted mutations were introduced on these 
proteins. By site–directed mutagenesis H190 was reverted to wild-type N190 in mutant DT002 (Fig. 
2E). Previous studies indicated the importance of N190 on RbsB stability and/or translocation[13, 25]. In 
the mutant DT016 the residue 235, which had also been suggested to be implicated in RbsB stability 
[25], was changed from M235 to V235. Position W164 in the DT016 protein, which is very close to the 
binding pocket and might block ligand access, was randomized (Fig. 2D). Back mutation of H190N in 
DT002 led to complete loss of inducibility by 13CHD (Table 3). Also the M235V mutation in mutant 
DT002 led to complete loss of 13CHD inducibility. Of the randomized positions at W164 in mutant 
DT016, only a replacement to Gly maintained 13CHD and CH induction (Table 3). The periplasmic 
abundance of DT002H190N improved compared to DT002, whereas that of DT016W164G remained the 






PBPs have attracted wide interest because of their potential for biosensing and as universal 
scaffold for engineering ligand-binding properties à la carte [6]. However, despite detailed structure 
information on a number of PBPs [2], and their biochemical, biophysical and genetic characterization, 
this à la carte design has remained largely elusive [14, 26]. Structure-guided computational predictions 
to change ligand-binding specificities have been to some extent successful for other sensory-type 
proteins, such as transcription factors [26-28], but for PBPs have remained limited to small modifications 
of binding properties in existing ligands [29]. Using the well-characterized RbsB protein from E. coli as a 
model, we showed here that computational predictions of altered amino acid residues in the RbsB 
binding pocket can indeed lead to a change of functional binding of the cognate substrate (ribose) to 
foreign but chemically related ligands (13CHD and CH). We acknowledge that although the loss of 
ribose-binding by the derived mutant RbsB proteins is very clear, the gain of new functionality is 
detectable but small. The very modest functional gain is not surprising and has been more frequently 
observed in similar library-screening efforts for altered PBP ligand-binding pocket designs [15]. Our data 
suggest that the main reason for the limited functional gain is the apparent propensity of RbsB to 
become misfolded upon mutational redesign of the binding pocket. So far, we have not been able to 
improve these mutants further by secondary mutations. 
 Several lines of evidence support our conclusion that we obtained a true change of cognate 
ligand-binding specificity of RbsB to a non-natural ligand, starting from Rosetta simulations and 
predictions of improved 13CHD- and CH-binding by changes in 9 amino acids. First of all, six different 
mutant proteins were isolated from the synthesized clone library, with up to 1.5-fold times induction 
with 13CHD in the E. coli trz1-ompCp-gfpmut2 reporter strain. These mutants had lost completely the 
capacity to become induced in vivo by ribose, and RbsB as well as the majority of other mutants in the 
library showed no induction with 13CHD (Table 3). Further mutation of a number of altered residues 
in the mutants DT002 and DT016 resulted in loss of 13CHD induction (Table 3). Secondly, ITC 
measurements confirmed binding of 13CHD by the mutants DT002 and DT016, with estimated KD of 
190 µM and 5 µM, respectively (Fig. 4B, C). This is indicative for poor binding, but a KD of 5 µM is in the 
range of measured affinity (1.6 µM) of a grafted L-glutamine-binding domain on the Salmonella 
typhimurium LAO periplasmic binding protein [15]. Finally, circular dichroism spectroscopy and 
secondary structure fold-decomposition using a recent new approach [24] indicated structural changes 
to occur in DT016 upon 13CHD addition (Fig. 5B), although this was not consistently observed in 
independent protein preparations. 
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Our results corroborated previous observations that computationally designed PBP variants 
suffer from misfolding and instability [14, 15]. Despite showing some inducibility in the E. coli signaling 
reporter chain, four out of six proteins failed to show 13CHD binding in ITC, likely because they 
unfolded during purification. The two most stable mutant proteins DT002 and DT016, quickly lost 
functional activity in ITC upon purification and were dramatically less stable than wild-type in thermal 
denaturation (Fig. 5C). All mutant proteins showed evidence for chaperone co-purification after 
affinity chromatography, indicative for misfolding. This obviously hampers the screening of mutant 
libraries, given that the procedure relies on functional gain-of-GFP fluorescence (Fig. 1). If we assume 
that the observed induction is a combination of the ‘true’ affinity of the mutant protein for its new 
ligand and the ratio of correctly versus misfolded protein, the actual gain of 13CHD- and CH-binding 
may be higher than an induction factor of 1.5 suggests. 
Detecting and separating mutants from the initial library with such small improvement of 
inducibility by 13CHD required optimization of the screening method. We initially screened the library 
for gain-of-fluorescence upon induction on individual cells, but found that single cell variation was too 
high and resulted in many false-positive signals [30]. Instead, therefore, we switched to growing 
reporter cells inside alginate beads to microcolonies, which improved the reproducibility and screening 
efficiency, and reduced the number of false positives. Others have recently compared such procedures 
and have come to the same conclusion [31]. Surprisingly, around 0.5 % of the clones in our library were 
constitutively 'ON', showing high GFP fluorescence even in absence of inducer. Constitutives may be 
the result of combinations of mutations stabilizing the closed configuration without inducer being 
present. Once in the closed conformation the RbsB 'ON'-mutant may bind to the membrane receptor 
Trz1 and trigger the bioreporter system. The addition of a step to first sort mutants with lower 
fluorescence levels in absence of inducer was essential to remove the constitutive 'ON'-mutants and 
improve the screening efficiency (Fig. 1A).  
 
What do the recovered mutants tell us about potential ligand-binding in their designed 
pockets? The ribose-binding pocket of RbsB has been investigated in detail in previous studies. Vercillo 
et al. reported 13 amino acid positions (S9, N13, F15, F16, N64, D89, S103, I132, F164, N190, F214, 
D215 and Q235) to play an important role in ribose binding [25]. Molecular dynamics simulations 
suggested several of those to be limiting 13CHD- or CH-binding by RbsB (Fig. S2). In the final 
computational strategy we stripped the presumed RbsB binding pocket at nine positions (changing 
virtually to Ala-residues), sampled the positions for 13CHD and CH with the lowest ∆G, and predicted 
the sets of amino acid residues to contribute with improved 13CHD and CH binding. Although this 




by our group found four crucial residues for ribose recognition (D89, N190, D215, R141) [13], two of 
which (D215, R141) were not included in the library predictions. In contrast, that study found several 
residues critical for RbsB folding and/or translocation, notably D89 and N190, which were targeted 
here. Indeed, in four out of the six isolated 13CHD-responsive mutants the D89 residue was substituted 
by a polar amino acid. The N190 residue was substituted in 5 out of the 6 mutants, of which four times 
by a histidine, a positively charged amino acid (Fig. 2E). This may thus have indirectly contributed to 
mutant proteins with poorer stability. Perhaps not surprisingly at this stage, several different new 
binding pocket configurations appeared to confer measurable gain-of-function of 13CHD binding and 
loss of ribose binding (Fig. 2E). These converge to some extent in the character of the newly positioned 
amino acid residue, but not in their exact type. Given that the modeled mutant protein binding pockets 
may in reality deviate more than is suggested in Figure 2C and D, it is too speculative to infer how the 
introduced new amino acid residues might be contributing to the binding of 13CHD. 
Mass spectra analysis revealed that all 13CHD-responsive mutant proteins, except DT016 and 
its derivative DT016W164G, were less abundant in the periplasmic space than wild-type RbsB (Table 4). 
This is indirect evidence that the mutant proteins may have additional difficulties in translocation to 
the periplasm. Cells expressing DT011 and DT015 displayed higher periplasmic levels of MglB and other 
proteins (Table 4), which might be due to their increased flux through the Sec-translocation channel in 
absence of lesser abundant mutant RbsB. In case of cells expressing DT016 or DT016W164G, periplasmic 
space abundance of the mutant protein was higher but that of other PBPs was lower, perhaps because 
of competition with RbsB through the Sec-channel (Table 4). In case of DT002, both its own periplasmic 
space abundance, as well as that of MglB and other PBPs, were lower. This may be the result of a 
partial blocking of the translocation system by the DT002 protein. Four mutant proteins (DT001, 
DT002, DT011 and DT015) with lower abundance in the periplasm than wild-type RbsB carried an 
amino acid substitution at the N190 position. Ala-substitutions at this position resulted in loss of 
ribose-induction, potential misfolding and/or poor translocation into the periplasm [13, 25]. Back 
mutation of the H190 residue in DT002 to an Asn, indeed increased its periplasmic space abundance 
(Table 4), but also resulted in loss of induction by 13CHD (Table 3). Mutant DT016, on the other hand, 
still retained asparagine at position 190 and its periplasmic space abundance was twice as high as wild-
type RbsB protein (Table 4). Instead, we suspected that the bulky Trp-residue at position 164 in DT016 
would limit protein flexibility in the entry and hinge regions (Fig. 2D), and perhaps be responsible for 
the high observed fluorescence background in absence of inducer (Table 3). Indeed, replacing the Trp 
by a Gly (DT016W164G) resulted in a much lower background, similar periplasmic space abundance 
(Table 4) and retainment of 13CHD and CH induction potential (Table 3).  
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Our results underscore that design of new ligand properties in highly flexible proteins such as 
PBPs is very challenging. Scoring functions developed for evaluation of protein-ligand binding free 
energies are not accurate enough [26, 32], and it is extremely difficult to predict the intrinsic dynamics 
and conformational changes at the binding pocket caused by the interaction with the ligand [17, 33]. 
Further important advances have been made by grafting binding pockets between related PBPs [15, 16], 
although this has so far not expanded the spectrum to non-natural ligands. Therefore, we believe that 
our work is a crucial step forward and shows unmistakingly non-natural ligand-binding properties in 
RbsB mutants. Future studies on PBPs should focus on either improving experimental methods to 
select for better folders while maintaining designed or grafted new ligand-binding pockets, or on 























Materials and Methods 
Computational design 
Affinities of 13CHD and CH for the wild-type RbsB binding pocket were estimated by molecular 
dynamics simulations. First, the energetically best docking position of ribose, 13CHD and CH on RbsB 
in its closed configuration removed of ribose (PDB: 2RDI) were simulated from 15,000 binding modes 
using SwissDock [34]. The bound and unbound states of protein, ligand (best docked position) and 
solvent were then simulated in silico in an all-atom description. Solvation equations were simplified by 
restricting water molecules to a 20 Å-sphere around the RbsB binding pocket (this includes 
approximately 5000 water molecules). The sphere was divided into an inner reaction region (15 Å ø) 
and an outer buffer region, forming the stochastic boundary. Atom interactions were then simulated 
during 2 ns with 1 fs time-steps using CHARMM and MMFF forcefields [35, 36] implemented in Stochastic 
Boundary Molecular Dynamics (SBMD [37], from where the root mean square deviation of the ligand 
and the protein was calculated. 
Free energy of binding was estimated by using the Molecular Mechanics with Generalized Born 
and Surface Area approach (MM-GBSA), which takes bonded and non-bonded energy, electrostatic 
and non-polar parts of desolvation energy into account [37]. The free energy was averaged from 250 
frames of the 2 ns SBMD simulations.  
For in silico design of the mutant library the Rosetta protein design software package was used. 
In particular, the ligand docking and the enzyme design modules within the Rosetta framework [18] 
were used to predict amino acid changes in RbsB to potentially allow binding of 13CHD and CH. The 
protein design in Rosetta was carried out as a probabilistic simulated annealing algorithm for exploring 
the sequence space via rotamer replacement and optimization. The scheme has the following 
components: I- To parametrize and optimize the interaction via force-field terms; II- To determine the 
target residue positions to set the design and the one to repack; III- To iterate the cycles of sequence 
design and minimization; IV- To optimize structures using fixed rotamers without constraints. This 
defined the key residues in the RbsB binding pocket to be targeted (Table 1, Fig. 2) and computationally 
to be replaced by alanine. Subsequently, the 13CHD and CH molecules were docked 1000 times 
independently into the ‘”stripped” (Ala-substituted) RbsB binding pocket. The docked conformations 
were selected according to their energy values, and the ones with the lowest predicted energy values 
were used as a starting point for remodeling amino acid substitutions at the nine targeted positions. 
The final list of mutant positions was filtered according to the lowest minimal energy values, packing, 
hydrogen bond counts and ligand-solvent exposure. 
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Mutant library and plasmid construction 
Based on the in silico computational predictions, all the possible combinations of four alternate 
residues plus wild-type at nine positions (59 combinations, Table 1) were produced by DNA synthesis 
as a mixture of linear DNA fragments (DNA2.0, USA). Delivered fragments were amplified by PCR with 
primers carrying tails that incorporated SalI and NdeI restriction sites. After restriction enzyme 
digestion and purification, the fragments were ligated with plasmid pSTV28PAA [12] digested with SalI 
and NdeI, which brings expression of the rbsB- or its mutant gene under control of the PAA promoter 
[38] (Fig. S2). Multiple ligation reactions were independently transformed into batches of E. coli DH5α 
or MegaX-DH10B™ T1R Electrocomp™ cells (ThermoFisher Scientific). Transformants were cultured en 
masse on Luria-Bertani (LB) medium with chloramphenicol (Cm), from which the pool of pSTV28PAA-
library plasmids was isolated and purified. Batches of 200 ng library-plasmid DNA were subsequently 
transformed into competent cells of the reporter strain E. coli BW25113 ΔrbsB containing plasmid 
pSYK1 (containing trz1 under control of the LacI-repressed tac-promoter, and the ompCp-gfpmut2 
reporter; strain 4172) [12] (Fig. S2, Table 2). Small proportions of these transformed batches were plated 
to estimate the number of viable clones in the libraries. The remaining pooled library cultures were 
grown for 16 h in 10 mL of low phosphate minimal medium (MM LP) (Table S1) containing 20 mM 
fumarate as sole carbon and energy source, and supplemented with Ampicillin (Ap) at 100 µg ml–1 and 
Cm at 30 µg ml–1 to select for both plasmids. Batches of 1.5 mL were aliquoted and stored in 15% (v/v) 
glycerol at -80°C. 
Individual mutant clones selected from FABS screening (see below) were grown on LB plus Cm 
and Ap, and both plasmids (the pSTV28PAA-rbsB-mutant and pSYK1) were purified using NucleoSpin 
Plasmid columns (Machery-Nagel, Germany). Mutant rbsB genes were recovered on a fragment 
obtained by digestion with SalI and BstXI or XcmI, which was ligated into vector pET3d cut with the 
same enzymes [39]. This places the rbsB (mutant) gene with the hexahistidine tag at the C-terminal end 
under control of the T7 promotor, and removes the rbsB signal sequence for protein translocation to 
the periplasmic space. Ligations were transformed into E. coli BL21 (DE3) containing pLysS, for RbsB 
overexpression and purification (see below). 
Two further RbsB mutant derivatives were produced individually by site-directed mutagenesis 
(DT002H190N and DT016M235V) and one by site-saturation mutagenesis (DT016W164G), as follows. 
pSTV28PAA-derivative plasmids containing the respective mutant rbsB gene were amplified by PCR 
using overlapping but reverse complementary primers with point mutations at the desired positions. 
PCR products were digested with DpnI to remove template DNA [40]. After enzyme inactivation the PCR 




Cm, plasmids were purified and the mutations in rbsB were verified by sequencing, after which they 
were transformed into the E. coli signaling reporter strain 4172 (see above) [12]. 
  
RbsB-based bioreporter assays 
The capacity of RbsB or its mutants to induce the Trz1-OmpR ompCp-gfpmut2 signaling chain 
in E. coli strain 4172 (Fig. S2) was assessed by flow cytometry, either on individual clones, uninduced 
or induced with the appropriate ligand in 96-well plates, or on mutant libraries with encapsulated cells 
grown to microcolonies in alginate microbeads, incubated as mixtures with or without inducer.  
E. coli library aliquots of 50 µl (containing approximately 108 cells) were inoculated in 10 ml 
MM LP medium (Table S1) containing 20 mM fumarate, and supplemented with 100 µg ml–1 Ap and 
30 µg ml–1 Cm. Library batches were grown overnight at 37°C and with 180 rpm shaking. The next 
morning, cultures were diluted with MM LP to a turbidity of 0.03 and mixed in a 10:1 v/v ratio with 1% 
(w/v) alginate (PRONOVA UP LVG, FMC, Norway) in MM LP solution, to encapsulate the cells at 
approximately one starting cell per bead. Alginate beads were then formed using a VAR J30 bead 
machine (Nisco, Switzerland) at nozzle size of 150 µm and pressure set to 4-5 bar, and sprayed into 
100 mM CaCl2 solution under constant stirring to solidify the alginate. This produces beads with an 
average diameter of 50 µm. After 1 h hardening in solution, cell-loaded beads were filtered 
sequentially through 40 and 70 µm mesh size nylon strainers (Corning Inc.) and washed with MM LP 
(Table S1). Recovered beads in the 40–70 µm–diameter range were then incubated for 16 h at 37°C in 
5 ml MM LP containing 1 mM fumarate, Ap and Cm, in a rotating wheel (TC-7, New 
Brunswick/Eppendorf, Belgium). The next day, the cells had grown to microcolonies and individual 
beads were screened for fluorescence in a FACS Aria flow cytometer particle sorter (BD FACSAria Cell 
Sorter, Becton Dickinson, USA), equipped with a 100–µm nozzle at a flow rate of 2-5 µl s–1 and a density 
of between 100-1000 particles µl–1. Sensitivities for the FSC and FITC channels were set to 291 V and 
435 V, respectively. 
Microcolony-in-bead suspensions were screened first without induction and beads with 
fluorescence less than 1000 units were sorted to deplete the library of constitutive ‘ON’-mutants (Fig. 
1A). Sorted beads were collected in LB medium supplemented with Ap and Cm, and incubated 
overnight at 37°C and with 180 rpm rotary shaking to dissolve the alginate beads and grow the E. coli 
cells. Multiple library batches were sorted sequentially to cover the entire mutant library.  
The library depleted of constitutives was grown in multiple batches on MM with fumarate, 
cells were encapsulated and grown to microcolonies as described above, followed by 2.5 h induction 
with 1 mM 13CHD. Microcolony–in–bead fluorescence was again screened by flow cytometry, and 
beads displaying fluorescence levels higher than 1000 units were sorted in pools by FABS into tubes 
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containing LB plus Ap and Cm medium (Fig. 1B). The collected beads were dissolved, regrown, and 
stored in 15% glycerol (v/v) at -80°C.  
The resulting sub-libraries containing candidate 13CHD–responsive mutants were streaked on 
LB plates with Ap and Cm, and grown colonies were replica plated on MM agar with 20 mM fumarate, 
Ap and Cm (MM-FUM-ApCm) in presence or absence of 1 mM 13CHD. After 48 h incubation at 37°C 
the colonies were photographed under blue-light (Safe Imager Transilluminator, ThermoFisher) and 
their fluorescence intensities were compared by image analysis using the open source software: 
http://www.cheminfo.org/Image/Biology/Counting_plates/index.html?viewURL=https://couch.chem
info.org/cheminfo-public/b616aba5eda653bf97ce9b776976aa4d/view.json?rev=37-
e0a7762615ad2a544a1e5149ed1a2f21#). Colonies showing at least 1.25-fold increase in fluorescence 
in presence compared to absence of 13CHD were restreaked on LB-Ap-Cm agar plates and purified. 
Individual colonies were then inoculated in eightfold replicates in 96-well plates, containing per well 
200 µl of MM-FUM-ApCm. 96-well plates were incubated overnight at 37°C and 700 rpm in a 
THERMOstar shaker (BMG LABTECH, Germany). The next morning, 5 µl culture of each well was 
transferred into a new well in a 96-well plate with 195 µl of fresh MM-FUM-ApCm. After 2 h incubation 
at 37°C, 100 µl from each well was transferred to the corresponding position of a new 96-well plate 
and immediately analyzed by flow cytometry to measure the uninduced fluorescence levels. To the 
remainder, 95 µl of fresh MM-FUM-ApCm, and 5 µl of inducer solution were added. This plate was 
incubated for another 2 h at 37°C, after which each well was again sampled for cellular fluorescence. 
As inducers we tested 0.1 mM ribose, 1 mM 13CHD and 1 mM CH (final concentrations in the assay). 
Cellular fluorescence was measured in 20 µl-aliquots, autosampled from each well by a Novocyte flow 
cytometer (ACEA Biosciences, USA), at an aspiration rate of 14 µl min–1 and culture density between 
1000-5000 cells s–1. GFP fluorescence was recorded in the FITC-channel, which was set at a sensitivity 
of 441 V, and is reported as the average of the mean in each of the 8 replicates ± calculated standard 
deviations. Note that the fluorescence units of the FACS Aria (in Fig. 1) are not the same as the ones 
from the Novocyte (as in Table 4). Statistical significance was tested in pair-wise t-tests (one-sided, 
assuming increased response of the mutant).  
 
Expression and periplasmic space abundance analysis of RbsB wild-type or mutant 
proteins 
The abundance of RbsB wild-type and mutants in the E. coli periplasmic space was analyzed 
using direct peptide mass identification, as described previously [12]. Periplasmic fraction was prepared 
by EDTA–ice treatment [12] from E. coli BW25113 ∆rbsB carrying pSYK1 and the pSTVPAA-rbsB 




size range between 28 and 36 kDa were excised from the gel. Proteins were analyzed by the UNIL 
Proteome Facility (https://www.unil.ch/paf/en/home.html). In short: samples were digested with 
trypsin and peptides were separated on an Ultimate 3000 Nano LC System (Dionex), followed by 
detection in a Thermo Scientific LTQ-Orbitrap XL mass spectrometer (Thermo Fisher Scientific, 
Waltham, MA). Mass spectra were analyzed using Scaffold Viewer 4, using thresholds of 99.9%. The 
minimum number of peptides for identification was 2.  
 
RbsB-His6 overexpression and purification 
For purification of wild-type or mutant RbsB His6-tagged protein, 250 ml E. coli BL21 (pLysS) 
cultures with the corresponding pET3d-derivative plasmids grown in LB-Ap-Cm medium at 37°C until a 
culture turbidity at 600 nm of 0.3, were induced by addition of 1 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG, final concentration). Cultures were incubated further for 16 h at 20°C, 
after which the cells were harvested by centrifugation at 3,600 × g for 5 min at 4°C. Cell pellets were 
stored at –80°C until purification. 
 Thawed cell pellets were resuspended in 15 ml of buffer A (500 mM NaCl, 50 mM NaH2PO4, pH 
8.0), containing 20 mM imidazole. The cell suspension was transferred to a metallic chamber 
containing a single metallic bead (50 ml chamber, Retsch, Germany) and frozen in liquid nitrogen for 1 
minute. The cold chamber was transferred to a bead-beater machine (Oscillating Mill MM400, Retsch, 
Germany), and cells were crushed by constant vigorous shaking for 3 min at 30 s–1. The extract was 
transferred to a 50 ml centrifuge tube, which was centrifuged at 16,000 × g at 4°C for 30 min, after 
which the lysate supernatant was transferred to a clean tube. 
 The clean lysate was next loaded onto a HisTrap HP column (HisTrap FF crude 1 ml, GE 
Healthcare) at 4°C and flow rate of 0.5 ml min–1, followed by washes of, consecutively, 10 column 
volumes (cv, equal to 1 ml) of buffer A with 20 mM imidazole, 1.5 cv of buffer A with 40 mM imidazole 
and 1.5 cv of buffer A with 80 mM imidazole. Proteins were eluted with buffer A containing 250 mM 
imidazole in a total volume of 4 ml. The HisTrap eluate was subsequently loaded on a Superdex 200 
10/300 GL 24 ml gel filtration column (GE Healthcare), and eluted with buffer A plus 250 mM imidazole 
at a flow rate of 0.75 ml min–1. Protein eluates were collected in aliquots of 150 µl, which were 
immediately frozen in liquid nitrogen and stored at –80°C, or used immediately for ITC assays. In case 
of RbsB mutant proteins we tested the effect of adding 10 mM ATP to the eluted protein solution 
directly after the HisTrap column, in order to disassociate and remove contaminating E. coli 
chaperones before loading onto the Superdex 200 10/30 GL column. 
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Protein concentrations were determined by NanoDrop spectrophotometry (Thermo Scientific, 
USA), using absorbance at 280 nm. The theoretical molar extinction coefficient and molecular weight 
were used as parameters. Subsamples of 20 µl were analyzed by SDS-PAGE to examine protein purity. 
 
Analysis of ligand binding using isothermal microcalorimetry (ITC) 
A volume of 280 µl of purified protein extract (mostly the Superdex gel filtration eluate; 
between 5 and 10 mg protein ml–1) was pipetted into the measurement cell of a MicroCal ITC200 
isothermal titration calorimetry instrument (GE Healthcare Life Sciences, USA). To avoid potential 
further unfolding of mutant protein we directly analysed them in imidazole-containing buffer A 
without previous dialysis, but maintained exactly the same volume of buffer A with 250 mM imidazole 
in the reference cell. An appropriate concentration of the test ligand (ribose or 13CHD; either at 0.1 or 
at 1 mM in buffer A with 250 mM imidazole) was filled into the injection syringe. Heat release was 
measured at 25°C with a reference power of 11 µcal s–1 and a stirring velocity of 1000 rpm. Raw data 
were recorded as changes in µcal s–1, and regression curves were fitted based on a one-binding site 
model using the Microcal Origin software (GE Healthcare).                                                                                  
Circular dichroism and variable temperature measurements 
Purified wild-type RbsB-His6, and DT002-His6 and DT016-His6-mutant proteins were analyzed 
by circular dichroism spectroscopy and variable temperature measurements using a J810 
spectropolarimeter (Jasco, Japan). A volume of 100 µl of purified protein immediately after Superdex 
gel filtration or from thawed protein fraction stored at –80°C, was loaded on a PD minitrap G-25 
column (GE Healthcare) and eluted with 500 µl of buffer A to remove the imidazole at 4°C. Protein in 
buffer A was then kept on ice and analyzed within 2 h for its circular dichroism spectrum. 
Circular dichroism and thermal melting curves were determined in a quartz cuvette with a 0.1 
cm path length (L). Spectra (θ, mdeg) were measured at room temperature between 200 and 260 nm 
at a scanning speed of 10 nm min–1 and a protein concentration of 0.1 mg ml–1. Buffer A alone was 
used as negative control and its circular dichroism spectrum was subtracted from that of the protein 
fractions. Data were further normalized for Δε (M–1 cm–1) using the effective protein concentration (c, 
mg ml–1) and the mean residue weight of RbsB (MRW, 109 Da), as follows: 
Δε = (θ × 0.1 × MRW)/(3298 × c × L) 
Circular dichroism spectra were further analyzed on the BeStSel webserver for secondary structure 
fold composition, as per instructions in Ref [24]. 
Variable temperature measurements were conducted with a protein concentration of 0.3 mg 




temperature increment of 1°C; target temperature 95°C; temperature ramp rate of 2°C min-1. 




























Computational redesign of RbsB 
 51 
 
Table 1 – Mutations introduced into E. coli wild-type RbsB protein  
Amino acid Wild-type residue 
Tested 
mutations 
16 F H, T, S, A 
64 N V, I, H, A 
89 D G, T, S, V 
90 R S, N, T, L 
135 T S, A, R, V 
164 F D, G, H, W 
190 N H, S, T, A 
214 F H, A, S, N 









Table 2 – List of strains used in this study 









Host strain for overexpression from 
the T7 promoter 
[39] 
3725 E. coli BL21 (DE3) pLysS, pAR1 Cytoplasmic overexpression of 
RbsB-His6  
This work 
4172 E. coli BW25113 ΔrbsB pSYK1 Host strain containing the Ptac-trz1, 
PompC-gfpmut2 bioreporter system 
[12] 
4175 E. coli BW25113 ΔrbsB pAR3, pSYK1 Expression of RbsB with signal 
sequence for periplasmic 
translocation 
[12] 
5913 E. coli BW25113 ΔrbsB pSTV-DT001, pSYK1 As 4175, but for DT001 mutant 
protein of RbsB  
This work 
5903 E. coli BW25113 ΔrbsB pSTV-DT002, pSYK1 As 4175, but for DT002 mutant 
protein of RbsB 
This Work 
5904 E. coli BW25113 ΔrbsB pSTV-DT011, pSYK1 As 4175, but for DT01 mutant 
protein of RbsB 
This Work 
5905 E. coli BW25113 ΔrbsB pSTV-DT013, pSYK1 As 4175, but for DT013 mutant 
protein of RbsB 
This Work 
5906 E. coli BW25113 ΔrbsB pSTV-DT015, pSYK1 As 4175, but for DT015 mutant 
protein of RbsB 
This Work 
5907 E. coli BW25113 ΔrbsB pSTV-DT016, pSYK1 As 4175, but for DT016 mutant 
protein of RbsB 
This Work 
5999 E. coli BW25113 ΔrbsB pSTV-DT016 (W164G), 
pSYK1 
As 4175, but for DT016W164G 
mutant protein of RbsB 
This Work 
6054 E. coli BW25113 ΔrbsB pSTV-DT016 (M235V), 
pSYK1 
As 4175, but for DT016M235V mutant 
protein of RbsB  
This Work 
5927 E. coli BL21 (DE3) pET3d-DT001, pLysS Cytoplasmic overexpression of 
DT001-His6 
This Work 
5908 E. coli BL21 (DE3) pET3d-DT002, pLysS Cytoplasmic overexpression of 
DT002-His6 
This Work 
5909 E. coli BL21 (DE3) pET3d-DT011, pLysS Cytoplasmic overexpression of 
DT011-His6 
This Work 
5910 E. coli BL21 (DE3) pET3d-DT013, pLysS Cytoplasmic overexpression of 
DT013-His6 
This Work 
5911 E. coli BL21 (DE3) pET3d-DT015, pLysS Cytoplasmic overexpression of 
DT015-His6 
This Work 
5912 E. coli BL21 (DE3) pET3d-DT016, pLysS Cytoplasmic overexpression of 
DT016-His6 
This Work 
6016  E. coli BL21 (DE3) pET3d-DT016(W164G), 
pLysS 
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Wild-type 6180 ± 1580c 13 ± 2.2d 0.8 ± 0.03 0.8 ± 0.05 
DT001 6846 ± 1658 0.9 ± 0.05 1.3 ± 0.16 0.9 ± 0.13 
DT002 6019 ± 886 1.0 ± 0.05 1.4 ± 0.13 0.9 ± 0.08 
DT011 8462 ± 440 0.9 ± 0.09 1.2 ± 0.04 0.8 ± 0.05 
DT013 6154 ± 1319 0.9 ± 0.09 1.3 ± 0.6 0.8 ± 0.08 
DT015 4481 ± 694 0.9 ± 0.16 1.3 ± 0.12 0.8 ± 0.11 
DT016 24430 ± 3460 1.0 ± 0.08 1.5 ± 0.01 1.5 ± 0.05 
DT002H190N 5054 ± 805 0.9 ± 0.07 0.9 ± 0.15 0.7 ± 0.03 
DT016W164G 11627 ± 2028 0.8 ± 0.12 1.3 ± 0.04 1.3 ± 0.01 
DT016M235V 5960 ± 1300 0.8 ± 0.09 1.2 ± 0.08 1.2 ± 0.06 
a Mean GFPmut2 fluorescence in the assay with inducer divided by that of the assay with buffer only. 
Assay incubation time is 2h30 at 37°C. Values from eight replicates, ± calculated SD. b Final 
concentration of inducers in the assay: ribose, 0.1 mM; 13CHD, 1 mM; CH, 1 mM. c Mean values from 
eight replicates, ± calculated SD. d Values in bold indicate statistically significant induction (pair-wise 












Exclusive peptide count a Normalized count b 








RbsB 115 46 91 72 29 57 
DT001 56 38 235 46 31 193 
DT002 13 7 55 24 13 101 
DT002H190N 59 38 301 53 34 268 
DT011 39 161 348 42 175 379 
DT015 24 202 407 16 133 268 
DT016 143 19 141 181 24 179 
DT016W164G 148 20 183 159 21 197 
a Absolute number of peptides exclusive to the indicated respective protein(s) detected by mass 
spectrometry. b Exclusive peptide count normalized to the total number of identified peptide 
fragments per sample. c MglB, galactose-binding protein. d Number of all counted peptide fragments 
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Table S1- Composition of mineral medium (MM) and low phosphate mineral medium (MM LP) used 
in this study.  
Component Mineral medium 
Low phosphate 
mineral medium 
Na2HPO4 60 g 0.36 g 
KH2PO4 30 g 0.33g 
NaCl 5 g 
NH4Cl 10 g 
Recipe for 1L. pH set to 7.4 












Figure S1- Interactions between RbsB wild-type and the ligands ribose, 13CHD or CH using docking 
and molecular dynamics simulations. A) Contribution of each residue of RbsB to the change of Gibbs 
free energy G (kcal/mol) during binding of the indicated ligand molecules using per-residue binding 
free energy decomposition based on Molecular Mechanics-Generalized Born Surface Area (MM-
GBSA) method. B) Average spatial deviation of the RbsB binding pocket with placed ligands (ribose, 




Figure S2 -  The hybrid RbsB-OmpR signaling chain of the E. coli Trz1-OmpR bioreporter strain. (A) 
Ribose (ligand) is bound by the ribose-binding protein (RbsB), which docks to the Trz1 hybrid receptor 
(fusion between the periplasmic part of Trg and the cytoplasmic part of EnvZ). The binding starts a 
phosphorylation cascade, where OmpR is phosphorylated and increases transcription of gfp from the 
ompC promotor. (B) Scheme of relevant plasmids used in this work. Plasmid pSTV-DTXXX expresses 
the rbsB or mutant rbsB gene with its translocation signal sequence and hexahistidine tag (His6) under 
control of the weak constitutive PAA promoter [2]. Plasmid pSYK1 contains the gfpmut2 gene under the 
ompC promoter control and the trzI gene under control of Ptac. Relevant restriction sites are indicated.  
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Random and semi-random mutagenesis to improve 
and understand the binding mechanism of ribose-






















Periplasmic binding proteins (PBPs) have been proposed as a general scaffold to design new 
receptor proteins. Designed PBPs can be integrated in bioreporter systems to detect the presence of 
molecules of interest in the cell’s environment. For the past years many groups have explored this 
exciting concept. However, very limited success was achieved. Most studies working on PBPs have 
therefore explored their natural properties and studied ligand binding through binding pocket grafting 
from existing other PBPs or have tried to improve native ligand binding capacity by mutagenesis.  
So far, only one successful attempt to completely change the ligand specificity from a natural 
ligand to a non-natural compound has been reported. This was accomplished on the ribose binding 
protein (RbsB) from E. coli, which was redesigned based on computational simulations to bind 1,3-
cyclohexanediol (13CHD). Six proteins with modest but consistent 13CHD binding were isolated. In 
vitro characterization of these RbsB variants confirmed they were no longer responsive to ribose and 
had gained binding to 13CHD, but were impaired in their stability and/or folding capacity. 
The goal of this work was to improve binding capacity and/or solve stability issues of the six 
13CHD-binding mutants by random mutagenesis, site saturation and DNA shuffling approaches. 
Several mutant libraries were constructed, cloned in an appropriate E. coli bioreporter system and 
screened for improved induction of the GFPmut2 reporter fluorescence in presence of 13CHD. 
Screening was carried out with encapsulated cells in alginate beads grown to microcolonies, induced 
or not in presence of 13CHD, thresholded at different fluorescence settings. Collected clones by FACS 
were then used as starting point for the next round of evolution. After three rounds of mutagenesis 
and screening we isolated 7 mutants with 13CHD concentration-dependent GFPmut2 induction up to 
3.2-fold and a lower detection limit of 0.25 mM. Random mutagenesis was the only strategy yielding 
improved mutants. All observed mutations except one were located outside the direct ligand-binding 
pocket, suggesting they were compensatory and helping protein folding or functional behaviour other 











Proteins are important ‘’players’’ with multiple applications in health, research and industry [1, 
2]. Protein engineering techniques have been used to design new proteins, including enzymes and 
antibodies, or improve natural properties of existing proteins [3-6]. The most common approaches used 
to engineer a protein of interest are rational design, directed evolution and de novo design [2].  
Rational design has successfully improved the functions of proteins [7-9]. However, this 
approach requires an extensive and frequently unreachable knowledge of the relationship between 
structure and function of proteins [10]. This strategy involves site directed mutagenesis (SDM), where 
defined protein residues are targeted by mutagenesis, replacing the residue by a different one. SDM 
has the advantage to produce small mutant libraries, reducing significantly the screening time [2].  
To overcome the situations where limited knowledge about the protein of interest is available, 
a technique named ‘’directed evolution’’ has emerged. Over the past years directed evolution has 
generated powerful and interesting results [11-13]. The power of this technique has been internationally 
recognized by awarding its pioneers with the Nobel Prize of Chemistry in 2018. Directed evolution 
involves four key steps: (i) selecting a starting gene sequence, (ii) creating a library of variants, (iii) 
selecting variants by high-throughput screening with improved function, (iv) repeating the process 
until the improvement or function is achieved [14]. Error-prone PCR (ep-PCR), site saturation 
mutagenesis (SSM) and DNA shuffling are the common mutagenesis methods creating the variants 
underlying directed evolution [15].  
Protocols of ep-PCR consist in small modifications of the standard PCR methods in order to 
enhance the natural error rate of the DNA polymerase. The ep-PCR protocols usually contain high 
concentrations of MgCl2, in order to stabilize non-complementary base pairs. Other ways to increase 
the mutation rate include variation of the nucleotide ratios, inclusion of multiple pairing nucleotides 
or the addition of MnCl2 [16]. Due to its simplicity and versatility, ep-PCR has emerged as the most 
common mutagenesis technique and can result in mutation frequencies as high as 2% per nucleotide 
position [17]. SSM enables to create libraries of mutants containing all possible mutations at one or more 
pre-determined target positions in a target gene sequence [15]. This is achieved by introducing all 
possible base triplets at a given codon, thereby resulting in the insertion of all 20 amino acids at this 
position of the protein. This method, however, restricts random mutations to predefined sites in the 
protein of interest, creating therefore what is called focused libraries. SSM requires structural 
information in order for the appropriate residues sites to be mutagenized [18]. Finally, DNA shuffling 
randomly recombines several related and previously selected gene templates of interest. This in vitro 




generated by random fragmentation of the different parental genes [17]. This thus results in assembly 
of genes that include different combinatorial parts of the parental genes. This technique is extremely 
useful to reveal synergistic effects between mutations. Although mostly effective for enzymes, random 
mutagenesis was also successfully applied to alter transcription factor binding specificity [19-21].  
 Periplasmic binding proteins (PBPs) form a family of proteins with a conserved bilobal 
structure [22, 23]. PBPs scavenge molecules (ligands) for the cell, which upon binding are presented to 
transport channels and/or to membrane receptors involved in chemotaxis [24]. Crystal structures and 
nuclear-magnetic resonance data have shown that PBPs can adapt two semi-stable conformations. In 
absence of the ligand the majority of the protein adopts an open conformation, in which the binding 
site is exposed. In presence of the ligand, the molecule is buried in the binding pocket and the PBP 
adopts a closed conformation [25, 26]. Due to this particular characteristics PBPs are an attractive protein 
class for biosensing purposes. They can be integrated in an in vivo hybrid signaling chain leading to 
expression of a reporter protein, which can be easily measured [27, 28]. In the context of this work, we 
focused on the ribose binding protein (RbsB) of E. coli, which in presence of the natural ligand ribose 
changes from open to close conformational. RbsB ribose binding has been deployed as a bioreporter 
system through use of a hybrid membrane receptor named Trz1 [29]. This hybrid receptor is formed by 
fusion between the C-terminal part of the E. coli natural EnvZ osmoregulation histidine kinase and the 
N-terminal part of the natural Trg chemotaxis receptor [30]. Ribose-bound RbsB interacts with Trz1, 
triggering its autophosphorylation cascade and yielding increased expression of the ompC promoter 
fused reporter gene. 
PBPs have been proposed as a flexible platform to design new receptor proteins based on 
protein engineering approaches [31], with, however, very limited and controversial successes. Several 
studies attempted to engineer PBPs based on rational design and computational approaches [32-34]. 
Most studies exploited the natural properties of the PBPs to reduce or increase binding specificity [35, 
36] or to graft binding-pockets between closely related PBPs [32, 33]. In the case of RbsB, two studies used 
alanine replacement mutagenesis to describe and understand the role of each residue in the overall 
function of the protein [37, 38]. The goal of this work was to improve by directed evolution the only so 
far reported RbsB designed mutants for binding of the non-natural ligand 1,3-cyclohexanediol (13CHD) 
[39].  
Previously, we showed how six RbsB mutants with moderate but significant response to 13CHD 
were obtained through a combination of computational prediction of binding pocket mutations in 
RbsB and screening for gain of GFPmut2 fluorescence output in an E. coli  bioreporter system[39]. 
Despite de novo 13CHD binding, all six mutant proteins showed signs of poor stability, mis- or unfolding 
and potentially translocation problems compared to wild-type RbsB, indicating that the poor 
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inducibility by 13CHD may partly be due to protein instability caused by the introduced binding pocket 
substitutions. Several studies have shown that mutations both in the ribose binding pocket and protein 
periphery can destabilize RbsB [38-40]. Our hypothesis was thus that it should be possible to increase 
binding capacity and stability by directed evolution, by using the isolated mutants as starting template. 
In addition, we expected that random mutagenesis may also lead to mutations in other parts of the 
RbsB variants, which may help to understand the effects of those positions on stability and overall 
functioning of the protein. 
We used three different random and semi-random mutagenesis approaches to create allelic 
variants in six variants of RbsB with primitive 13CHD binding. The libraries were produced in the E. coli 
GFPmut2 bioreporter strain and extensively screened for improved GFPmut2 induction in presence of 
13CHD, using different thresholding methods. Recovered mutant clones by fluorescence assisted cell 
sorting were then used in fresh rounds of random mutagenesis of either single or mixed templates, for 
up to three rounds of directed evolution. We describe 7 mutants of the final screening round, showing 
two with up to 3.2-fold induction by 13CHD and a lower detection limit of 0.25 mM 13CHD. Mutations 
were mapped and threaded on inferred protein structure, mostly located outside the direct binding 
pocket. Our results thus showed that it is possible to improve the overall function of RbsB mutants by 

















Random mutagenesis of RbsB protein variants with primitive 13CHD affinity 
We previously obtained six mutants in RbsB (DT001, DT002, DT011, DT013, DT015 and DT016) 
that had lost binding to ribose and instead gained primitive affinity to 13CHD as new ligand [39]. Purified 
mutant proteins, however, displayed severe problems of folding, stability and/or translocation into the 
periplasmic space [39], which we hypothesized could be partly responsible for their relatively poor 
ligand binding. We set out in this first part, therefore, to randomly create further mutations in each of 
those DT mutants, under the assumption that this might improve their stability and lead to a higher 
induction signal with 13CHD. The respective rbsB-DT mutant genes were first used as individual 
templates for random mutagenesis library (RML) preparation, using error prone PCR (ep-PCR). Ep-PCR 
in presence of different MnCl2 concentrations (0.025-0.06 mM) resulted in between 1 to 3 mutations 
per 1000 bp. RMLs produced from each starting RbsB-variant were transformed into the E. coli 
bioreporter strain carrying the Trz1-ompR-ompC’::gfpmut2 signaling chain [29]. Library clones were 
tested individually encapsulated in alginate beads and grown to microcolonies, which were then 
induced with 1 mM 13CHD as previously described [39].  
Some 10 million beads, covering three times the estimated sizes of the RML002 and RML016 
(derivates of DT002 and DT016, respectively) were screened by fluorescence-activated cell sorting 
(FACS), in first instance separating beads with an 13CHD-induced fluorescence above the 98th 
percentile threshold observed in a separate screen of the same amount of beads in presence of 13CHD. 
105 beads were recovered, from which plasmid DNA was isolated and used as template for a new round 
of random mutagenesis. The new libraries (with estimated sizes of 5.5 x 106 and 8.5 x 106 clones) were 
again encapsulated, induced and screened, but now restricting recovery to the top 0.1 % of GFPmut2 
fluorescence (from all induced beads). Some 6 × 103 beads were collected, purified to individual clones, 
and screened in 8-fold replicates in 96-well plates for 13CHD induction. This resulted in finding three 
mutants (named: DT020, DT021 and DT022) with consistent and up to 2.1-fold 13CHD induction, a 
significant increase and/ or reduction of fluorescence background when compared with parental 
DT002 and DT016 (Table 1). Sequencing revealed a single different amino acid substitution in each of 
the three mutants (Table 1). Mutant DT020 had the exact same 1.5-fold induction as its parent DT016, 
but showed a 30 % reduced fluorescence background intensity (p = 2.25 x 10–5, n = 12 replicates, 
Table1). Mutants DT021 and DT022 displayed a small increase in fold induction to 1.66 ± 0.09 (n = 13 
replicates) and 2.09 ± 0.16 (n = 14 replicates), respectively (Table 1). 
Separate RMLs produced from the initial variants DT001, DT011, DT013 and DT015 (named 
RML001, RML011, RML013 and RML015, and with library sizes of 3.4 x 106, 2.2 x 106, 1 x 106 and 4.1 x 
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106 clones, respectively), were encapsulated, induced with 13CHD and similarly screened on an 
estimated three times library coverage for higher GFPmut2 fluorescence compared to non-induced 
conditions. In total, 151 beads were recovered that showed GFPmut2 fluorescence higher than any 
bead observed in non-induced conditions, which were purified and individually tested for 13CHD 
inducibility in eight-fold replicates. Unfortunately, all mutants also showed significant increase in 
fluorescence in absence of 13CHD and none had induction levels above 1.5. Sequencing of some of 
these mutants showed gene deletions resulting in truncated RbsB mutant proteins. Pooled DNA from 
those 151 mutants used as template for a new library (estimated size of 1.5 x 106 variants) did not yield 
further improvements. In contrast, almost all tested clones showed deletions of the rbsB variant open 
reading frames resulting in truncated proteins. These RMLs were therefore abandoned for further 
investigation. 
 
Table 1- GPFmut2 fluorescence in E. coli expressing wild-type- and mutant-RbsB proteins under 
uninduced and 13CHD-induced conditions.  
a Mean (± one SD) GFPmut2 fluorescence values of uninduced cultures (n = 8–14 replicates). b Mean 
fold induction ± one SD, as the ratio of mean GFPmut2 fluorescence of induced cultures with 1 mM 
1,3-cyclohexanediol, by that of uninduced cultures. c Additional mutations in comparison to the 
parental protein. d Values in bold indicate statistically significant fluorescence background and/or fold 
induction compared to DT016 (p < 0.05, t-test, equal variance). e DT016 carries eight mutations 
compared to wild-type RbsB: F16S, N64V, D89V, R90S, T134A, F164W, F214A and Q235M. f Underlined 







Fold induction b 
1 mM 1,3- cyclohexanediol 
Additional 
 mutation(s) c 
RbsB - 25226 ± 4066 d 0.91 ± 0.05 - 
DT016 RbsB 127887 ± 12650 1.51 ± 0.02 [39] e 
DT020 DT016 87877 ± 21152 1.48 ± 0.07 V10I f 
DT021 DT016 151009 ± 22735 1.66 ± 0.09 K206R 
DT022 DT016 132129 ± 25700 2.09 ± 0.16 G89V 
DT032 DT022 95492 ± 34689 2.97 ± 0.37 L170S 
DT033 DT022 100256 ± 50431 2.63 ± 0.59 L201P   S207P   K250R 
DT035 DT022 95073 ± 23566 2.60 ± 0.50 K5N 





Random mutagenesis of 2nd generation mutant RbsB proteins with 13CHD affinity 
Because of the accumulation of truncated gene variants in the libraries we decided to create 
three new RMLs based on the newly isolated (slightly) improved DT variants (DT020, DT021 and DT022, 
Table 1). These libraries (RML020, RML021 and RML022, with estimated sizes of 1.5 x 106, 3 x 106 and 
2.5 x 106 clones, respectively) were again encapsulated to individual cells, grown to microcolonies and 
screened both under uninduced and 13CHD-induced conditions. In this screening, only beads with a 
fluorescence signal higher than the maximum observed signal under non-induced conditions for the 
same number of screened beads, were collected. These mutants were purified and screened in 96-well 
plates in 13CHD-induced conditions. This resulted in four mutants with consistent and significant 
increase of 13CHD-dependent induction of GFPmut2 fluorescence and/or reduced background in 
absence of 13CHD (Table 1, n = 8–14 replicates). Three of those mutants displayed a single amino acid 
substitution, and one (DT033) showed three substitutions (Table 1). In one case (DT035) the 
substitution affected an amino acid in the signal peptide. Mutants DT033 and DT035 showed a similar 
fold induction, around 2.6 times, in presence of 13CHD (n = 9 – 12 replicates, Table 1). Mutants DT032 
and DT038 were the most promising, with fold-inductions of 2.97 ± 0.37 and 3.19 ± 0.48 times (n = 13 
– 14 replicates, Table 1). All four mutants displayed a reduction in GFPmut2 fluorescence in absence 
of inducer in comparison to parental DT016, except DT033. The highest reduction was observed with 
DT038, with a background reduction of approximately 2 times (Table 1). 
 
Figure 1- GFPmut2 fluorescence of E. coli BW25113 ΔrbsB expressing DT016 (white diamonds), DT022 
(light grey triangles) DT032 (dark grey squares) or DT038 (black circles) in presence of different 13CHD 
concentrations. A) Average GFPmut2 fluorescence in flow cytometry after 2 h incubation with a range 
of 13CHD concentrations. B) As (A), but as fold induction compared to uninduced conditions. Each 
point shows the mean of 8 biological replicates (each from a 100 000 cells’ measurement). Error-bars 
Random and semi-random mutagenesis 
71 
 
indicate calculated SD (not visible when inside the symbol). Dashed line represents the non-induction 
level. 
 
GFPmut2 fluorescence in E. coli cells expressing DT016, DT022 DT032 and DT038 displayed a 
typical dose-dependency at different 13CHD concentrations (Fig. 1). For the four mutants, the 
GFPmut2 fluorescence signal after 2h induction was saturated at 0.5–0.75 mM 13CHD with 1.5 – 3 
times fold induction (Fig. 1B). Higher concentrations of 13CHD, up to 2.5 mM, did not lead to further 
increase of fluorescence (Fig. 1A, p = 0.06 – 0.99, t-test equal variance, n = 8 replicates). The lowest 
concentrations of 13CHD that yielded significant induction compared to medium without inducer after 
2h incubation were 0.25 mM for DT022 and DT032 and 0.5 mM 13CHD for DT032 and DT038 (Fig. 1B).  
The four 3d generation (e.i., DT032, DT033, DT035 and DT038) mutants were subsequently 
used to create four new random mutagenesis libraries, which were screened as before, but this did 
not lead to isolation of mutant proteins with improved induction with 13CHD (i.e., more than 3 times 
GFPmut3 fluorescence increase upon induction compared to uninduced levels). Interestingly, 
however, we noted that populations of several mutants displayed double fluorescence levels 
simultaneously, almost irrespectively of 13CHD presence (Fig. 2). These subpopulations corresponded 
to completely uninduced and fully induced fluorescence levels seen from wild-type RbsB with ribose 
(Fig. 2A, Low_Pop and High_pop). For example, mutant 1F6 displayed one subpopulation with a mean 
fluorescence value of 15,000 and a second of 220,000 (Fig. 2B). The proportion of cells within the low 
and high subpopulation was approximately 36 % and 62 %, respectively. Upon 2h incubation with 1 
mM 13CHD the proportion of cells within either subpopulation change to 25 % and 74 %, respectively 
(Fig. 2B). Similar results were obtained with mutant 2C10, showing a reduction of 8 % in the proportion 
of cells within the low fluorescence subpopulation upon 13CHD induction, and an increase of 9% in the 
high subpopulation (Fig. 2C). Mutant 1F8 displayed a different behaviour, with an almost equal 
proportion of cells distributed between the low and high subpopulations under uninduced conditions; 
but an increase up to 87% within the subpopulation with lowest fluorescence in presence of 13CHD 
(Fig. 2D).  
Across multiple tests and replicates, the proportions of cells within those subpopulations 
differed substantially, making it hard to judge whether this was consistent behaviour one would expect 
from an inducible protein. This suggested, therefore, that these mutants had become hypersensitive 
and spontaneously switched between open (i.e., uninduced signal) and closed (i.e., induced) state at 






Figure 2- DT038-derivative mutants displaying subpopulations with two fluorescence states. Low_Pop 
and High_Pop represents cells with low and high fluorescence levels, respectively. Proportions of cells 
within both gates are indicated. A) Wild-type RbsB uninduced and induced with 0.1 mM. B)–D) As (A), 
but for mutant 1F6, 2C10 and 1F8 induced with 1 mM 13CHD. Each density plot shows 100 000 cells.  
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Positions of 2nd and 3rd generation mutations with improved induction with 13CHD 
The positions of the amino acid substitutions observed in the various new mutants (Table 1) 
were threaded on the closed structure of wild-type RbsB (PDB ID: 2DRI). Six out the seven isolated 
mutants displayed a single amino acid substitution. Exception was DT033 that displayed three amino 
acid changes. Mutant DT020 displayed a conservative substitution within the signal peptide (V10I) 
(Table 1). DT021 and DT022 displayed conservative amino acid substitutions K206R and G89V, 
respectively (Fig. 3A, Table 1). The V89 residue of DT022 is located within the binding pocket, 1.9 Å 
from the 13CHD molecule (Fig. 3A). This suggests that the G89V substitution is directly responsible for 
the 50 % increase of GFPmut2 fluorescence upon 13CHD induction, when compared to its parent 
DT016 [39]. Previous studies demonstrated the importance of residue 89 for ligand binding [37-39], 
suggesting that V89 improves the capacity to bind 13CHD in comparison with G89. Finally, mutation 
K206R found in DT021 is located in a peripheral turn of the structure (Fig. 3A).  
Two out of the four 3rd generation mutants displayed non-conservative mutations, notably, 
DT032 had a leucine at position 170 instead of serine, whereas DT033 displayed a S207P substitution. 
DT033 showed two conservative mutations (L201P and K250R; Fig. 3A, Table 1). Mutant DT035 again 
displayed a mutation in the signal peptide (K5N). This and the V10I substitution of DT020 in the signal 
peptide may have improved the translocation and/ or stability of the mutant protein. Of the other five 
substitutions observed in this 3rd round of evolution, three (L170S, L201V and K250R) were located 
outside the binding pocket in three different α-helices of the protein (Fig. 3A). The two others (K206R 
and S207P) were localized in a peripheral turn of the protein structure (Fig. 3A). All of them led to an 
increase of the fold–induction with 13CHD (Table 1). However, their peripheral position suggested they 
play a role in protein stability and not directly in ligand binding. Interestingly, five out the seven 
substitutions found in 2nd and 3rd generation mutants localized in the same region of the protein (Fig. 
3A), suggesting that changes in that area improve protein function (e.g., stability or intramolecular 
hinge movement). Interestingly, leucine at position 201 was substituted twice independently by two 
different amino acids (i.e., proline and valine), underscoring its critical role. None of the positions 
recovered in these DT variants for 13CHD binding had been previously described as critical for the 





Figure 3- Positions of amino acid substitutions observed in various 13CHD mutants, visualized on the 
closed structure of wild-type RbsB (PDB ID: 2DRI). A) Mutated residues in 2nd (blue) and 3rd generation 
mutants (pink). B) Acquired mutations in DT038, seen as a superposition of 1st (orange, in DT016; the 
original Rosetta designed binding pocket mutations), 2nd (blue, in DT022) and 3rd generation mutations 
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(pink). C) Superposition of wild-type RbsB (PBD ID: 2DRI, blue), and the threaded DT038 structure (light 
grey). D) Details view from C) panel, showing the interaction between ligand and residues located at 
89 position. Asp89 of RbsB and Val89 of DT038 are colored in purple and blue, respectively. Light green 
line indicates a H-bond. Molecular structures of 13CHD (red) are placed in the binding pocket. Signal 
peptide mutations are not shown on the structure as this is cleaved off. 
 
To further infer potential structural changes of observed mutants in comparison to wild-type 
RbsB, we used Swiss-Model [41-45], Phyre2 [46] and Missense3D [47]. Swiss-Model, Phyre2 did not predict 
any structural differences of the new mutations compared to the closed structure of wild-type RbsB 
(Fig. 3C, shown for DT038). Analysis of each of the eight amino acid substitutions in DT016 by 
Missense3D indicated expansion of the binding cavity by F16S and R90S, and H-bond breakage by D89V 
and T135A. This was expected, since these were designed and engineered ligand binding pocket 
mutations to accommodate 13CHD. However, none of other four mutations in DT016 were predicted 
by Missense3D to cause any (individual) structural difference compared to RbsB. Interestingly, the 
G89V mutation in DT022 compared to DT016 (or D89V compared to wild-type) was predicted to cause 
further expansion of the ligand binding pocket and to H-bond breakage (Fig. 3D). This is probably the 
consequence of replacing a buried amino acid (Gly) by an exposed one (Val). Other individual amino 
acid substitutions, found in other isolated mutants, were not predicted to cause any structural 
difference compared to wild-type RbsB, but we acknowledge that Missense3D only tests single 















DNA shuffling and site saturation mutagenesis 
Rescreening of the 2nd round RML002 and RML016 libraries, led not only to the isolation of the 
second generation mutants (e.i., DT020, DT021 and DT022) but to 8 more variants as well (Table 2). 
Individual retesting of those eight variants showed no change in the mean fold-induction of GFPmut2 
in presence of 1 mM 13CHD compared to DT016 itself (Table 2, p = 0.245 – 0.89, n = 6 replicates). On 
the other hand, five mutants (named here: 2H2, 7B2, 7B9, 7C5 and 7G4) displayed a lower background 
fluorescence in uninduced conditions, when compared to DT016 (Table 2, p = 0.01 – 0.00001, n = 6 
replicates).  The highest background reduction was two-fold, observed in 7G4 mutant (Table 2).  The 
lower fluorescence background suggests a better equilibrium between open and closed conformation. 
The DNA of the 8 mutants was then shuffled in the hope to create synergetic effects, but no mutant 
with improved induction by 13CHD was isolated from this screening. 




Fold induction b 
1 mM 1,3- cyclohexanediol 
New mutation(s) c 
Wild-type 25226 ± 4066 d 0.91 ± 0.05 - 
DT016 160622 ± 33495 1.87 ± 0.26 e 
2H12 112793 ± 16657 2.01 ± 0.13 Q80R 
3B11 157805 ± 24521 1.88 ± 0.13 V17E  T58A 
5H2 128273 ± 13989 1.97 ± 0.11 K29R  A214T 
6H9 132217 ± 12670 1.92 ± 0.1 I132T 
7B2 95166 ± 8064 1.97 ± 0.11 T93M 
7B9 91342 ± 14436 1.75 ± 0.06 T10A 
7C5 85631 ± 15553 1.89 ± 0.14 N175S  K228Q  T232D 
7G4 78653 ± 8090 1.81 ± 0.16 N73S 
a Mean ± one SD GFPmut2 fluorescence values of uninduced cultures (n = 6 – 8). b Mean fold induction 
± one SD, as the ratio of the mean GFPmut2 fluorescence of induced cultures with 1 mM 13CHD and 
the mean fluorescence of uninduced cultures. c Newly observed mutations in comparison to DT016. d 
Values in bold are statistically significantly different from those of DT016 (p < 0.05, t-test, equal 
variance). e DT016 carries eight mutations compared to wild-type RbsB: F16S, N64V, D89V, R90S, 
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Computational simulations had previously suggested nine amino acids as being critical for 
changing the specificity of RbsB protein to 13CHD [39]. Two residues were later found by ala-substitution 
scanning to be important for ribose binding (R141 and D215) [38]. We therefore tested whether site-
saturation mutagenesis of these residues could further improve DT002 and DT016 variants for 13CHD 
induction (Fig. 4). Replacement of R141 and D215 by each of the other 20 possible amino acids was 
confirmed by sequencing and 250 colonies of each site saturation library were tested individually by 
flow cytometry for gain of 13CHD induction. None of the tested mutants from DT002R141X, DT002D215X, 
or DT016R141X and DT016D215X libraries showed improved 13CHD induction, compared to parental 
strains, whereas several were worse. However, this showed that R141 in mutant DT016 can be 
replaced by a serine without impairing inducibility by 13CHD.  
 
 
Figure 4- Inferred binding pocket of DT016 in presence of 13CHD (in red) and with the substituted 
residues for ligand binding color-coded based on characteristics (nonpolar- orange; polar- green). A) 
Arginine at position 141, selected for site saturation mutagenesis, is highlighted in dark blue. Distance 






Mutagenesis of neighboring residues in DT016 
 Finally, we tested whether substitutions in the direct neighborhood of the previously 
engineered ligand binding pocket mutations would affect induction by 13CHD, through synergistic or 
compensatory effects on the overall protein function or behaviour. For this we focused again on 
DT016, the most promising mutant with newly obtained specificity to 13CHD [39]. Next, we designed a 
strategy to mutate the two amino acids flanking (i.e., those before and after) each of the eight ligand 
binding pocket mutations of DT016 (Fig. S2). We reconstituted the dt016 open reading frame in 12 
overlapping PCR fragments (Fig. 5A). PCR primers covered the regions of the eight introduced 
mutations in DT016, with flanking amino acids of those being replaced by all other 20 possible amino 
acids (Table 3). The disadvantage of this strategy was that stop codons could not be avoid in primer 
design. A library with an estimated size of 1 x 106 clones (RML-DT016AA) was screened as before by 
agarose encapsulation and flow cytometry. As expected, a large fraction of clones carried truncated 
proteins (75% from 25 randomly picked colonies from the library on plates). None of the clones 
displayed higher fold induction than DT016 itself. We concluded that this strategy was not worth 
further pursuing.  
 
 
Figure 5- Flanking residue mutagenesis. A) Scheme of the design strategy to reconstitute dt016 with 
12 overlapping primers (purple), positioned at the sites of the previous ligand binding pocket 
mutations, and each covering the two neighboring codons on each side. The assembly was carried out 
in 3 steps (A, B and C) and followed by a final extension reaction with external primers (orange). Gene 
not drawn to scale. B) Inferred structure of DT016 based on RbsB structure (PDB ID: 2DRI). Molecular 
structure with 13CHD (red) bound in its pocket. The eight designed substitutions in DT016 are 
highlighted in orange and flanking residues mutated with this strategy are highlighted in green. 
 





Periplasmic binding proteins (PBPs) have been used as a starting point to design new receptor 
proteins [31]. Despite the vast knowledge on PBPs structures and their natural ligands [23], the successful 
design of new ligand binding domains has been very limited so far [48, 49]. Introducing amino acid 
substitutions in a protein is challenging, since they can easily lead to an abnormal function or behaviour 
of the mutated protein [38]. In a previous study nine residues were identified and substituted in the 
binding pocket of RbsB, with the goal to change the binding specificity from the natural ligand ribose 
to the non-natural compound 13CHD [39]. Despite the modest achieved success (up to 1.5-fold 
induction with 13CHD), six mutant proteins without ribose recognition but with 13CHD binding were 
isolated. However, the introduced substitutions were assumed to lead to unstable proteins with 
translocation and misfolding issues [39].   
The goal here was to produce and select complementary mutations by random or semi-
random approaches, which might either have a stabilizing effect or further improve 13CHD ligand 
binding, or both. We focused on the previously isolated mutants, which we used as scaffolds for 
mutagenesis. Several rounds of random mutagenesis by ep-PCR and increasing selectivity of sorting of 
bead-grown microcolonies induced with 13CHD, led to recovery of a few mutants with consistently 
higher induction of GFPmut2 fluorescence than their parental strains (up to 3.2-fold at 1 mM 13CHD). 
As these mutants carried substitutions outside the direct ligand binding pocket, we assume that they 
are compensatory mutations that improve functions other than ligand binding itself, for example, 
L170S in DT032 or L201V in DT038. 
In order to maximize our chances to isolate a variant with improve 13CHD binding capacity 
and/ or stability, we used different mutagenesis approaches to create genetic variability. Our semi-
random approaches did not produce the expected results, since no improved variant was isolated from 
created libraries. Site saturation mutagenesis of R141 and D215 residues on DT002 and DT016 resulted 
in decrease of the capacity for induction by 13CHD, except for a R141S substitution in DT016 that did 
not affect inducibility. This indicated that we could not improve the 13CHD induction by replacing R141 
and D215 residues; in contrast, it showed that their presence is essential for 13CHD binding and 
signaling. The importance of both R141 and D215 residues in RbsB for ribose induction and signaling  
[38] and for ligand binding (D215) had been previously demonstrated [37]. Also DNA shuffling did not lead 
to isolation of mutants with potential synergistic improvements, although background reduction in 
absence of inducer was observed (Table 2). Random mutation of the 32 residues flanking the 9 
substitutions engineered for 13CHD ligand binding did not yield improved variants either, possibly 




comparable induction level to their parent DT016 (around 1.5 times). However, given the high number 
of substitutions in these variants (up to 32 amino acid substitutions) the interpretation of their effect 
was impossible. These results indicated that changing several parts of the RbsB-mutant proteins at the 
same time may not be the best way to find variants with improved function. Introducing multiple 
mutations increases the probability to find proteins with improved capacities, but at the same time 
increases the chances to introduce mutations that may impair the protein function. This creates an 
important trade-off, and has to be considered each time when designing and implementing a 
mutagenesis strategy. 
In contrast, random mutagenesis across the complete gene variants led to the isolation of 
seven mutants with significantly improved 13CHD inducibility (up to 3.2 times, Table 1). As these 
consisted relatively large libraries, we conceived two selection and sorting strategies that were more 
or less restrictive in their recovery. In the less restrictive sorting, all beads above the 98th fluorescence 
percentile of the 13CHD induced library were collected. The DNA of the sorted variants was then used 
as template for a new random library, from which we recovered the top 0.1 % fluorescence beads. This 
strategy led to isolation of 3 variants with up to 2.1 times induction with 13CHD. In the more restrictive 
sorting, only beads with a fluorescence higher than any bead under uninduced conditions were 
recovered. Here we isolated 4 mutants with up to 3.2-fold induction by 13CHD. Since both strategies 
allowed us to isolate mutants with improved 13CHD binding capacity, we conclude that the restrictive 
sorting is a better strategy. Being less restrictive is more time consuming and required two rounds of 
cloning and FACS screening, plus leading to more downstream screening of individual clones. More 
restrictive sorting thus significantly reduces the time to screen potential mutants. A disadvantage of 
the restrictive strategy is that mutants are missed, which have low fluorescence background under 
uninduced conditions and intermediate fluorescence upon induction (i.e., a fluorescence signal less 
than the maximum observed in the uninduced library). Alternatively, one could try to ‘bin’ mutants in 
different fluorescence categories in the hope of finding some with lower fluorescence backgrounds 
and still some induction. The difficulty is that a priori the evolutionary path of a variant highly inducible 
by 13CHD is not known and may pass through intermediates with high uninduced levels to regain 
background, or through those with low uninduced levels and gain specificity [14, 15, 50]. Selectively 
focusing on the high fluorescence makes for an easier screening.  
Multiple rounds of mutagenesis thus allowed to improve 13CHD binding capacity in a step-by-
step manner. This suggests that further rounds of random mutagenesis could eventually lead to the 
isolation of a variant with similar binding capacity to 13CHD as wild-type RbsB towards ribose (13 fold) 
[39], although we could not achieve that here. Some studies show that multiple rounds of evolution are 
needed to improve a specific protein ability without impairing the protein [51]. 




What can we conclude from the obtained DT variants in terms of amino acid substitution 
effects? Two mutants (DT020 and DT035) displayed an amino acid substitution in the signal peptide 
(V10I and K5N). The improved 13CHD induction might have been due to higher periplasmic protein 
levels, being the result of a positive effect on peptide recognition by SecB chaperone, responsible for 
presenting RbsB to the translocation channel, and or improved stability. Only one variant (DT022) 
carried a substitution (G89V) in the binding pocket (Fig. 3A and 3D). This residue is less than 2 Å away 
from inferred position of 13CHD and previous studies demonstrated the importance of residue 89 for 
ligand binding [37-39]. An exposed valine residue at this position thus seems to improve 13CHD binding, 
yielding a 50 % higher fold induction when compared with parent DT016 (Table 1). All other mutations 
were found outside the binding cavity, and we assume that they must have improved other aspects of 
protein functionality than ligand binding itself. This could affect, for example, protein stability or 
improved hinge flexibility, or binding to the chemoreceptor Trz1. Five out the seven mutations were 
located in the same peripheral region of the protein (Fig. 3A), but none concerned positions previously 
implicated in RbsB functioning by Ala-substitution scanning [38]. Leucine at position 201 was replaced 
by two other non-polar residues in two different isolated mutants and neighboring residues K206 and 
S207 were replaced by arginine and proline, respectively. The concentration of observed mutations in 
this region suggests that previous introduced mutations, possibly, disturbed this region of the protein 
and compensatory mutations were needed. This specific region of the protein, therefore, could be a 
promising target for future rounds of mutagenesis, aiming to find variants with better overall function. 
Importantly, the new variants were not only a higher induced by 13CHD, but also displayed reduced 
fluorescence background, especially DT032, DT035 and DT038. This is further evidence that these 
mutations play an important role in the stabilization of the protein.  
The two most promising mutants DT032 and DT038 displayed similar threefold induction in 
presence of 13CHD, mostly as a result of background reduction in absence of inducer (Table 1). The 
variants react in a dose-dependent manner, with the lower detection limit around 0.25 mM 13CHD, 
which gives further credence that these DT variants are genuine new ligand-binders. Moreover, we 
could observe the 3rd generation mutation (e.i, DT032 and DT038) displayed a higher fold induction 
than 1st and 2nd generations mutants (e.i., DT016 and DT022, respectively) (Fig. 1B). Confirming that 
introduced mutations improve the binding capacity and/or the overall function of these variants. It 
would be interesting to confirm this by protein purification and determining in vitro stability and 





Creation of new ligand-binding cavities in PBPs had been heralded more than a decade ago as 
one of the key advance areas for computational protein design [52], but more recent de novo design of 
protein (and peptide) structure design have focused more on small-molecule-binding proteins [53], 
switchable/ allosteric capacity [54], protein folding [55] and epitopes scaffolds design [56]. Much of the 
initial claimed successes of PBP ligand pocket engineering has not hold the scrutiny of independent 
repetitions [29, 48]. Different advances have been reported, such as by grafting of existing ligand pockets 
and de novo design of 13CHD binding [32, 33, 39]. It might thus well be that, in contrast to the original 
assumption of a wide protein family with known crystal structures of open and closed configurations, 
PBPs are actually particularly difficult to engineer. The reasons may be that PBPs need an inherent 
intramolecular protein movement between open and closed configuration and have manifold 
functional constraints, such as ligand binding, binding to the receptor, or translocation. Current ligand 
pocket predictions do not take the other constraints into consideration, which make complete rational 
computational design challenging. 
For example, in the RbsB-based bioreporter configuration wild-type- and mutant-RbsB 
proteins have to be expressed and translocated to the periplasmic space. Once in the periplasmic they 
recognize and bind their ligand, leading to a conformational change of the protein [34, 57]. Subsequently, 
the closed form of the protein binds the hybrid Trz1 receptor, starting a phosphorylation cascade that 
in the end leads to induction of GFPmut2 expression [29]. It is important to understand that if an 
introduced mutation affects a single of these steps the final outcome (e.i., GFPmut2 signal) is affected. 
The transition between open and closed conformation is extremely important for PBPs with bilobal 
structure such as RbsB. It is assumed that PBPs in absence of ligand can be found in a dynamic 
equilibrium of open and close state [48, 58], which is important for their function. Similar characteristics 
are observed in other PBPs, for example in the closely related galactose-binding protein of E. coli [59].  
In presence of the proper ligand, the closed form is stabilized [48] and, like in case of RbsB can present 
the ligand molecule (ribose) to either the chemoreceptor (i.e., Trg and Trz1) or to ribose transport 
channels [24, 60, 61]. We observed that introduced mutations can block RbsB variants in either of the two 
states, and consequently, disable its function to bind the ligand and trigger the bioreporter system, or 
trigger the receptor signaling cascade without binding the ligand. We also observed RbsB-DT variants 
that in the E. coli bioreporter strain caused ‘stable’ double populations with different GFPmut2 
fluorescence intensities both in absence or in presence of inducer. This is in contrast to wild-type RbsB 
behaviour, which (despite reported open-closed form dynamics in absence of ligand) in absence of 
ribose results in coherent low reporter output and in its presence in coherent high fluorescence. This 
suggests that the time-scale of the dynamics is affected by the introduced mutations, blocking the DT 
variants in either open or closed form long enough to trigger (or not) the bioreporter signaling cascade 
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leading to GFP expression. This is supported by the fact that these subpopulations corresponded to 
completely uninduced and fully induced fluorescence levels seen from wild-type RbsB with ribose (Fig. 
2). A small percentage of the low fluorescence population shifts to high fluorescence upon induction, 
indicating that ligand-binding is still affecting the transition states, but is insufficiently discriminating 
between the two (Fig. 2B and 2C). Further biochemical characterization of such protein variants may 
be interesting from the point of view of observing the transition states. 
 
 In conclusion, the results obtained in this study showed that it is possible to improve the ligand 
binding capacity and stability of previously designed RbsB mutants with de novo ligand binding pockets 
using random mutagenesis. Unfortunately, despite extensive library screening, we could not improve 
the 13CHD bioreporter system to more than 3-fold induction and 0.25 mM lower detection limit (in 2 
h assay), which is not yet comparable to that of RbsB and ribose (13-fold induction and 50 nM lower 
detection limit) [29, 39]. This suggests that further randomized screening from existing variants by 
bioreporter output itself may not be on the proper ‘evolutionary path’ [15, 50, 62]. Of note that the 
screening approach we used here would ignore potentially interesting other variants, for example, that 
have better translocation, binding of 13CHD and stabilizing the closed conformation, but that are 
unable to interact and bind Trz1. For this reason, follow-up studies should focus on other functional 
constraints in the bioreporter cascade, such as protein translocation, folding, ligand binding, 
conformational change, stability and receptor binding. The complete set of mutants thus obtained may 






Table 3- Strain list used in this study. 
 
Strain E. coli host Plasmids Relevant characteristics 
Reference 
or source 
3044 DH5αλPir  Host for plasmid propagation [63] 
3671 DH5α pSTVPAA_mcs pSTVPAA to clone rbsB and its derivatives [29] 
4172 BW25113 ΔrbsB pSYK1 Host strain containing the Ptac- trzI, PompC- gfpmut2 bioreporter system [29] 
4175 BW25113 ΔrbsB pSTVPAA_rbsB, pSYK1 RbsB expression with signal peptide for periplasmic translocation [29] 
5913 BW25113 ΔrbsB pSTVPAA_DT001, pSYK1 As 4175, but for DT001 mutant protein of RbsB [39] 
5903 BW25113 ΔrbsB pSTVPAA_DT002, pSYK1 As 4175, but for DT002 mutant protein of RbsB [39] 
5904 BW25113 ΔrbsB pSTVPAA_DT011, pSYK1 As 4175, but for DT011 mutant protein of RbsB [39] 
5905 BW25113 ΔrbsB pSTVPAA_DT013, pSYK1 As 4175, but for DT013 mutant protein of RbsB [39] 
5906 BW25113 ΔrbsB pSTVPAA_DT015, pSYK1 As 4175, but for DT015 mutant protein of RbsB [39] 
5907 BW25113 ΔrbsB pSTVPAA_DT016, pSYK1 As 4175, but for DT016 mutant protein of RbsB [39] 
7241 BW25113 ΔrbsB pSTVPAA_DT020, pSYK1 As 4175, but for DT020 mutant protein of RbsB This work 
7242 BW25113 ΔrbsB pSTVPAA_DT021, pSYK1 As 4175, but for DT021 mutant protein of RbsB This work 
7243 BW25113 ΔrbsB pSTVPAA_DT022, pSYK1 As 4175, but for DT022 mutant protein of RbsB This work 
7244 BW25113 ΔrbsB pSTVPAA_DT032, pSYK1 As 4175, but for DT032 mutant protein of RbsB This work 
7245 BW25113 ΔrbsB pSTVPAA_DT033, pSYK1 As 4175, but for DT033 mutant protein of RbsB This work 
7246 BW25113 ΔrbsB pSTVPAA_DT035, pSYK1 As 4175, but for DT035 mutant protein of RbsB This work 
7247 BW25113 ΔrbsB pSTVPAA_DT038, pSYK1 As 4175, but for DT038 mutant protein of RbsB This work 
2H12 BW25113 ΔrbsB pSTVPAA_2H12, pSYK1 As 4175, but for 2H12 mutant protein of RbsB This work 
3B11 BW25113 ΔrbsB pSTVPAA_3B11, pSYK1 As 4175, but for 3B11mutant protein of RbsB This work 
5H2 BW25113 ΔrbsB pSTVPAA_5H2, pSYK1 As 4175, but for 5H2 mutant protein of RbsB This work 
6H9 BW25113 ΔrbsB pSTVPAA_6H9, pSYK1 As 4175, but for 6H9 mutant protein of RbsB This work 
7B2 BW25113 ΔrbsB pSTVPAA_7B2, pSYK1 As 4175, but for 7B2 mutant protein of RbsB This work 
7B9 BW25113 ΔrbsB pSTVPAA_7B9, pSYK1 As 4175, but for 7B9 mutant protein of RbsB This work 
7C5 BW25113 ΔrbsB pSTVPAA_7C5, pSYK1 As 4175, but for 7C5 mutant protein of RbsB This work 
7G4 BW25113 ΔrbsB pSTVPAA_7G4, pSYK1 As 4175, but for 7G4 mutant protein of RbsB This work 




Table 4- List of primers used to introduce new mutations in RbsB-derivate proteins. NNN indicates mutated positions for production of the libraries. 
 
Mutagenesis Technique Target Primers DNA sequence (5' to 3') 
DNA shuffling 




130401 R CTGAGCACATCAGCAGGAC 
rbsB (inner primers) 
160401 F CACGACGTTGTAAAACGACGGCC 
190102 R CTGGCTACCCTGGTTTCCGCTG 
Site saturation mutagenesis  
pSTVPAA-DT002R141X 
180901 F GAAGCCTTCGCCNNNTTCACGGGCTGCGGACGCACC 
180702 R GCAGCCCGTGAANNNGGCGAAGGCTTCCAGCAGGCC 
pSTVPAA-DT002D215x 
180705 F ATCCGGTGTACCNNNAGCTCCGACGACCATCACATC 
180706 R GTCGTCGGATCGNNNGGTACACCGGATGGCGAAAAA 
pSTVPAA-DT016R141X 
180901 F GAAGCCTTCGCCNNNTTCACGGGCTGCGGACGCACC 
180702 R GCAGCCCGTGAANNNGGCGAAGGCTTCCAGCAGGCC 
pSTVPAA-DT016D215x 
180901 F ATCCGGTGTACCNNNCGCTCCGACGACCATCACATC 













Table 5- List of primers used to introduce new mutations close to pre-existing mutations on DT016 protein. NNN indicates positions for introduction of random 
amino acids.  
Primers Target, assembly reaction DNA sequence (5' to 3') 
190201 For dt016 gene, 1st assembly - reaction A 
ATGGCAAAAGACACCATCGCGCTGGTGGTCTCCACGCTTAACAACNNNNNNAGCNNNNNNCTGAAAGATGGCGC
GCAG 
190202 Rev dt016 gene, 1st assembly - reaction A 
TCGCCGGGTTGTTCTGGGAGTCCAGCACCACCAGGTTATAGCCAAGTTTATCCGCCTCTTTCTGCGCGCCATCTTTCA
GNNNNNNGCTNNNNNNGTTGTTAAGCGTGGAG 
190203 For dt016 gene, 1st assembly - reaction A 
AGAACAACCCGGCGAAAGAGCTGGCGAACGTGCAGGACTTAACCGTTCGCGGCACAAAAATTCTGNNNNNNGTG
NNNNNNGACTCC 
190204 Rev dt016 gene, 1st assembly - reaction A 
ACCTTTCGTNNNNNNGCTGCCNNNNNNGATAACCGGGATGTTCGCCTGGTTAGCCATCTTCACAGCATTACCCACT
GCGTCGGAGTCNNNNNNCACNNNNNNCAGAATTTTTGT 
190205 For dt016 gene, 1st assembly - reaction B 
TCCCGGTTATCNNNNNNGGCAGCNNNNNNACGAAAGGTGAAGTGGTGAGCCACATTGCTTCTGATAACGTACTG
GGCGGCAAAATCGCTGGTGATTACATCGCG 
190206 Rev dt016 gene, 1st assembly - reaction B 
ACGTTCACGGGCNNNNNNCGCNNNNNNAATGCCTTGCAGCTCGATAACTTTGGCACCTTCACCCGCTTTCTTCGC
GATGTAATCACCA 
190207 For dt016 gene, 1st assembly - reaction B 
AGGCATTNNNNNNGCGNNNNNNGCCCGTGAACGTGGCGAAGGCTTCCAGCAGGCCGTTGCTGCTCACAAGTTTA
ATGTTCTTGCCAGCCAGCCANNNNNNTGGNNNNNNATTAAAGGT 
190208 Rev dt016 gene, 1st assembly - reaction B 
CCCAGCGCCATNNNNNNGTTNNNNNNGAATACAGCCTGAACATCCGGATGAGCGGTCAACAGGTTCTGCATTAC
GTTCAAACCTTTAATNNNNNNCCANNNNNNTGGCTGGCTGGC 
190209 For dt016 gene, 1st assembly - reaction C 
GGCTGTATTCNNNNNNAACNNNNNNATGGCGCTGGGCGCGCTGCGCGCACTGCAAACTGCCGGTAAATCGGATG
TGATGGTCNNNNNNGCGNNNNNNACACCGGATGGCGA 
190210 Rev dt016 gene, 1st assembly - reaction C 
AATCTGATCNNNNNNCATNNNNNNAGTCGCTGCTAGTTTGCCATCATTCACCGCTTTTTCGCCATCCGGTGTNNN
NNNCGCNNNNNNGACCATCACATC 
190211 For dt016 gene, 1st assembly - reaction C 
AGCAGCGACTNNNNNNATGNNNNNNGATCAGATTGGCGCGAAAGGCGTCGAAACCGCAGATAAAGTGCTGAAA
GGCGAGAAAGTTCAGGCTAAG 
190212 Rev dt016 gene, 1st assembly - reaction C 
CAAGCTTGCATGCCTGCAGGTCGACTCAGTGGTGGTGGTGGTGGTGGAGCTGCTTAACAACCAGTTTCAGATCAAC
CGGATACTTAGCCTGAACTTT 
190301 For pSTVPAA before dt016 gene, final extension TGCGAATGCGATGGCAAAAGACACCATCGC 
190302 Rev pSTVPAA after dt016 gene, final extension ACGGCCAGTGCCAAGCTTGCATGCCTGCAGG 
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Material and Methods 
 
Bacterial strains and culture conditions 
Expression of the RbsB-Trz1-ompCp-gfpmut2 signaling chain (or the RbsB variants) was tested 
in E. coli BW25113 ΔrbsB as host. In this case, cells were cultured in minimal medium (MM) 
supplemented with 20 mM fumarate. For selection of mutants by fluorescence activated cell sorting, 
cells were first grown within alginate beads in low phosphate minimal medium (MM LP) supplemented 
with 20 mM fumarate and appropriate antibiotics to produce microcolonies, as described previously 
[39]. The cells-in-beads were then induced with 0.1 mM ribose or 1 mM 1,3-cyclohexanediol (13CHD) 
for 2 h, as described previously (Chapter 1). E. coli DH5α cells were used for cloning and plasmid 
propagation. Random libraries were transformed into ElectroMAX DH10B T1 Phage-Resistant 
competent cells (Thermofisher). 
All strains used in this study are listed in Table 3. 
 
Random mutagenesis libraries and plasmid construction 
 Mutations in the rbsB gene or its dt variants were generated by error-prone PCR (ep-PCR). 
Gene variants were amplified by primers flanking the coding sequence in the plasmids pSTVPAA-DTxxx 
and located up- and downstream of the SalI and NdeI sites (Fig. S1). Ep-PCR reactions were carried out 
with 4 ng of DNA template in presence of varying MnCl2 concentrations (0.025–0.06 mM).  Six reactions 
were prepared simultaneously to average stochastic biases. After an initial denaturation period of 10 
min at 94°C, the following steps were repeated for 25 cycles: 1 min at 94°C, 1 min at 70°C and 1.5 min 
at 72°C, followed by an extension of 10 min at 72°C. Amplicons were then visualized by agarose 
electrophoresis, and products of around 1 kb were excised, pooled and purified. Purified PCR products 
and pSTVPAA plasmids were digested with SalI and NdeI at 37°C and 300 rpm for 45 min. Plasmid self-
ligation was prevented by treating the digested plasmid with Shrimp Alkaline Phosphatase (rSAP, NEB). 
The digestion products were visualized by agarose electrophoresis, and the correctly sized digested 
bands were excised from the gel and purified.  
Plasmid and amplicon fragments were ligated with T4 DNA ligase using a ratio of 1:2 vector to 
insert. The ligation mixture was incubated overnight at room temperature, and aliquots of 100 were 
electro-transformed into ElectroMAX DH10B cells. Cells were recovered after the electroporation by 
addition of 1 mL of SOC medium, pooled from five separate reactions and incubated for 1h30 at 37°C, 




number of CFUs in the libraries. The remainder was cultured en masse in 200 ml LB medium (Cm), 
which was used to isolate and purify a plasmid-library pool. Aliquots of 1.6 mL of the grown culture 
were stored in 15% (v/v) glycerol at - 80°C. Five aliquots of each 100 ng of purified pSTVPAA-mutant 
plasmid pool were then re-transformed into the bioreporter strain E. coli BW25113 ΔrbsB, for testing 
of ribose- and 13CHD-dependent expression of GFPmut2. Library aliquots were again stored at - 80°C. 
 
DNA shuffling and site saturation mutagenesis 
 As alternative to ep-PCR we used DNA shuffling to create new rbsB variants. For this we used 
eight rbsB variants as template (Table 2), which were amplified by PCR using primers outside the coding 
regions and beyond the XcmI and SalI sites (Fig. S1, Table 4). PCR-amplified templates (200 ng each) 
were mixed and digested with 0.5 U of DNase I for 3 min at 15°C, after which the reaction was 
inactivated at 80°C for 10 min.  Subaliquots of 200 ng of fragmented DNA were then reassembled by 
PCR in progressive hybridization in presence of 2.5 U of GoTaq polymerase and 200 µM of each dNTP 
in the following temperature cycles. After an initial denaturation period of 2 min at 94°C, the following 
steps were repeated for 35 cycles: 40s at 94°C, 90s from 65°C to 41°C in intervals of 3°C and 90s at 
68°C, followed by a final 30 min period at 68°C. The PCR reassembly products were next re-amplified 
with primers located inside the previous ones (Fig. S1, Table 4), visualized by agarose electrophoresis 
and 1–kb DNA bands were isolated and purified.  These products were digested with XcmI and SalI and 
ligated to pSTVPAA digested with the same enzymes. Ligation mixture aliquots of 100 ng each were 
then transformed into the bioreporter strain E. coli BW25113 ΔrbsB. 
 Positions R141 and D215 in the DT002 and DT016 were changed by site-saturation 
mutagenesis. For this, the entire plasmid(s) pSTVPAA-DT002 or -016 (5 ng) was amplified by Q5 High-
Fidelity DNA polymerase using overlapping but reverse complementary primers with ambiguous bases 
at the desired positions (Fig. 4, Table 4). PCR products were digested with DpnI to remove template 
DNA and after enzyme inactivation were directly transformed into the bioreporter strain E. coli 
BW25113 ΔrbsB. Variant genes were confirmed by sequencing. 
 
Mutagenesis of neighboring residues in DT016 
In order to reconstitute the rbsB gene 12 overlapping primers were designed (Table 5). 
Assembly of the 12 designed primers was carried out in 2 steps. In the first step, primers were divided 
in 3 independent annealing groups (Fig. 5A). Reaction for every group was performed with 200 µM of 
dNTPs, 50 nM of each primer and 0.02 U/ µL of Q5 High-Fidelity DNA polymerase. After an initial 
denaturation period of 30s at 98°C, the following steps were repeated for 10 cycles: 10s at 98°C, 15s 
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at 45°C and 20s at 72°C, followed by a final 2 min period at 72°C. In the second step, 2 µL of the 3 
independent reactions were mixed with 200 µM of dNTPs and 0.02 U/ µL of Q5 High-Fidelity DNA 
polymerase (same PCR conditions as in step1). PCR products had a final extension reaction with 
external primers, 1 µL of the 2nd assembly reaction was amplified by PCR and reactions were performed 
in triplicate to remove any bias. Initial denaturation period of 30s at 98°C, the following steps were 
repeated for 35 cycles: 10s at 98°C, 30s at 68°C and 30s at 72°C, followed by a final 5 min period at 
72°C. Amplified products were visualized by agarose electrophoresis and 1 kb DNA bands were isolated 
and purified.  Final products were digested with XcmI and SalI and ligated to pSTVPAA digested with 
same enzymes. After overnight ligation with T4 DNA ligase, D5Hα cells were transformed with 100 ng 
of DNA for plasmid replication. After rescue a small percentage of cells were plated and were send for 
sequencing to estimate library size and variability. 
  
RbsB-based bioreporters assays 
 RbsB- or mutant-RbsB based libraries in E. coli, or single purified clones were screened for 
GFPmut2 expression by FACS and/or flow cytometry, as described in detail previously (Chapter 1, [39]). 
In short, library screening of clones was done of cells encapsulated and grown to microcolonies in 
alginate beads, before induction. Beads (microcolonies) expressing higher FITC signal than the set 
thresholds were sorted and collected in tubes containing 1 ml LB medium supplemented with Amp 
and Cm. Sorted mutants were regrown and re-screened either as alginate-bead mixtures or as pure 
cultures in 96-well plates (in at least eight individually grown replicates).  




Flow cytometry induction of GFPmut2 in E. coli cultures was measured in multiple 
independently grown biological replicates (n = 6 – 14). Induction is then expressed as the ratio of the 
mean GFPmut2 fluorescence of induced cultures by that of their uninduced (split) halves. Differences 






Structure threading and analysis 
 Threaded structures of RbsB variants were determined with Swiss-Model [41-45] and Phyre2 [46], 
wild-type RbsB structure (PDB ID: 2DRI) was used as a scaffold. Structural superpositions and distance 
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Figure S1- Scheme of used primers for DNA shuffling and important restrictions sites. Outer and inner 
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Figure S2 – Amino acid sequence of the DT016 variant. Nine residues mutated based on Rosetta 
predictions, 1st generation mutations, are highlighted in yellow. Neighboring residues targeted by site 





An in vivo system to follow wild-type and mutant 
























Periplasmic-binding proteins have been proposed as a general scaffold to design sensor 
proteins with new recognition specificities for non-natural compounds. They can be integrated in 
bacterial bioreporter systems, which produce a concentration-dependent signal after ligand binding 
to the sensor. However, computational based design approaches to create new ligand-binding 
properties ignore more general properties of the protein, such as proper translocation into the 
periplasm, folding and interaction with membrane receptor. This may be one of the reasons for the 
poor success in recent periplasmic-binding protein design studies. 
 To facilitate downstream screening of secondary mutants with potentially improved folding, 
translocation and receptor interactions of periplasmic-binding proteins we developed and tested an in 
vivo system based on mCherry protein fusions and subcellular localisation measurements. As proof of 
concept, we studied translocation and periplasmic localisation of the wild-type ribose-binding protein 
RbsB in Escherichia coli and mutant-RbsB with altered ligand-binding properties obtained through 
protein design and selection. Whereas RbsB-mCherry protein clearly localized to the periplasmic space 
and centered in polar regions depending on chemoreceptor availability, mutant-RbsB-mCherry 
expression resulted in high proportions of cells devoid of clear foci and low proportions of cells with 
multiple fluorescent foci, suggesting poorer translocation and mislocalisation. In addition, polar foci of 
mutants were less fluorescent, suggesting poorer chemoreceptor binding. By spiking further derivative 
mutant libraries generated by error-prone PCR without or with different proportions of E. coli 
expressing wild-type RbsB-mCherry we could estimate the potential improvement and deterioration 
of mutants with wild-type-like periplasmic localisation. Our results show that an in vivo system can be 
used to detect cells expressing mutant proteins with better periplasmic localisation, helping to increase 













Periplasmic binding proteins (PBPs) are part of a large family of proteins with a typical and 
conserved bilobal structure [1, 2]. PBPs are involved in nutrient and mineral scavenging for bacterial cells 
[2], binding specific ligands (e.g., sugars), and presenting the bound molecules to specific transport 
channels and/ or membrane receptor involved in chemotactic movement [3]. Their unique ligand-
binding properties have propelled PBPs as an attractive class of proteins to use for biosensing. PBPs 
can be either purified and their ligand-binding capacity be exploited using in-vitro measurements (e.g., 
isothermal titration calorimetry), or the PBP ligand-binding activity can be integrated in an in vivo 
hybrid signaling chain leading to fluorescent protein expression [4, 5]. In that configuration the presence 
of a ligand to the cell leads to conformational changes of the PBP, which binds to its membrane 
receptor and triggers the synthetic signaling chain. The synthetic signaling chain that has been perused 
for this purpose consisted of RbsB (the ribose-binding protein of E. coli) and its hybrid receptor Trz1 [6], 
formed by fusion between the C-terminal part of the E. coli EnvZ osmoregulation histidine kinase and 
the N-terminal part of the Trg chemotaxis receptor[7]. Addition of ribose to cultures carrying the 
signaling chain starts a phosphorylation cascade that leads to gfp expression[6], which can be easily 
measured in a variety of ways [5]. 
With the aim to expand detection specificity of the biosensors, PBPs have been proposed as a 
scaffold to design novel proteins with new binding capacities. Unfortunately, in vitro and in vivo based 
mutagenesis approaches to design new receptor PBP-based proteins have had limited success and 
shown poorly reproducible outcomes [8-11]. Several studies have shown ligand-binding reconstruction 
through grafting of semi-natural binding pockets [8, 9], but so far there has only been one report of new 
PBP variants for non-natural compound recognition based on redesign of the RbsB ligand-binding 
pocket [12]. Although the obtained RbsB-variants displayed no more ribose recognition, their affinity for 
the new ligand 1,3-cyclohexanediol was much lower (mM-range) and the (purified) proteins suffered 
from poor stability and or misfolding [12].  Since ligand-prediction algorithms, mutagenesis and 
screening methods mostly focused on the ligand-binding properties of the PBP, other key steps of the 
signal transduction chain by the PBP have been largely ignored. For a protein like RbsB in E. coli, this 
involves (i) proper translocation by SecB into the periplasm through the Sec pathway, (ii) proper folding 
in the periplasm enabling ribose-binding, (iii) docking of the RbsB-bound ribose to the transport 
channels (RbsAC) and, partly, to the Trg chemoreceptor [13-15]. Ribose transport in E. coli involves the 
cytoplasmic membrane transporter RbsC and the cytosolic ATPase RbsA to provide energy. Ribose is 
presented to the channel in its bound form by RbsB, and released into the cytoplasm by the ribokinase 




towards ribose upon binding by ribose-bound RbsB [16]. The primary goal of this work was thus to design 
an in vivo screening system that would enable studying the localisation aspects of the RbsB-signaling 
chain with the idea that this might help to improve the selection of mutant RbsB with designed 
different ligand-binding properties for further mutations that favor their proper localisation. 
RbsB mutations introduced to improve ligand-binding do not specifically take into account 
proper translocation into the periplasm after cytosolic expression, and, therefore, such mutants may 
display misfolding and poor translocation into the periplasmic space, which reduces their ligand and 
membrane receptor binding capacity and hence, their signaling capacity. The translocation of fusion 
proteins to the periplasm of Gram-negative bacteria (e.g., E. coli) has been widely studied [17-20]. Due 
to low costs and high production yields E. coli is commonly used as a platform to express and purify 
target proteins (e.g., therapeutic antibodies) [21, 22]. Translocation to the extracellular space offers 
several advantages for protein purification when compared with intracellular expression. Translocated 
proteins do not require disruption of the cellular membranes, suffer less from inclusion bodies, and 
have less contamination with cytosolic proteins[23]. In addition, proteases are less abundant in the 
periplasmic or extracellular space, which is further a favorable environment for folding [24]. 
The two major bacterial translocation mechanisms are i) the twin-arginine translocation (Tat) 
and ii) the ubiquitous general secretion (Sec) pathways [25]. The twin-arginine pathway recognizes a 
twin-arginine pair (RR) in the signal peptide, and translocate its substrate proteins in a complete folded 
form through the Tat translocase [26]. After cytosolic expression and folding the RR motif binds to the 
membrane receptor complex, formed by TatB and TatC. Subsequently, the protein is translocated 
through a membrane pore formed by multiple homooligomeric complexes of TatA [27]. A signal 
peptidase cleaves the signal peptide and the mature protein is released in the periplasm[25]. The Sec 
translocation system is the most important route to export proteins from the cytoplasm to periplasmic 
space[28]. In the Sec system the substrate proteins are translocated in an unfolded state [28]. After 
translation, chaperones (e.g., SecB) protect the substrates from aggregation and maintain them in an 
unfolded configuration. Subsequently, they present the unfolded protein to SecA, which recognizes 
the signal peptide and the protein through the translocase pore SecYEG. The signal peptide is removed 
by peptidase cleavage and the protein is folded and released in the periplasm [25, 29]. 
In order to study the translocation and periplasmic localisation of RbsB and a number of 
previously generated RbsB-mutants with new ligand binding properties [12], we deployed fluorescent 
protein fusions and single cell epifluorescence microscopy. We tested mcherry gene fusions to either 
the 5’- or 3’-end of wild-type rbsB gene, and used either the natural signal peptide of RbsB (and the 
corresponding Sec translocation pathway) or introduced a TorA signal sequence for the Tat pathway. 
PBPs-fluorescent protein variants have been constructed before, but only to improve their purification 




signal peptides are a characteristic consensus motif (S/T-R-R-X-F-L-K) present in all Tat signal peptides, 
which is absent in  Sec-recognized peptides. The choice of optimal translocation and signal peptide 
depends on the fused protein of interest and has to be tested for each case individually [18, 30, 32]. RbsB 
wild-type and mutant-mCherry proteins were expressed in different E. coli backgrounds [12], and 
relative positions of fluorescent foci in individual cells were quantified and compared. Finally, we 
constructed three further random mutation libraries on the basis of the existing ligand-binding 
mutants and spiked those with wild-type RbsB/mCherry to estimate how well mutants with potential 
improved translocation behaviour could be detected using this imaging pipeline. The presented in vivo 
system may be used to highlight signaling deficiencies of PBPs and help to improve mutant selection 























Fusion constructs inform about RbsB expression and translocation  
In order to follow wild-type RbsB expression and distinguish the localisation steps in the ribose-
RbsB mediated signaling cascade, we produced mCherry fluorescence protein fusions. We first tested 
functionality and effects on expression levels of C- or N-terminal fusion positions, driven from two 
different promoters in E. coli and in presence or absence of a different translocation signal sequence. 
RbsB/mCherry fusion constructs introduced on plasmids and expressed from the constitutive PAA 
promoter with the native rbsB signal sequence (nss, Fig. S1) [6], were poorly reproduced in E. coli, 
irrespective of the position of the mCherry tag. E. coli transformants carrying PAA-nss-rbsB-mcherry or 
PAA-nss-mcherry-rbsB grew poorly, and faster growing colonies harbored plasmids with deletions and 
mutations (not shown). In contrast, transformants expressing PAA-rbsB-mcherry without signal 
sequence were viable, showing bright fluorescence (not shown). This indicated that not expression of 
RbsB-mCherry itself, but its translocation was deleterious for the cells.  
In contrast, plasmid-cloned RbsB/mCherry fusion constructs with either the RbsB native signal 
sequence (Nss) or the TorA-signal sequence (TorAss) for the TAT translocation pathway, expressed 
under control of the arabinose-inducible PBAD promotor (Fig. S2) were stably maintained in absence of 
arabinose in E. coli DH5α. However, after 3 h induction with 0.5% L-arabinose, cells expressing 
RbsB/mCherry fusions with the TorAss were longer than cells with the same constructs but carrying 
the wild-type RbsB signal sequence (Fig. 1A–D). Cells expressing TorAss-RbsB/mCherry displayed a size 
range of 8.46 ± 4.8 µm whereas those expressing Nss-RbsB/mCherry were on average 3.50 ± 0.7 µm (p 
= 0.000014, n = 18 replicates, 103 cells per replicate, Fig. 1A-D). In case of the TorAss fused to the N- 
and mCherry to the C-terminal end of RbsB, induction further yielded cells with swollen ends and 
cytoplasmic accumulation of the fusion protein, but without sign of periplasmic localisation (Fig. 1A). 
In contrast, fusing both the torAss and mCherry to the RbsB N-terminus yielded cells with visible 
periplasmic fluorescence, and in some cells, a visible fluorescent spot near the cell poles (Fig. 1B). Much 
clearer periplasmic fluorescence and polar fluorescent spots, however, were obtained for the 
constructs with wild-type RbsB signal sequence to N- and mCherry fused to the C-terminal end (Fig. 
1C). Fusing both wild-type Nss and mCherry to the N-terminus of RbsB again led to very poorly visible 






Figure 1- Effect of fluorescent protein fusion positioning and signal sequences on RbsB expression and 
translocation. A) E. coli DH5α expressing torA-rbsB-mCherry from PBAD. B) as (A) but for torA-mCherry-
rbsB. C) as (A) but for rbsB-mCherry with the native RbsB signal sequence. D) as (C) but for mCherry-
rbsB. E) E. coli DH5α expressing rbsB-mCherry with the native RbsB signal sequence without L-
arabinose induction. F) Induction of rbsB-mCherry from PBAD but without native RbsB signal peptide. 
Fusion constructs are schematically drawn on top of each micrograph (not to scale).  Cells were 
incubated for 3 h and expression of fusion protein was induced with 0.5% L-arabinose (except in panel 
E). Arrows indicate promotors and the transcription direction. PhC, phase-contrast. mCHE, mCherry 





In order to test whether the observed periplasmic signal of E. coli DH5α cells expressing nss-
rbsB-mCherry was specific, we examined cells without induction with arabinose and without Nss signal 
sequence. Without induction, no fluorescent signal was observed (Fig. 1E). Furthermore, the clear 
polar fluorescence in arabinose-induced cells, and their weak fluorescence halo of periplasmic 
localized RbsB-mCherry (Fig. 1C), were lost when the Nss signal sequence was removed (Fig. 1F). As a 
consequence, a homogenous distribution of RbsB-mCherry fluorescence in the cytoplasm was 
observed (Fig. 1F), indicating that only in presence of the proper signal sequence, RbsB-mCherry is able 
to translocate to the periplasm and accumulate at the cell poles. Collectively, these results indicated 
that the C-terminal end fusion (rbsB-mcherry) fused to the native RbsB Nss signal sequence was the 
optimal configuration for expression and translocation into the periplasm. 
 
Functionality of RbsB-mCherry 
 
Next we studied the functionality of the RbsB-mCherry fusion protein to respond to its native 
ligand ribose in E. coli by measuring induction of GFP formation from the Trz1-ompR-ompC’::gfp hybrid 
signaling chain [6]. The plasmid carrying the PBAD-nss-rbsB-mCherry fusion was hereto cotransformed 
into E. coli ΔrbsB cells, further containing the ribose-RbsB-dependent Trz1-ompC’::gfp bioreporter 
system that was previously developed [12] (Fig. 2A, inset). Incubation with 0.1 mM ribose for 2h30 
resulted in a 1.7-fold induction of GFP fluorescence in flow cytometry (Fig. 2A), which was statistically 
significant (p<0.001, ANOVA followed by post-hoc Tukey test), although lower than the 13-fold 
induction of wild-type rbsB in the same E. coli background [12].  In contrast, none of the other three 
configurations resulted in any statistically significant change of GFP expression of the Trz1-ompC’::gfp 
signaling pathway (Fig. 2A), suggesting these are proteins inactive in signaling or insufficiently present 
in the periplasm. This confirmed that the C-terminally fused mCherry to RbsB is a functional protein, 
and thus the best proxy to follow RbsB localization and signaling. Adding ribose caused a slight increase 
of mCherry fluorescence in all four strains (Fig. 2B), which may have been due to an increased induction 
from the PBAD promoter. Consequently, we used this construct to further study effects of RbsB 






Figure 2- Ribose-dependent induction of the Trz1-ompC’::gfp signaling chain in E. coli ∆rbsB by 
different plasmid-expressed RbsB/mCherry fusion constructs. (A) Fold induction of GFP fluorescence 
in presence of 0.1 mM ribose for 2h30 compared to no ribose. Bars show the mean ratio (bars) from 
twelve replicates (black dots). Letters indicate significance groups in ANOVA followed by post-hoc 
Tukey test (pa,b <0.001). Inset shows principle of ribose-dependent RbsB-Trz1 induction of gfp from the 
ompC promoter. (B) Effect of ribose addition on RbsB/mCherry signal intensities for four fusion 
constructs. Bars indicate the mean of population fluorescence means in flow cytometry across twelve 
replicates (black dots) in absence (light grey) or presence of ribose (dark grey). P-values derived from 
two-sided t-test (n = 12). Ns- not significant p-value. 
 
Wild-type and mutant-RbsB-mCherry proteins localize in the periplasm  
In previous work, we isolated a number of RbsB mutants with novel ligand-binding properties 
[12]. Although these proteins had altered ligand-binding properties, biochemical and cell data showed 
them to be impaired in stability and potentially, in their translocation behavior [12]. In order to better 
understand if and where in the signaling pathway those RbsB mutants might be impaired, we 
constructed similar C-terminal end fusions as above and compared mCherry fluorescence localization 
to that of the wild-type RbsB. We concentrated on five RbsB mutants named DT002, DT016, DT020, 
DT021 and DT022, which were no longer responsive to ribose but instead to 1,3-cyclohexanediol [12]. 
Constructs were in first instance transformed into and tested for expression in E. coli DH5α cells (Table 
1), grown in liquid culture until mid-exponential phase in presence of 0.5% (w/v) L-arabinose and 




fluorescence, although different in intensity and localization, and with occasional additional non-polar 
fluorescent spots (Fig. 3, blue arrows). In some cells inclusion bodies were observed (e.g., white arrow 
in DT002-mCherry, Fig. 3). Side periplasmic foci were in general less intense than polar ones (e.g., blue 





Figure 3- Expression and cellular localization of RbsB-mutant mCherry C-terminal translational fusions 
in E. coli DH5α cells. Images show phase-contrast (PhC) and mCherry (mCHE) fluorescence of cells 
induced for 3 h with 0.5% L-arabinose. All mutant-mCherry proteins were expressed from PBAD and 
with the native RbsB signal sequence. The white arrow in DT002-mCherry points to possible 
cytoplasmic inclusion bodies. Blue arrows in DT020- and DT022-mCherry indicate non-polar 
periplasmic fluorescent foci. All fluorescence images (mCHE) were scaled to the same brightness (300-
900). 
 
In order to contrast expression and localization differences from RbsB- or mutant-mCherry 
proteins, and to better understand potential defects in signaling steps, we quantified and compared 
(relative) foci intensities, foci positions and the number of foci per cell among the various strains. In 
addition, we tested an E. coli host with the native chemoreceptor for RbsB (i.e., Trg) and one in which 
Trg was deleted, both in absence or presence of a plasmid co-expressing the Trz1 hybrid receptor, to 
which RbsB is also expected to bind [7]. Moreover, we studied expression of the fusion proteins in an 
E. coli host without the chromosomal rbsB, and one with rbsK deletion (coding for a protein involved 




To analyze foci intensities among wild-type RbsB- and mutant-mCherry fusion proteins, we 
quantified the mean of the 95th percentile fluorescence pixel per cell across all segmented cells in the 
images (n = 103 cells per replicate, Fig. 4A). The mean 95th percentile fluorescence of RbsB-mCherry 
increased tenfold both in presence or absence of Trg upon induction with L-arabinose (Fig. 4A, p = 
0.00018, two-sided t-test, n = 3 biological replicates). In contrast, the mean 95th percentile fluorescence 
decreased six-fold in E. coli DH5α expressing RbsB-mCherry without the Nss signal sequence (Fig. 4A, 
p = 0.0248, n = 3). This indicated that the mean 95th percentile fluorescence is an appropriate measure 
for foci fluorescence, and showed that appearance of foci is specific for periplasmic translocated RbsB-
mCherry. 
To study the possible influence of host background in foci formation and intensity, four E. coli 
host cells (i.e., MG1655 wild-type, Δtrg, ΔrbsB and ΔrbsK) were transformed with wild-type- and 
mutant-RbsB-mCherry fusion proteins (Table 1). Notably, expression in E. coli ΔrbsB in all cases resulted 
in a slight increase of the mean 95th percentile fluorescence when compared with wild-type (i.e., 
MG1655) and Δtrg hosts (Fig. 4B), suggesting there is some competition due to wild-type unlabeled 
RbsB. The mean 95th percentile fluorescence in E. coli ∆rbsK of both RbsB- and DT016-mCherry, but 
not DT022-mCherry, was even higher than that in ∆rbsB background, indicating that more fluorescent 
protein localized to the poles in absence of ribose transport into the cytoplasm (Fig. 4B). Also the 
median fluorescence of cells was higher in E. coli ΔrbsB and Δrbsk than in MG1655 and Δtrg 
backgrounds (Fig. S3A), suggesting that these deletions may affect expression levels themselves. In 
contrast, deletion of the trg gene (for the Trg chemoreceptor) did not result in significant differences 
of the mean 95th percentile fluorescence compared to wild-type (Fig. 4B).  
We investigated the importance of Trg and the hybrid Trz1 receptor on RbsB- or mutant-
mCherry protein localisation a little further by comparing expression in E. coli DH5α and E. coli 
BW25113 ∆trg, in absence or presence of a plasmid-expressed Trz1 (Fig. 4C). Foci fluorescence was 
higher for equivalent constructs in E. coli BW25113 ∆trg than in DH5α (p = 0.009, Wilcoxon rank-sum 
test, n = 15). Co-expression of the Trz1-hybrid receptor caused an increase of foci fluorescence by 3-4 
fold in the ∆trg background (p = 3.16 x 10-7, two-sided t-test, n = 25, Fig. 4D), but not in DH5α (p = 
0.2656, Fig. 4C). This indicated that specific expression of the Trz1 receptor in absence of the cognate 
Trg chemoreceptor favors RbsB- or mutant-mCherry binding in the periplasmic polar regions. Globally, 
expression of RbsB- or mutant-mCherry was also higher in ∆trg background with co-expressed Trz1 
than without (Fig. S3B, median fluorescence, p = 0.0003, two-sided t-test, n = 25).  
Visualized across all cells in a biological replicate (n = 103) in a z-projection of the mean top 20 
percentiles per pixel, the higher protein accumulation at the cell poles was visible even in absence of 




DH5α cells expressing wild-type- and mutant-RbsB-mCherry proteins (Fig. S4A). This suggested either 
some inherent property of RbsB-mCherry to accumulate in membrane curved regions or hidden 
interactions with other E. coli chemoreceptors, which are typically located at the poles [33-35]. The 
localisation of the RbsC-ribose transporter is, to the best of our knowledge, not known. RbsB-mCherry 
fluorescence intensity in the polar regions further increased upon co-expression of Trz1, indicating 
positioning of this hybrid chemoreceptor to the polar regions and RbsB-mCherry binding to it. Similar 
results were obtained in cells expressing DT016- and DT022-mCherry proteins (Fig. 4E), or DT002-, 
DT020- and DT021-mCherry (Fig. S4B). In summary, this showed that RbsB- or mutant-RbsB-mCherry 
fluorescence mostly localized at the poles and was dependent to some extent on the presence of 






Figure 4- Foci intensity and localisation in E. coli cells expressing RbsB- or mutant-mCherry fusion 
proteins. (A) Mean 95th percentile mCherry fluorescence intensity as measure for foci intensity. 
Example image and cartoon show the measurement principle. Bars show mean values from biological 
replicates with black dots representing the individual mean 95th percentiles from around 1000 cells of 
a single replicate. With arabinose; 0.5 % L-arabinose during 3 h. p-values from two-sided t-tests (n = 6 
for arabinose difference, n = 3 for signal sequence difference). (B) Comparation of mean 95th percentile 
fluorescence intensity of wild-type-RbsB-, DT016- and DT022-mCherry expressed in four different E. 
coli strains. Bars and dots as in (A).  Induction with 0.5% L-arabinose for 3 h. P-values derived from one-
way ANOVA, compared to the respective fusion protein expressed in E. coli MG1655 background. (C) 
Effect of host DH5α background in presence (grey bars) or absence (white bars) of co-expressed Trz1 
hybrid signaling receptor. Bars and individual dots as in (A). p-values from two-sided t-test (n =15 for 
Trz1 difference, n = 3 for DT021 difference). (D) As in (C) but for E. coli Δtrg background. P-value from 
two-sided t-test (n = 25). (E) z-projection of the mean top 20 percentiles per pixel across all cells in a 
biological replicate (n = 103) standardized to the same cell length and width. Heatmap representation 
of fluorescence intensity in the cells. Blue and orange colors represent low and high intensity, 
respectively. Scale is not comparable between heat maps.  
 
Mutant RbsB-mCherry proteins tend to localize less at the cell poles 
If translocation or periplasmic folding would be affected by ligand-binding mutations (as was 
suspected for DT002 and DT016[12]), one would expect to detect differences in the positions and 
quantities of fluorescent mCherry fusion protein in the cells compared to wild-type. In case of E. coli 
∆trg expressing RbsB-mCherry (irrespective of co-expressing Trz1), around 33% of imaged cells carried 
no foci, 50% carried one or two foci, and 17% carried 3 or 4 (Fig. 5A). The proportion of cells without 
any foci increased for cells expressing mutant-RbsB-mCherry, in particular when Trz1 was co-expressed 
(Fig. 5B, p = 0.004, one-sided t-test, n = 6, taking all mutants as a group). Among the cells that showed 
fluorescent foci, the proportion of those with 1 or 2, or 3 and 4 foci, was not different among expressed 
RbsB- or mutant-mCherry (Fig. 5C, two-sided t-tests, n = 6). Globally, however, the proportion of cells 
with 3 and 4 foci (among those that showed presence of foci) decreased for cells co-expressing Trz1 
(Fig. 5C, p = 0.037, one-sided t-test, n = 20). This suggested that there are differences in periplasmic 
translocation between wild-type- and mutant-RbsB mCherry fluorescent fusion proteins, in particular 
in the increased number of cells without foci.  
In order to understand whether the positioning of foci was different between cells expressing 
wild-type RbsB- or mutant-mCherry, we plotted foci positions across some 800 cells, normalized to the 




mCherry, the absence of any localization in uninduced cells, and aberrant localization in e.g., cells 
expressing mutant DT002-mCherry (Fig. 5D). Note that a threshold of 3 is relatively low and as a 
consequence, the segmentation program also picks up spurious variations in cytoplasmic fluorescence 
as in case of uninduced cells (Fig. 5D). In two different backgrounds, however, statistically significant 
differences occurred among mutants and wild-type RbsB-mCherry in the fraction of polar foci (defined 
as foci positions within 6 pixels from the detected cell edge on the long axis, Fig. 5E).  
Whereas uninduced E. coli DH5a cells and those expressing RbsB-mCherry without Nss 
displayed background proportions of polar foci (15-20%, Fig. 5E), those in presence of arabinose 
displayed up to 56% of polar foci, irrespective of co-expressed Trz1 (Fig. 5E, p = 0.86, Wilcoxon ranked 
sum test, n = 9). Particularly cells expressing mutant DT002-, DT016-, DT020- or DT022-mcherry, 
showed lower polar foci fractions (between 30–45%, p-values from 3.27 x 10-5 - 0.0057, one-sided t-
test, n = 3–6, Fig. 5E). In contrast, mutant DT021-mCherry localized indifferently from wild-type (p = 
0.28, two-sided t-test, n = 3 – 6, Fig. 5E). Mutant differences persisted in absence of Trg and/or co-
expressed Trz1, except for mutant DT022-mCherry (Fig. 5F). Co-expression of Trz1 in ∆trg background 
globally decreased the proportion of polar foci for all constructs (Fig. 5F) and leading to a higher 
proportion of side foci (p = 0.0131, Wilcoxon ranked sum test, n = 14). These results showed that 
mutant-mCherry fusions, except for DT022, tend to be poorer localized to the cell poles, which may 








Figure 5- Localization and number of detected mCherry foci in E. coli cells. (A) Fraction of cells with 
detected foci numbers between 0 – 4, for E. coli ∆trg expressing wild-type RbsB-mCherry. Bars show 
means of combined data from 8 biological replicates (black dots), half of which co-expressed Trz1. (B) 
Proportion of E. coli ∆trg cells expressing wild-type RbsB-mCherry (RbsB) or mutant-mCherry (Mut, 




presence (pink) or co-expressed Trz1. Bars show means of combined data from mutants or RbsB-wild-
type with dots indicating individual replicate values. P-values derived from paired t-testing. (C) 
Proportion of cells carrying 3 or 4 foci among those that showed any foci, in absence (salmon) or 
presence (pink) of co-expressed Trz1. Bars and dots and p-values as in (B). (D) Foci position plots for 
single replicate experiments of the indicated strains, with normalized cell lengths and widths (dotted 
pink line), scattering n = 800 foci. Length and width in pixel units. Foci threshold = 3. (E) Fraction of foci 
among all detected (as in panel D) attributed to the cell poles (i.e., within 6 pixels of the defined original 
cell length) for expressed wild-type (WT) or mutant-mCherry (DT numbers), induced or not with L-
arabinose (Ara), in absence or presence of the nss signal sequence. P-values calculated from pair-wise 
t-test compared to combined WT data set (grey dots, in absence of; pink dots, in presence of co-
expressed Trz1, all one-sided tests, n = 3 – 6). Justified because polar foci fractions for WT in presence 
or absence of Trz1 are not significantly different (p = 0.98). (F) as panel E, but for E. coli ∆trg cells, co-
expressing or not Trz1. P-values derived from one-sided t-tests compared to WT in absence of Trz1 (n 
=3), or compared to WT in presence of Trz1 (grouped to n = 6, compared to grouped mutant DT in 
presence of TrzI, n = 3 – 6).  
 
Detection of proper signaling behavior in mutant RbsB libraries 
In order to test if we could use the differences in periplasmic localisation behaviour to detect 
RbsB-mutants with different signaling behavior in a library, three mutant libraries generated by error-
prone PCR (named epDT016, epDT021 and epDT022; the DT number referring to the parental mutant) 
were constructed in which the RbsB-variant was C-terminally fused to mCherry. Libraries were induced 
as before and examined either as such, or after spiking with E. coli cells expressing wild-type RbsB-
mCherry in proportions of 50 %, 10%, 1% and 0.1% (cell/cell).  
The mean 95th fluorescence decreased for most library mixtures at lower proportions of spiked 
cells expressing RbsB-mCherry, whereas also the proportion of cells with 1-2 foci decreased, as 
expected (Fig. 6A, B; p-values from < 0.0001 – 0.0009, one-way ANOVA, n = 9 – 17). This indicated that 
we would expect to be able to observe and quantify the presence of potentially favorable signaling 







Figure 6 – Detection of wild-type RbsB-behaviour in error-prone libraries, based on periplasmic 
localisation of mCherry fusion proteins. (A) Foci intensity (as mean 95th percentile mCherry 
fluorescence intensity of combined biological replicates, colored bars) in L-arabinose induced E. coli 
DH5a expressing wild-type RbsB-mCherry (WT) or error-prone libraries (epDTxx) mixed with cells 
expressing WT (number below indicating their proportion). Black dots, individual replicates (n = 9 – 17, 
103 cells per replicate). P-values derived from one-way ANOVA, compared to RbsB-mCherry alone 
(WT). ns, p-values > 0.05. (B) Percentage of cells with 1 and 2 detected foci in WT and spiked libraries, 
as in (A). (C) Gating (solid rectangle) imposed to consider individual cell foci values as that of RbsB-
mCherry (scatter plot of cells with between 1–3 fluorescent foci; each dot corresponding to a single 
cell). Horizontal dashed lines indicate 5th and 95th percentile. Vertical dashed line indicates the 25th 
percentile. Green dots, WT; ochre dots, epDT022-mCherry library. (D) Proportion of cells in unspiked 




thresholds of (C). Jitter plot indicates the percentage of cells with WT behavior in a technical replicate 
(individual colored dots) from a single biological replicate (n= 300-1000 cells). Black line represents the 
median and whiskers indicates the 95% confidence intervals for the median. Percentages represent 
the mean values from 9-15 technical replicates, ± calculated SD. P-values as in (A). (E) Percentage of 
cells with 0 and 4 detected foci in same biological replicates as in (D). Bars show means of technical 
replicates (black dots). P-values as in (A). 
 
Based on cells expressing wild-type RbsB-mCherry we defined gating thresholds to consider 
mutant cells displaying wild-type-like localisation. Cells with 0 and 4 foci were excluded, and only those 
with 1–3 foci were retained (as in, Fig. 5A). Secondly, we retained cells with expressing levels within 
the 5th and 95th percentile of the median fluorescence and above the 25th percentile of the mean 95th 
fluorescence observed for RbsB-mCherry (Fig. S5). For cells expressing RbsB-mCherry itself, this 
produced a true positive rate of 65.5 ± 14.1 % (Fig. 6C and D, p-values from < 0.0001 – 0.002, one-way 
ANOVA, n = 9 – 15), whereas those with DT002-mCherry showed a true negative rate of 7.1 ± 7.4 % 
(Fig. 6D, Table S1). Error-prone libraries (epDTxxx) produced from mutants DT022, DT016 and DT021 
gave 16.7 ± 9.5 %, 3.0 ± 2.5 % and 11.2 ± 7.0 % of cells passing the thresholds, respectively (Fig. 6D, Fig. 
S6). Not unexpectedly, this is a drastic decrease compared to the strain expressing parental proteins 
(Fig. 6D, Fig. S6). Mutant libraries also displayed a higher number of cells with 0 and 4 detected foci, 
especially epDT021 and epDT022, when compared with wild-type and parental RbsB mutants (Fig. 6E, 
p-values from < 0.0001 – 0.0064, one-way ANOVA, n = 9 – 15). This suggested that most library mutants 
lost capacity to accumulate at the cell poles and/ or interact with membrane receptor. In summary, 
with this analysis we can clearly detect the signaling capacity differences between a true positive and 
negative fusion protein (e.i, wild-type RbsB and DT002). Moreover, we could quantify the number of 
cells with promising signal transduction capacity in three mutant derivative libraries allowing us to 
understand in each library we have higher chances to isolate a mutant with improved signaling 
behaviour. Finally, we observed that a high number of derivative mutants have signaling issues as a 









 Here we developed an in vivo system to follow RbsB or mutant-RbsB expression, their 
translocation into and localisation within the periplasmic space from mCherry fluorescent protein 
fusions. Among the different tested genetic configurations only C-terminally fused mCherry, native 
RbsB signal sequence and inducible expression from PBAD resulted in viable cells with proper 
periplasmic localized highly fluorescent foci. Translocation of other translational fusion proteins 
probably blocked the Sec translocation channels, leading to abnormal cells. Despite this, the RbsB-
mCherry fusion protein was only partly functional in its capacity to be induced by ribose, but we 
considered this sufficient to follow its subcellular localisation and to be the best proxy to compare wild-
type to mutant behavior to in terms of expression, translocation and localization and signaling capacity 
[6]. 
Our results with wild-type RbsB-mCherry indicated clear foci formation at both cell poles in E. 
coli in an L-arabinose-induced dependent manner and depending on translocation signal sequence. 
From this we conclude that these are not cytoplasmic but periplasmic polar foci. Their localization at 
the cell poles is most likely the result of RbsB-mCherry binding to the (Trg) chemoreceptors, which 
preferentially concentrate at the cell pole [33-35]. However, RbsB-mCherry also produced polar foci in an 
E. coli Δtrg background, which does not produce the RbsB-specific Trg chemoreceptor and therefore 
was expected to show more even fluorescence around the periplasmic space. This would thus indicate 
that polar accumulation is not only the result of a direct interaction between RbsB and Trg, but either 
to other chemoreceptors, to the ribose transporter channel, or a result of the intrinsic membrane 
curvature, as previously reported for other fluorescent proteins [34, 36-41]. On the other hand, there must 
be a definitive interaction between the periplasmic exposed Trg part and RbsB-mCherry, since 
expressing the hybrid chemoreceptor Trz1 (a protein fusion of the periplasmic Trg part and cytoplasmic 
EnvZ part) in Δtrg background increased RbsB-mCherry fluorescence in the polar regions. Expression 
of Trz1 in E. coli DH5α did not yield higher RbsB-mCherry fluorescence at the cell poles, possibly 
because expressed Trz1 is in competition for space with the other E. coli chemoreceptors in the polar 
zones. The increased polar fluorescence of RbsB-mCherry in ∆trg background with co-expressed Trz1 
also indicates that the majority of Trz1 would be located at the cell pole (despite having EnvZ-
cytoplasmic tails). Results with RbsB-mCherry in ΔrbsB background also showed slight increase of polar 
foci fluorescence, which we attribute to less competition for chemoreceptor binding sites from native 
RbsB. Interestingly, polar foci fluorescence increased even more in ∆rbsK background, which interrupts 
the ribose transport [42, 43]. This may have two consequences: the rbsK deletion interrupts ribose 




mCherry, favoring the closed ligand-bound form, which interacts with the chemoreceptor [13]. 
Secondly, there is no turnover of ribose-bound docked RbsB-mCherry to the transport channels in 
absence of RbsK. If we assume the transporters to be evenly distributed along the cytoplasmic 
membrane, more ribose-bound RbsB-mCherry would therefore available to dock to the 
chemoreceptors, causing the observed increased foci fluorescence. Finally, although the majority of 
RbsB-mCherry locates to the cell poles, a distinct diffuse halo is visible in the periplasmic space, 
suggesting circulating open/closed RbsB-mCherry complexes and or ephemeral binding to transporter 
channels. Wild-type RbsB-mCherry rarely produced clear ‘side’ foci and the majority of cells displayed 
1 or 2 polar located foci. 
In order to understand if and where mutant-RbsB might differ in their translocation and 
periplasmic localisation properties we constructed mutant-RbsB-mCherry fusions, and expressed them 
from identical promoters and using identical translocation signal sequences as in case of RbsB-
mCherry. We concentrated on five mutants with changed ligand-binding properties that were designed 
by computational approaches, and that instead of ribose bind 1,3-cyclohexanediol (but at lower 
efficiency than wild-type binding to ribose). Two of these have been described previously, and were 
shown to have intrinsic folding problems, reduced cytoplasmic stability and reduced translocation 
efficiency [12]. We used these mutants, because we wondered whether their poor in vivo ligand 
detection might be partly due to this poorer expression, translocation and possibly, less efficient 
receptor binding. One of the mutants, (DT002), bound to mCherry was indeed quantifiably less 
abundant in the periplasmic space and polar regions in comparison to wild-type RbsB-mCherry. This is 
thus in agreement with previous periplasmic space mass spectra analysis that showed that wild-type 
RbsB is more abundant than DT002 [12]. We speculated that this may be the result of partially blocked 
Sec translocation channels by misfolded DT002 (or DT002-mCherry). Indeed, our microscopic images 
also suggested the presence of DT002-mCherry fluorescent foci in the cytoplasm, which might be 
caused by the protein being stocked in inclusion bodies and was not observed in cells expressing other 
RbsB-or mutant-RbsB-mCherry fusions. Populations of cells expressing DT002-mCherry also carried a 
much larger proportion of cells without any polar fluorescence, even in absence of Trg or Trz1, 
suggesting that there is effectively much less fluorescent protein present in the periplasmic space, 
which in addition may not dock as efficiently to the chemoreceptors. 
The four other expressed mutant-RbsB-mCherry yielded more consistent polar periplasmic foci 
in cells than DT002-mCherry, although also in those cases overall the proportion of cells without any 
foci was increased compared to wild-type RbsB-mCherry, their polar foci were less intense and more 
frequently side foci appeared. Further individual differences were observed in the tested host 




comparison to wild-type. Of the various mutants, the DT021- and DT022-mCherry proteins behaved 
most similar as wild-type in their foci distribution pattern, but still tended to be poorer located at the 
polar regions, which might thus partly explain their observed lower in vivo signal transduction capacity 
through the Trz1 receptor. 
Do the periplasmic localisation patterns of RbsB-mCherry permit some kind of testing or 
screening of further mutant PBP libraries for variants that behave more like wild-type and in that sense 
may be exemplary for improved secondary mutations beyond just the ligand binding itself? In order to 
test this, we produced three libraries starting from the dt016, dt021 or dt022 alleles, introducing 
further mutations by error-prone PCR at a rate of 1 amino acid substitution per 1000 bp and comparing 
foci localisation in individual cells with the expected behaviour of wild-type RbsB-mCherry, a true 
negative like DT002-mCherry and the starting alleles. By mixing libraries in different proportions with 
cells expressing RbsB-mCherry we could observe expected increase of foci fluorescence and polar 
localisation the more RbsB-mCherry expressing cells were present. Moreover, the percentage of cells 
with 1 and 2 foci diminished with decreasing proportions of spiked cells expressing RbsB-mCherry. The 
three libraries themselves (without spiked wild-type RbsB-mCherry cells) showed pronounced 
individual variability, with particularly low numbers of cells with potentially ‘correctly’ localized 
fluorescent foci in epDT016 (the derivative of the dt016 allele). On the other hand, their numbers 
seemed to increase in the epDT021- and epDT022-mCherry libraries. Thresholding cells to within wild-
type behaviour on the basis of foci localisation and fluorescence suggested that we could not expect 
to detect any potentially wild-type-like mutants in the epDT016 library (percent thresholded smaller 
than in the true negative DT002-mCherry). In contrast, the epDT021- and epDT022-mCherry libraries 
showed percentages higher than in the negative control (11.2 % and 16.7 %, respectively, compared 
to 7.1 % in the negative control). This would suggest that the epDT021 and epDT022 libraries have, 
potentially, a higher number of variants with signaling transduction capacity equaling wild-type RbsB-
mCherry behaviour. On the other hand, in comparison to their starting alleles, the epDT021 and 
epDT022-mCherry libraries has an increased number of cells with apparent deleterious mutations to 
RbsB-mutant folding, translocation and periplasmic binding. This is not unexpected, given the random 
nature of the introduced secondary mutations on the alleles by the error-prone PCR. Thresholding for 
outliers may therefore be important as a criterium to judge appearance of wild-type-like translocation 
behaviour. 
In conclusion, we demonstrate specific localisation patterns mirroring the expected 
periplasmic targets of RbsB (studied by its proxy of a C-terminal mCherry fusion protein) in E. coli, and 
apparent defects in foci positioning, intensity and proportions of foci numbers per cell across the clonal 




properties. We propose that visualized expression and subcellular localization of fusion proteins is 
sensitive enough to detect potential improvements of secondary mutations introduced into RbsB-
variants by typical random library screening. Although it is currently technically very challenging to 
isolate single cells from microscopy studies, knowing population behaviour and observing increased 
proportions of potentially correctly performing mutants, may help to devise other strategies to isolate 















Table 1- Strain list used in this study. 
Strain E. coli host Plasmids Relevant characteristics Reference 
or source 
3044 DH5αλPir  Host for plasmid propagation [44] 
3671 DH5α pSTVPAA_mcs pSTVPAA to clone rbsB and its derivatives [6] 
4076 BW25113 ΔrbsB  Genomic deletion of rbsB gene [45] 
4172 BW25113 ΔrbsB pSYK1 Host strain containing the Ptac- trzI, PompC- gfpmut2 bioreporter system [6] 
4175 BW25113 ΔrbsB pSTVPAA_rbsB, pSYK1 RbsB expression with nss for periplasmic translocation [6] 
4498 MG1655   
E. coli Genetic 
Center, Yale 
(CGSC#8237) 
4501 BW25113 Δtrg  Genomic deletion of trg gene [45] 
4505 BW25113 ΔrbsK  Genomic deletion of rbsK gene [45] 
6686 BW25113 ΔrbsB pSTVPAA_nss-rbsB-mCherry, pSYK1 RbsB-mCherry expression with nss for periplasmic translocation This work 
6952 DH5αλPir pSTVPBAD_nss-rbsB-mCherry Inducible rbsB-mCherry expression and translocation (nss) This work 
6953 DH5αλPir pSTVPBAD_torAss-rbsB-mCherry Inducible rbsB-mCherry expression and translocation (torAss) This work 
6955 DH5αλPir pSTVPBAD_nss-mCherry-rbsB Inducible mCherry-rbsB expression and translocation (nss) This work 
6957 DH5αλPir pSTVPBAD_torAss-mCherry-rbsB Inducible mCherry-rbsB expression and translocation (torAss) This work 
6958 DH5αλPir pSTVPBAD_nss-DT002-mCherry As for 6952, but wild-type RbsB was replaced by DT002 mutant This work 
6959 DH5αλPir pSTVPBAD_nss-DT016-mCherry As for 6952, but wild-type RbsB was replaced by DT016 mutant This work 
6960 BW25113 Δtrg pSTVPBAD_nss-rbsB-mCherry Same as 6952 in host 4501 This work 
6962 BW25113 Δtrg pSTVPBAD_nss-rbsB-mCherry, pSYK1 Same as 6972 in host 4501 This work 
6963 BW25113 Δtrg pSTVPBAD_nss-DT002-mCherry Same as 6958 in host 4501 This work 
6965 BW25113 Δtrg pSTVPBAD_nss-DT002-mCherry, pSYK1 Same as 6973 in host 4501 This work 
6967 BW25113 Δtrg pSTVPBAD_nss-DT016-mCherry Same as 6959 in host 4501 This work 
6969 BW25113 Δtrg pSTVPBAD_nss-DT016-mCherry, pSYK1 Same as 6974 in host 4501 This work 
6972 DH5αλPir pSTVPBAD_nss-rbsB-mCherry, pSYK1 Inducible rbsB-mCherry expression and translocation (nss), Ptac- trzI, 
PompC- gfpmut2 bioreporter system 
This work 
6973 DH5αλPir pSTVPBAD_nss-DT002-mCherry, pSYK1 As for 6972, but wild-type RbsB was replaced by DT002 mutant This work 
6974 DH5αλPir pSTVPBAD_nss-DT016-mCherry, pSYK1 As for 6972, but wild-type RbsB was replaced by DT016 mutant This work 




6976 DH5αλPir pSTVPBAD_nss-DT021-mCherry As for 6952, but wild-type RbsB was replaced by DT021 mutant This work 
6977 DH5αλPir pSTVPBAD_nss-DT022-mCherry As for 6952, but wild-type RbsB was replaced by DT022 mutant This work 
6991 DH5αλPir pSTVPBAD_nss-DT020-mCherry, pSYK1 As for 6972, but wild-type RbsB was replaced by DT20 mutant This work 
6992 DH5αλPir pSTVPBAD_nss-DT021-mCherry, pSYK1 As for 6972, but wild-type RbsB was replaced by DT021 mutant This work 
6993 DH5αλPir pSTVPBAD_nss-DT022-mCherry, pSYK1 As for 6972, but wild-type RbsB was replaced by DT022 mutant This work 
6996 BW25113 Δtrg pSTVPBAD_nss-DT020-mCherry Same as 6975 in host 4501 This work 
6997 BW25113 Δtrg pSTVPBAD_nss-DT021-mCherry Same as 6976 in host 4501 This work 
6998 BW25113 Δtrg pSTVPBAD_nss-DT022-mCherry Same as 6977 in host 4501 This work 
6999 BW25113 Δtrg pSTVPBAD_nss-DT020-mCherry, pSYK1 Same as 6991 in host 4501 This work 
7000 BW25113 Δtrg pSTVPBAD_nss-DT021-mCherry, pSYK1 Same as 6992 in host 4501 This work 
7001 BW25113 Δtrg pSTVPBAD_nss-DT022-mCherry, pSYK1 Same as 6993 in host 4501 This work 
7007 BW25113 ΔrbsB pSTV PBAD_nss-RbsB-mCherry, pSYK1 
Inducible nss-RbsB-mCherry expression for periplasmic translocation 
in host 4172 
This work 
7035 DH5αλPir pSTV PBAD_RbsB-mCherry Inducible rbsB-mCherry expression and without nss for translocation This work 
7146 BW25113 ΔrbsB pSTV PBAD_nss-mCherry-RbsB, pSYK1 As 7007, but for nss-mCherry-RbsB This work 
7147 BW25113 ΔrbsB pSTV PBAD_torAss-rbsB-mCherry, pSYK1 As 7007, but for torAss-rbsB-mCherry This work 
7148 BW25113 ΔrbsB pSTV PBAD_torAss-mCherry-RbsB, pSYK1 As 7007, but for torAss-mCherry-RbsB This work 
7189 BW25113 ΔrbsK pSTVPBAD_nss-rbsB-mCherry Same as 6952 in host 4505 This work 
7190 BW25113 ΔrbsK pSTVPBAD_nss-DT016-mCherry Same as 6959 in host 4505 This work 
7191 BW25113 ΔrbsK pSTVPBAD_nss-DT022-mCherry Same as 6977 in host 4505 This work 
7192 MG1655 pSTVPBAD_nss-rbsB-mCherry Same as 6952 in host 4498 This work 
7193 MG1655 pSTVPBAD_nss-DT016-mCherry Same as 6959 in host 4498 This work 
7194 MG1655 pSTVPBAD_nss-DT022-mCherry Same as 6977 in host 4498 This work 
7195 BW25113 ΔrbsB pSTVPBAD_nss-rbsB-mCherry Same as 6952 in host 4076 This work 
7196 BW25113 ΔrbsB pSTVPBAD_nss-DT016-mCherry Same as 6959 in host 4076 This work 








Table 2- List of primers used to create the different fusion construct 
 
Fusion construct Target Primers DNA sequence (5' to 3') 
pSTVPAA_ Nss-
RbsB-mCherry 




190401 R AGAGCCAGAGCCACCACTAGTGTGGTGGTGGTGGTGGTGCTCGAGCTGCTT 
mcherry 
190404 F ACTAGTGGTGGCTCTGGCTCTGGCTCGAGAATGGTGAGCAAGGGCGAGGAGGA 
190403 R CAAGCTTGCATGCCTGCAGGGGAATTGGGGATCGGAAGCT 
pSTVPBAD_ Nss-
RbsB-mCherry 
araC / PBAD 
200102 F CTGCAGGTCGACGGAGCTCGTGTTTGACAGCTTATCATCGATGCATAATGTGCCTG 
200103 R GCTAGCCCAAAAAAACGGGTATGG 
nss-rbsB (without stop codon) 
200104 F ACCCGTTTTTTTGGGCTAGCGAAGGAGATATACATATGAA 
190401 R AGAGCCAGAGCCACCACTAGTGTGGTGGTGGTGGTGGTGCTCGAGCTGCTT 
mcherry 
190404 F ACTAGTGGTGGCTCTGGCTCTGGCTCGAGAATGGTGAGCAAGGGCGAGGAGGA 




araC PBAD + torAss 
200102 F CTGCAGGTCGACGGAGCTCGTGTTTGACAGCTTATCATCGATGCATAATGTGCCTG 
200106 R GGCCGCTTGCGCCGCAGTCGCACG 
rbsB (without stop codon) 
200105 F CGACTGCGGCGCAAGCGGCCATGGCAAAAGACACCATCGCGCTG 
190401 R AGAGCCAGAGCCACCACTAGTGTGGTGGTGGTGGTGGTGCTCGAGCTGCTT 
mcherry 
190404 F ACTAGTGGTGGCTCTGGCTCTGGCTCGAGAATGGTGAGCAAGGGCGAGGAGGA 
200101 R TATGACCATGATTACGAATTGGAATTGGGGATCGGAAGCT 
pSTVPBAD_ Nss-
mCherry-RbsB 
PBAD region + nss 




mcherry (without stop codon) 
200109 F CCACCGTCAGTGCGAATGCGATGGTGAGCAAGGGCGAGGAGGATAAC 
200110 R AGAGCCAGAGCCACCACTAGTCTTGTACAGCTCGTCCATGCCGCCGGTGGA 
rbsB 
200111 F ACTAGTGGTGGCTCTGGCTCTGGCTCGAGAATGGCAAAAGACACCATCGCGCT 




araC / PBAD + torAss 
200102 F CTGCAGGTCGACGGAGCTCGTGTTTGACAGCTTATCATCGATGCATAATGTGCCTG 
200105 R CGACTGCGGCGCAAGCGGCCATGGCAAAAGACACCATCGCGCTG 
mcherry (without stop codon) 
200112 F CGACTGCGGCGCAAGCGGCCATGGTGAGCAAGGGCGAGGAGGATAAC 





200111 F ACTAGTGGTGGCTCTGGCTCTGGCTCGAGAATGGCAAAAGACACCATCGCGCT 




Materials and methods 
Bacterial strains and culture conditions 
 Five E. coli strains were used as host for expression of fusion constructs (Table 1). Strains 4076, 
4501 and 4505 from the Keio Collection carry genomic deletions of the rbsB, trg, and rbsK genes, 
respectively [45]. As wild-types, we used E. coli MG1655, obtained from the E. coli Genetic Stock Center 
(Yale university; CGSC#8237), and DH5αλPir cells [44]. Cells were grown overnight in LB medium 
supplemented with appropriate antibiotics. The medium was supplemented with 30 µg 
chloramphenicol ml-1 and with 100 µg ampicillin ml-1 for strains containing pSTV and pSYK1 plasmids, 
respectively. To maintain the PBAD promoter in the off state [46] 0.4 % (w/v) glucose was added to the LB 
culture medium (LB-Glc). To activate expression from PBAD, overnight cultures were 100 times diluted 
in fresh LB medium (without glucose) supplemented with 0.5 % L-arabinose (w/v). 
All strains and plasmid constructions used in this study are listed in Table 1. 
 
Cloning of mCherry fusion protein constructs 
To study localization, we translationally fused rbsB and mcherry open reading frames in 
different configurations. Recombinant proteins were fused with the cognate RbsB signal peptide or 
with the TorA signal peptide. Products amplified with primers listed in Table 2 were cloned into 
pSTV28PAAmcs [6] digested with NdeI and SalI using a ClonExpress kit according to manufacturer 
instructions (Vazyme, China).  
In short, the wild-type rbsB gene (including or not the signal peptide) was amplified without 
its stop codon using pSTV28PAA_RbsB6His as template (extracted from strain 4175). The gene coding 
for mCherry was amplified from pARS1003 (extracted from strain 4600). Primers used to amplify rbsB 
and mCherry add a unique SpeI restriction site and include a coding sequence for an eight-amino acid 
linker (GGSGSGSR) between the two proteins. 
In case of the constructs cloned under control of the inducible PBAD promoter [46] pSTV28PAAmcs 
was double digested with EcoRI (to remove the PAA promoter region). The PBAD promoter region and 
TorA signal peptide were amplified by PCR from pCRO4 (extracted from strain 4651) [47].  
ClonExpress reactions (~ 180 ng DNA) were transformed into DH5α cells by heat shock. The 
DNA sequences of the different fusion constructs were confirmed by sequencing on purified plasmids. 
Plasmids carrying different fusion constructs were then transformed in five E. coli backgrounds 





Expression of rbsB-mCherry fusions for epifluorescence microscopy  
To study RbsB-mCherry fusion protein expression and localisation, a single E. coli colony grown 
on a selective plate to maintain the respective plasmid(s) was inoculated in 5 mL of LB-Glc medium 
(supplemented with the appropriate antibiotics) and grown overnight at 37 °C with 180 rpm shaking. 
The next morning the culture was diluted 100 times in the same medium. Protein expression was 
induced by addition of 0.5% L-arabinose (w/v) to the culture, which was incubated further at 37°C and 
with 180 rpm shaking until reaching exponential phase (OD600 of 0.5).  
Samples of 4 µL of cell suspension (at OD=0.5) were pipetted on a 1%-agarose-in-M9 medium 
coated standard microscopy slide (Menzel-Gläser) and covered with a cover slip. Images were acquired 
with a Zeiss Axioplan II epifluorescence microscope with a 100 x Plan Apochromat oil objective (Carl 
Zeiss, Jena, Germany), 10 x ocular and a Sola SE light engine (Lumencor, USA). A SPOT Xplorer slow-
can charge coupled device camera (1.4 Megapixels monochrome w/o IR; Diagnostic Instruments) fixed 
on the microscope was used to capture images. Up to ten images at different positions were acquired 
using Visiview software (Visitron systems GMbH), with exposures set to 10 ms and 500 ms for phase 
contrast (PhC) and mCherry, respectively. 
 
Mutant library and spiked library construction 
Mutant libraries (epDT016, epDT021 and epDT22) were generated by error-prone PCR. 
Mutations were introduced in dt016, dt021 and dt022 genes at a frequency of achieving 1 sense 
mutation per 1000 bp. Library genetic material (> 106 potential variants) was extracted as a DNA pool. 
Library mutants were C-terminally fused to mCherry protein as explained above, with the difference 
that here mutant rbsB genes were directly amplified from the plasmid library pool (ClonExpress Kit, 
Vazyme, China). ClonExpress reactions (~ 180 ng DNA) were transformed into DH5α cells by heat shock. 
The DNA sequences of 20 fusion constructs were confirmed by sequencing on purified plasmids to 
confirm correct cloning and variability. 
Cells carrying PBAD-nss-epDTxxx-mCherry were induced for 3h with 0.5 % L-arabinose before 
epifluorescence microscopy analysis, as explained above. Cells expressing epDTxxx-mCherry 
constructs were analyzed alone or after spiking with E. coli cells expressing wild-type RbsB-mCherry in 






 Individual cells were segmented on images using SuperSegger [48] and relevant cell (e.g., length, 
width, orientation, mean fluorescence) and foci information (e.g., number of foci per cell, foci position, 
score and intensities) were recorded. Cell and foci lists were combined to extract median fluorescence 
and mean 95th percentile fluorescence values (MatLab R2019a), which are representative for the 
mCherry expression in general and foci fluorescence intensity, respectively. The number of foci 
detected per cell was extracted at a foci intensity threshold of > 3. Their positions with respect to the 
cell long and short axis were normalized and plotted to a ‘standard’ cell length and width, to show the 
average localization patterns across a cell population. Foci were considered as polar when located less 
than 6 pixels from the detected cell edge on the long axis.   
 For visualization of fusion proteins accumulation at the cell poles, we used a custom-written 
MatLab (R2019a) script to prepare a z-projection of the mean top 20 percentiles per pixel across all 
imaged cells in a biological replicate (n = 1000 cells). Heatmaps were standardized to the same cell 
length and width. 
 
Statistical analysis 
Statistical analysis was done using GraphPad Prism software (Version 8.4.3). Fold induction of 
cells expressing fusion constructs in presence of ribose (Fig. 2A) were calculated using an ANOVA 
followed by post-hoc Tukey test. The differences in mCherry fluorescence were tested using Student’s 
t-test on cells with and without ribose induction. Differences in mean 95th percentile fluorescence, 
median fluorescence of two groups were tested using Student’s t-test. To compare multiple groups an 
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Figure S1- Scheme of the genes for Nss-RbsB and Nss-RbsB-mCherry fusion protein under control of 












Figure S2- Representative scheme of fusion protein genes under control of inducible PBAD promotor 
used in this study (not drawn to scale). A) Schematic representation of Nss-RbsB-mCherry construct. 
B) as (A) but for TorAss-RbsB-mCherry. C) as (A) but for Nss-mCherry-RbsB. D) as (A) but for TorAss-
mCherry-RbsB. E) as (A) but for Nss-RbsBmutants-mCherry. F) as (A) but for Nss-epRbsBmutants-
mCherry (e.i., error prone PCR library based on mutant-RbsB was C-terminal fused to mCherry. Arrows 











Figure S3- Cellular mCherry fluorescence comparison of four E. coli strains expressing wild-type- and 
mutant-RbsB-mCherry fusion proteins.  (A) Bars show means of median cellular fluorescence from 
biological replicates (black dots, each dot calculated from around 1000 cells). With arabinose, 0.5 % L-
arabinose during 3 h. P-values derived from one-way ANOVA, compared to the respective fusion 
protein expression in E. coli MG1655 background. (B) Trz1 co-expression leads to higher median 
mCherry fusion protein fluorescence. Bars show means of the median cellular fluorescence from 







Figure S4- E. coli cells expressing wild-type- and mutant-RbsB-mCherry fusions were used to prepare a 
Z-projection of the mean top 20 percentiles per pixel across all cells in a biological replicate (n = 103) 
standardized to the same cell length and width. (A) Heatmap representation of fluorescence intensity 
in the E. coli DH5α cells after 3h incubation with 0.5% L-arabinose (ARA) and in presence or absence of 
TrzI chemoreceptor. Blue and orange colors represent low and high intensity, respectively. Scale is not 









Figure S5- Distribution of mean 95th percentile (A) and median background (B) fluorescence of single 
cells (n = 270 – 1000 cells). Dashed lines in the violin plot show Q1 and Q3 quartiles. Solid line indicates 
















Figure S6- Detection of mutant-RbsB-mCherry fusions with wild-type behavior in E. coli cells expressing 
error-prone libraries (epDTxxx) and RbsB-based mutants. Proportion of cells displaying 1-3 foci and 
between 5th-95th percentile median fluorescence of wild-type RbsB-mCherry cells. Plots are jittered 
single cell mean 95th fluorescence values (individual colored dots) in a single replicate (n = 300-1000) 
with black line representing the median and whiskers indicating the 95% confidence intervals for the 

















Table S1- Indication of the percentage of cells that were removed with application of the different 
thresholds. 
 % of removed cells 
Threshold 
WT 
(n = 267)   
 
epDT016 
(n = 798)   
 
epDT021 
(n = 475)   
 
epDT022 
(n = 988)   
 
DT002 
(n = 335)   
 
DT016 
(n = 538)   
 
DT021 
(n = 595)   
 
DT002 
(n = 755)   
 
1st 14.8 25.5 55.3 65.9 39.7 24.8 31.2 29.2 
2nd 7.5 65.9 29.3 13.8 17.3 7.2 39.2 11.4 
3rd 13.5 6.0 1.9 3.1 4.5 12.5 0.5 7.7 
n= total number of cells 
1) Remove all cells with 0 and 4 detected foci 
2) Remove all cells all cells out of the 5th and 95th percentile of the median fluorescence observed in WT-mChe 
cells 

































The aim of this thesis was to develop a high-throughput strategy, based on a bioreporter 
system, and to isolate variants of the RbsB periplasmic binding protein with new recognition 
specificities. I performed in vitro assays to characterize isolated variants of interest, and executed 
further rounds of random and semi-random mutagenesis to improve the affinity and overall function 
of the most promising variants. 
 
Previously in our group the ribose-binding protein of Escherichia coli (RbsB) was used as a 
template to design binding pockets that might accommodate 1,3-cyclohexanediol (13CHD) and 
cyclohexanol (CH). These two molecules have a similar structure to ribose, but wild-type RbsB shows 
no binding capacity for either. The Rosetta software was used to simulate and calculate new binding 
pockets, from which a list of critical amino acid residues to mutate in RbsB was selected. In total 9 
positions were selected, with five possible amino acid substitutions each. The library containing 2 
million mutants was produced by DNA synthesis and cloned into an E. coli bioreporter strain [1], which 
carries the Trz1 hybrid signaling pathway coupled to GFP expression upon (new) ligand binding by the 
(mutant) RbsB. 
 
My first goal was to develop a strategy to isolate variants with 13CHD and/or CH binding 
capacity. Clones were grown as individual microcolonies in alginate beads rather than screened as 
individual cells, which clearly reduced GFP expression variability. Others have compared screening of 
single cells vs microcolonies and came to the same conclusions [2]. Approximately 0.5 % of library 
variants were capable of interacting with the hybrid receptor Trz1 even in absence of the ligand, which 
might be the result of some combinations of introduced mutations spontaneously stabilizing the closed 
conformation of the RbsB mutants, and thus triggering the bioreporter system (i.e., GFP expression). 
In order to remove such constitutive-ON mutants an additional sorting step under uninduced 
conditions was added to the screening, and only beads with low level of GFP were collected. These 
variants were cultured, encapsulated, grown to microcolonies and screened in presence of 13CHD. In 
the second sorting step, high GFP producers were collected. The decision of screening the library in 
microcolonies and add a sorting step to deplete library from constitutive-ON mutants was essential to 
reduce the number of false positives and increase the efficiency of the screening strategy. 
Six mutants (DT001, DT002, DT011, DT013, DT015 and DT016) with up to 1.5-fold induction 
with 13CHD were finally isolated from this procedure. These mutants lost completely the capacity to 
bind ribose. Isothermal microcalorimetry confirmed in vitro 13CHD binding by mutants DT002 and 
DT016, with estimated KD of 190 µM and 5 µM, respectively. This is indicative of poor binding, 




However, it was the first time of isolating genuine periplasmic binding protein (PBP) variants with 
affinity towards a non-natural compound. The other four purified mutants did not show any 13CHD 
binding in isothermal microcalorimetry, likely because they suffered from poor stability and/or 
unfolded even during purification. These results were in agreement with other studies showing that 
computationally designed PBP variants yield misfolded and/or instable proteins [3, 4]. This notion was 
further supported by thermal denaturation data showing that DT002 and DT016 were indeed much 
less stable than wild-type RbsB. Moreover, inclusion of 13CHD did not stabilize the mutant proteins 
like is the case of wild-type RbsB in presence of ribose. Further evidence for instability and misfolding 
of DT mutant proteins was the observation of co-purified chaperones. Circular dichroism and mass 
spectra analysis showed clear secondary structure differences and lower periplasmic abundance of DT 
mutants in comparation to wild-type RbsB. We concluded that the introduced mutations in the RbsB 
binding pocket indeed changed the binding specificity from ribose to 13CHD, but severely impaired 
their secondary structure, stability and translocation process. If we assume that the displayed GFP 
induction is the result of the complete chain of true ligand-binding affinity, periplasmic abundance and 
proper folding, the actual gain of 13CHD binding might have been higher than the induction of 1.5 
suggested. 
 
Despite the frustration resulting from independent unsuccessful reproduction [1, 3] of the initial 
studies from Hellinga’s group suggesting easy and expandable ligand binding pocket design in PBPs [5], 
we could thus demonstrate that de novo design of PBPs for a non-natural molecule is feasible. Design 
of PBP variants with de novo binding specificities thus remains very challenging, and, likely, 
computational simulations are not accurate enough [6, 7] to properly predict the intrinsic dynamics and 
conformational changes caused by the interaction with the ligand [8, 9], and primarily by introduced 
mutations. The resulting designed PBP variants are thus impaired in stability and overall function. As a 
consequence of this, most recent studies on PBPs have exploited their natural ligand binding properties 
and used mutagenesis techniques to reduce or increase binding specificity [10, 11] or to graft binding-
pockets between closely related PBPs [4, 12], without new attempts for de novo ligand binding design. 
However, we clearly (and for the first time) demonstrated that a combination of rational design and 
efficient screening allowed to isolate RbsB variants with recognition of a non-natural compound (i.e., 







In the second part of my thesis the goal was to improve the binding capacity and/or solve 
stability issues of the six isolated mutants with 13CHD-binding capacity. These mutants were used as 
a scaffold to produce several new mutant libraries based on random mutagenesis, site saturation or 
DNA shuffling approaches. Libraries were cloned in an E. coli strain carrying the bioreporter system 
and screened for improved induction of GFPmut2 reporter fluorescence in presence of 13CHD [13]. In 
contrast to our expectations, none of the semi-random approaches, DNA shuffling and random 
mutation of the 32 residues flanking the 9 substitutions engineered for 13CHD-binding, yielded 
improved variants. Probably because introducing multiple mutations (in multiple parts of the protein) 
increased the chance for further functional degeneration, despite a probability to improved binding 
capacity. This thus creates an important trade-off. I focused specifically on two residues (R141 and 
D215) that were later shown to be important for ribose induction and signaling [14] and for ligand 
binding (D215) [15]. However, also site saturation mutagenesis of both residues in DT002 and DT016 
mutants could not improve the GFP mut2 induction of 1.5 times in presence of 13CHD. In fact, all 
substitutions reduced or abolished 13CHD induction, except for R141S in DT016. This showed that both 
R141 (or S141) and D215 are currently essential for 13CHD-induction in the DT002 and DT016 proteins. 
 
In contrast, the random mutagenesis approach across the complete gene variants led to 
isolation of seven mutants with significantly improved 13CHD inducibility (up to 3.2 times). I tried to 
use two different selection and sorting strategies that were less and more restrictive to separate 
potential mutant microcolonies in FACS. My results suggested that being more restrictive to the upper 
outlier fluorescence response is a better strategy, because it involves fewer rounds of mutagenesis 
and less variants are recovered, reducing significantly the time to screen individual mutants. Although 
we acknowledge that by selection and sorting of high fluorescence outlier variants we are missing 
those, which have low fluorescence background under uninduced conditions and intermediate 
fluorescence upon induction, this is again a trade-off between screening time and chance to find better 
mutants. It is, however, difficult to predict a priori the evolutionary path of a variant to its final aspired 
success (e.g., high induction, low nM binding affinity) [16]. Recent work on protein evolution showed 
that a strong and restrictive screening is extremely important to improve a desire protein property, 
and not allow the possibility to accumulate neutral and deleterious mutations [17]. 
 
Interestingly, all observed mutations in variants recovered from directed evolution, except 
one, were located outside the direct ligand-binding pocket, suggesting they were compensatory and 
helping protein folding or functional behaviour other than interaction with 13CHD ligand. Two 




hypothesis is that these mutations had a positive effect on peptide recognition by the SecB chaperone, 
resulting in a higher periplasmic presence and/or improved stability of these variants. All other 
mutations were found outside the binding cavity, and we assume that they must have improved other 
aspects of protein functionality than ligand binding itself. This could affect, for example, protein 
stability or improved hinge flexibility, or binding to the chemoreceptor Trz1. Only variant DT022 
displayed a mutation (G89V) in the binding pocket. Structure threading indicated this residue to be 
less than 2 Å away from inferred position of 13CHD and we must assume that the exposed valine is 
beneficial for 13CHD-binding. Previous studies demonstrated the importance of residue 89 for ligand 
binding [13-15]. Of note, that these interpretations were based on inferred structures of variants 
(threaded on the crystal structure of wild-type RbsB) and the real effect of introduced mutations may 
have been underestimated. Phyre2 and Swiss-Model also did not predict any structural differences 
caused by introduced mutations in DT002 and DT016. However, in vitro characterization showed that 
these variants have significant secondary structure differences when compared with wild-type RbsB 
[13]. 
Some mutants seemed to be blocked in open and closed state simultaneously, possibly 
impairing their dynamic transition between open and closed conformation. Similar results have been 
observed in transcription factors with allosteric behaviour [18]. The effect of this was that populations 
carrying these variants in the bioreporter systems caused ‘stable’ double populations with different 
GFPmut2 fluorescence intensities both in absence or in presence of inducer. This suggests that the 
time-scale of the dynamics is affected by the introduced mutations, blocking the DT variants in either 
open or closed form long enough to trigger (or not) the bioreporter signaling cascade leading to GFP 
expression. A small percentage of the low fluorescence population shifts to high fluorescence upon 
induction, indicating that ligand-binding is still affecting the transition states, but is insufficiently 
discriminating between the two. This suggested that only a small percentage of the population is still 
active and able to bind the ligand, changing the conformation and triggering the bioreporter cascade. 
 
The second part of my thesis thus demonstrated that it is possible to improve binding capacity 
and solve stability issues of variants with de novo recognition specificities using a combination of 
random mutagenesis and restrictive screening. Improved variants displayed a dose-dependent 
induction in presence of 13CHD, with a maximal induction of 3 times and 0.25 mM of lower detection 
limit. Despite the clear improvement, the affinity of these variants is not yet comparable to wild-type 
RbsB towards ribose (i.e., 13-fold induction and 50 nM detection limit) [1, 13]. Of note that our 
mutagenesis was extremely laborious and time consuming, and did not allow to isolate a variant with 




GFPmut2 expression as the final step of the signaling cascade, other variants with improved 
translocation, binding capacity and stabilization of the closed conformation, but unable to interact and 
bind Trz1 would be ignored.  
 
Finally in the third part of my thesis, I screened the differences in subcellular localisation of 
RbsB and DT variant proteins, in order to understand their different behaviour. I was also interested 
to see if subcellular variations could be developed into an in vivo screening system for variants with 
potentially improved folding, translocation and receptor interactions. Wild-type- and mutant-DT 
proteins were translationally fused to mCherry, as a fluorescent reporter for their abundance and 
subcellular localization. Despite a small loss of function by carrying the mCherry tag, my results showed 
that wild-type RbsB-mCherry protein clearly localized to the periplasmic space and centered in polar 
regions. This may be indicative for its propensity to react to the available chemoreceptors. In contrast 
to wild-type RbsB, DT-mCherry expression resulted in high proportions of cells devoid of clear foci and 
low proportions with multiple fluorescent foci, confirming the previously obtained in vitro poorer 
folding, and the observed poorer translocation. In addition, polar foci in cell expressing some DT-
mutant-mCherry were less fluorescent, suggesting poorer chemoreceptor binding. This was 
particularly clear for DT002 and is thus in agreement with previous periplasmic space mass spectra 
analysis that showed that wild-type RbsB is more abundant than DT002 [13]. The four other expressed 
mutant-RbsB-mCherry yielded more consistent polar periplasmic foci in cells than DT002-mCherry, 
although also in these cases the overall proportion of cells without foci was increased compared to 
wild-type RbsB-mCherry, their polar foci were less intense and more frequently side foci appeared. Of 
the various mutants, the DT021- and DT022-mCherry proteins behaved most similar as wild-type in 
their foci distribution pattern, but still tended to be poorer located at the polar regions, which might 
thus partly explain their observed lower in vivo signal transduction capacity through the Trz1 receptor. 
However, this showed that our random mutagenesis approach improved not only the binding capacity, 
but also the signaling behaviour of DT021 and DT022 (in comparison with their parent DT016).  
Microscopy analysis of individual cells expressing random mutagenesis libraries based on 
DT016, DT021 and DT022 fused to mCherry indeed showed a large proportion of cells without any 
visible periplasmic mCherry signal nor polar localized foci. This confirmed that a majority of introduced 
mutations lead to RbsB mistranslocation and/or poorer receptor interaction. Based on cells expressing 
wild-type RbsB-mCherry I tried to estimate the percentage of cells in the libraries with potentially 
improved variants having proper expression, translocation and signaling transduction.  
The screening approach can thus reveal if PBP variants are impaired in some other part of the 




bioreporter (ligand binding) system. The in vivo system is sensitive enough to detect potential 
improvements of secondary mutations introduced into RbsB-variants by typical random library 
screening and may be helpful to find protein variants with improved signaling capacity. 
 
In conclusion, my work showed the importance of combining computational ligand-binding 
pocket design and further directed evolution approaches. I have no doubt that a successful design of 
PBP variants for detection of non-natural compounds is dependent on both methods. Completely 
random and even semi-random approaches, however, are very time consuming and still a matter of 
‘’trial and error’’. Computational algorithms can drastically reduce the ‘’sampling pool’’ size, however, 
they have to improve and take in consideration other aspects of PBP behaviour (not only binding). For 
example, proper translocation, folding, dynamic transition between open and closed state and 
receptor interaction are aspects as important as binding capacity in order to design a function receptor 
protein. 
Another challenge encountered during this work was the fact that the structures of isolated 
mutants with 13CHD binding capacity were not available. It would have been important to better 
interpret the effect of selected amino acid substitutions on protein functionality, but doing so based 
on inferred structures is risky and imprecise. However, solving the crystal structure of an unstable 
protein is not possible, since it is unlikely to crystalize properly in its active form. Moreover, until very 
recently it was impossible to correctly predict protein structure based on the amino acid sequence. 
This may soon change, however, with further improvements on de novo structure predictions, such as 
AlphaFold [19] (an artificial intelligence-based software), which has shown considerable success in 
determining protein structures from amino acid sequences alone. AlphaFold achieved a median score 
of 92.4 GDT (global distance test) in the 14th Critical Assessment of protein Structure Prediction (CASP). 
Hopefully soon this will become available to the scientific community and the combination of modeling 
programs and further improvement of machine learning [20, 21], will be a tremendous advance in de 
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